Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3027135	s-igg1	g/l (g/l)	3427	4683	0.00%
3027135	s-igg1	— (—)	1518	2043	100.00%	Distribution not available
3027135	s-immunoglobuliinig,alaluokka1	g/l (g/l)	117	154	0.00%
3027135	s-igg1	g/l_______ (g/l)	67	75	0.00%
3027135	s-igg1	G/L (g/l)	22	43	0.00%
3027135	s-igg1	g/L (g/l)	20	25	0.00%
3027135	immunoglobuliinig1	g/l_______ (g/l)	17	17	0.00%	Distribution not available
3027135	s-immunoglobuliinig,alaluokka1	g/l_______ (g/l)	16	17	0.00%
3027135	immunoglobuliinig1	g/l (g/l)	11	13	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other systemic involvement of connective tissue (FG)

566

938

6.14

317.73

1.8

1.3

7.31

6.66

g/l

1.96

422

661

All pneumoniae

1627

3192

3.37

307.65

1.4

6.67

6.71

g/l

0.14

1218

2258

Acute pancreatitis

585

699

8.85

307.65

1.6

1.3

6.06

6.96

g/l

5.23

297

516

Immunodeficiencies

404

174

29.10

307.65

2.0

1.3

5.01

6.95

g/l

6.80

329

130

L04AX Other immunosuppressants

1041

2782

3.83

307.65

1.6

1.3

6.98

6.65

g/l

1.43

757

2024

Undetermined asthma

374

253

15.57

307.65

1.7

1.2

6.12

7.10

g/l

2.30

289

172

Asthma

1398

1049

7.03

307.65

1.5

1.3

6.32

7.05

g/l

5.88

1056

682

Chronic sinusitis

920

1782

5.32

307.65

1.6

1.4

6.25

7.08

g/l

7.93

735

1230

Asthma (only as main-diagnosis)

1431

1049

7.83

307.65

1.5

1.3

6.25

7.05

g/l

6.86

1082

682

Asthma, unspecified (mode), excluding more controls

909

935

7.12

307.65

1.5

1.3

6.37

7.04

g/l

4.19

648

616

Second line medication for Crohn's disease

1069

2861

3.82

307.65

1.7

1.3

7.01

6.64

g/l

1.68

774

2081

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1212

2542

4.25

307.65

1.5

1.4

7.04

6.68

g/l

1.92

875

1837

ILD medications: immunosuppressive drugs

1302

1894

6.40

307.65

1.6

1.2

6.92

6.82

g/l

0.32

946

1317

1110

1952

5.85

307.65

1.5

1.3

6.19

6.89

g/l

7.72

865

1398

Bronchiectasis

328

198

18.27

307.65

1.5

1.3

7.08

7.18

g/l

0.10

258

147

Fever of other and unknown origin

1086

1999

4.82

307.65

1.4

1.3

6.71

6.79

g/l

0.20

791

1433

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1587

3219

3.34

307.65

1.4

6.68

6.71

g/l

0.08

1192

2277

Asthma, including avohilmo

1730

3116

3.10

307.65

1.5

1.3

6.33

6.97

g/l

9.33

1310

2178

Inflammatory bowel disease treatment related agents

2259

2290

5.61

307.65

1.5

1.2

6.63

6.85

g/l

1.31

1662

1599

Asthma, excluding more controls

1360

991

7.21

307.65

1.5

1.3

6.33

7.00

g/l

5.06

1025

645

ILD medications: prednisolone, methylprednisolone, prednisone

2166

1994

6.19

307.65

1.5

1.2

6.60

6.86

g/l

1.68

1596

1386

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

342

136

18.67

307.65

1.5

1.2

7.44

6.88

g/l

0.91

242

Pneumonia, organism unspecified

1501

2936

3.57

307.65

1.4

6.69

6.72

g/l

0.09

1124

2071

Systemic connective tissue disorders

806

1518

5.51

307.65

1.7

1.3

7.03

6.59

g/l

1.70

596

1089

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1464

2001

4.36

307.65

1.4

6.66

6.95

g/l

1.46

1100

1373

Asthma (only as main-diagnosis), excluding more controls

1407

991

8.06

307.65

1.5

1.3

6.24

7.00

g/l

6.35

1068

645

1464

2001

4.36

307.65

1.4

6.66

6.95

g/l

1.46

1100

1373

Acute pancreatitis (for exclusion)

585

805

7.67

307.65

1.6

1.3

6.06

6.82

g/l

4.06

297

599

Asthma (diagnoses ohter than nonallergic)

1609

3330

3.99

307.65

1.5

1.3

6.27

6.93

g/l

10.46

1213

2368

Asthma, hospital admissions 3, pneumonia

838

1402

6.17

307.65

1.5

1.3

6.28

7.04

g/l

5.69

645

990

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1622

3148

3.54

307.65

1.6

1.3

6.56

6.78

g/l

1.06

1185

2276

ILD medications

2168

2038

5.87

307.65

1.5

1.2

6.63

6.84

g/l

1.15

1594

1418

Chronic lower respiratory diseases

1825

2930

3.33

307.65

1.5

1.3

6.45

6.90

g/l

4.69

1375

2045

Asthma-related infections

1339

2546

5.28

307.65

1.5

1.3

6.20

6.96

g/l

10.20

1031

1806

Asthma, hospital admissions , main diagnosis only

1512

3390

3.96

307.65

1.5

1.3

6.25

6.92

g/l

10.45

1145

2393

Influenza and pneumonia

1673

3106

3.38

307.65

1.4

6.64

6.72

g/l

0.31

1256

2194

Asthma (mode)

1354

1055

6.90

307.65

1.5

1.3

6.26

7.05

g/l

6.82

1024

686

Asthma, hospital admission 2, infections

1339

2546

5.28

307.65

1.5

1.3

6.20

6.96

g/l

10.20

1031

1806

Pneumonias (Asthma/COPD co-morbidities)

1623

3192

3.38

307.65

1.4

6.68

6.70

g/l

0.05

1215

2262

Oral corticosteroids

2249

2189

6.19

307.65

1.6

1.2

6.58

6.87

g/l

1.96

1658

1523

Undetermined asthma, excluding more controls

374

251

15.69

307.65

1.7

1.2

6.12

7.09

g/l

2.29

289

169

Abnormal findings on diagnostic imaging of lung

923

1795

5.01

307.65

1.4

7.04

6.77

g/l

0.99

689

1281

Asthma-related pneumonia or sepsis

838

1402

6.17

307.65

1.5

1.3

6.28

7.04

g/l

5.69

645

990

Immunodeficiency with predominantly antibody defects

317

49.88

307.65

2.2

1.3

4.90

7.09

g/l

4.11

266

Asthma-related pneumonia

837

1399

6.18

307.65

1.5

1.3

6.28

7.04

g/l

5.74

645

988

Asthma, unspecified (mode)

919

990

6.85

307.65

1.5

1.3

6.38

7.09

g/l

4.47

653

650

Asthma/COPD (KELA code 203)

1476

2921

3.43

307.65

1.5

1.3

6.19

6.90

g/l

11.07

1130

2039

Certain disorders involving the immune mechanism

676

817

8.88

307.65

1.9

1.3

5.68

6.79

g/l

8.84

513

581

First line medication for Crohn's disease

2011

2035

5.43

307.65

1.5

1.2

6.67

6.86

g/l

0.98

1474

1423

Autoimmune diseases related-to ILD

1291

3402

3.22

305.40

1.4

7.08

6.53

g/l

4.12

912

2470

Asthma and opportunity respiratory infection

234

123

21.67

304.52

1.5

1.3

6.71

7.09

g/l

0.36

183

Cough

719

1467

4.68

296.05

1.5

1.4

6.48

6.95

g/l

2.27

560

1031

Other systemic involvement of connective tissue

582

1114

5.41

287.73

1.9

1.3

7.27

6.53

g/l

2.76

434

800

Other pulmonary diagnosis

933

1060

4.47

286.93

1.4

1.3

6.58

7.04

g/l

2.15

683

690

Abnormalities of breathing

1266

2180

3.37

285.65

1.4

6.44

6.92

g/l

3.56

939

1512

Disorders of gallbladder, biliary tract and pancreas

1424

2969

3.03

279.46

1.5

1.4

6.61

6.78

g/l

0.75

904

2267

Non-allergic asthma (mode), excluding more controls

343

379

9.24

279.12

1.6

1.2

6.33

7.27

g/l

3.08

268

256

Allergic asthma (mode), excluding more controls

398

518

7.69

277.58

1.5

1.3

6.15

7.08

g/l

4.47

332

341

Acute sinusitis

911

2256

3.75

277.50

1.5

1.4

6.23

6.92

g/l

6.65

709

1573

Other respiratory diseases principally affecting the interstitium

428

630

7.11

277.41

1.4

1.3

7.26

6.88

g/l

0.73

298

451

Excluding asthma or asthma-COPD overlap

912

1060

4.37

273.38

1.4

1.3

6.61

7.04

g/l

1.86

664

690

Allergic asthma (mode)

398

528

7.54

273.03

1.5

1.3

6.15

7.12

g/l

4.59

332

348

Non-allergic asthma (mode)

343

391

8.95

272.43

1.6

1.2

6.33

7.35

g/l

3.42

268

267

COPD differential diagnosis

907

1056

4.36

271.39

1.4

1.3

6.61

7.05

g/l

1.95

660

686

ILD, hospital admission 2, with pulmonary infections

275

237

12.29

271.09

1.4

7.37

6.89

g/l

0.60

195

166

ILD differential diagnosis

905

1055

4.35

270.37

1.4

1.3

6.59

7.05

g/l

2.10

659

686

COPD/asthma related infections

1297

2001

3.29

268.91

1.4

6.57

6.95

g/l

2.24

968

1373

COPD/asthma/ILD related infections

1297

2001

3.29

268.91

1.4

6.57

6.95

g/l

2.24

968

1373

Other and unspecified immunodeficiencies with predominantly antibody defects

160

54.85

268.15

2.2

1.3

4.43

6.41

g/l

5.06

137

Other interstitial pulmonary diseases

383

520

7.74

267.39

1.4

1.3

7.50

6.68

g/l

2.15

266

376

Interstitial lung disease endpoints

383

525

7.66

265.14

1.4

1.3

7.50

6.67

g/l

2.22

266

378

Interstitial lung disease

383

525

7.66

265.14

1.4

1.3

7.50

6.67

g/l

2.22

266

378

ILD medications: azathioprine

342

414

8.62

262.70

1.8

1.2

7.16

6.85

g/l

0.54

258

297

ILD, hospital admissions

379

519

7.68

262.64

1.4

1.3

7.47

6.64

g/l

2.22

263

373

Obesity related asthma

629

1449

4.46

248.52

1.4

1.3

6.17

6.92

g/l

5.58

463

1025

Reimbursement for rheumatic diseases

923

2766

3.38

246.77

1.5

1.4

7.03

6.70

g/l

1.40

674

2009

1446

2563

2.89

245.97

1.5

1.4

6.46

7.03

g/l

5.42

1090

1775

Azathioprine

342

449

7.94

245.45

1.8

1.2

7.16

6.68

g/l

1.00

258

320

Any gastric operation

956

1274

3.81

243.39

1.4

1.3

6.58

6.74

g/l

0.52

652

1047

GASTRO-related operations

956

1274

3.81

243.39

1.4

1.3

6.58

6.74

g/l

0.52

652

1047

ILD, hospital admissions 3, with pneumonia sepsis

243

208

12.41

240.75

1.3

1.4

7.43

6.83

g/l

0.71

170

152

Bacterial pneumonia (organism specified)

712

1641

4.01

238.54

1.4

6.56

6.82

g/l

0.76

522

1168

ILD, hospital admissions 1, main diag only

340

465

7.69

235.99

1.4

1.3

7.52

6.73

g/l

1.82

239

332

Bacterial pneumoniae

645

1353

4.27

232.88

1.4

6.58

6.80

g/l

0.58

481

950

Chronic rhinitis, nasopharyngitis and pharyngitis

587

1349

4.46

232.48

1.5

1.4

6.34

7.12

g/l

5.55

480

940

Autoimmune diseases excluding thyroid diseases

1395

2724

2.81

230.68

1.4

7.01

6.48

g/l

3.96

1009

1967

General symptoms and signs

1338

2354

2.88

225.02

1.5

1.3

6.73

g/l

0.02

974

1672

Autoimmune diseases excluding thyroid diseases, strict definition

1342

2631

2.81

222.04

1.4

7.03

6.50

g/l

3.91

977

1910

Bacterial pneumonia, not elsewhere classified

600

1256

4.28

217.31

1.4

6.57

6.79

g/l

0.55

446

878

Dyspnoea

1239

3308

2.74

213.09

1.4

6.45

6.81

g/l

2.47

910

2395

Other acute lower respiratory infections

844

2537

3.22

207.12

1.5

1.4

6.41

6.81

g/l

2.16

643

1814

Bronchitis

1422

3364

2.56

204.72

1.4

6.48

6.85

g/l

2.84

1072

2371

Nonhereditary hypogammaglobulinemia

123

49.67

203.06

2.3

1.4

4.20

6.56

g/l

5.03

Chronic pancreatitis

295

411

7.52

201.31

2.0

1.2

6.30

6.89

g/l

1.75

165

312

Symptoms and signs involving the circulatory and respiratory systems

1215

2182

2.82

197.39

1.4

6.59

6.92

g/l

1.96

890

1512

Asthma and allergy, excluding more controls

246

284

8.81

192.72

1.5

1.4

6.13

7.00

g/l

2.69

210

191

Acute upper respiratory infections

1308

3075

2.58

190.34

1.5

1.4

6.36

6.96

g/l

6.44

995

2153

Asthma and allergy

246

289

8.66

189.97

1.5

1.4

6.13

7.07

g/l

2.93

210

192

Bacterial infection, other or unspecified

763

2007

3.26

185.09

1.4

6.88

6.73

g/l

0.38

556

1448

Pain in joint

772

1405

3.42

183.33

1.4

6.56

6.94

g/l

1.49

582

984

Bacterial infection, other or unspecified, including avohilmo

816

2190

3.10

180.91

1.4

6.87

6.70

g/l

0.46

601

1577

Kela reimbursement Agammaglobulinemia (D80-84)

106

57.53

180.53

2.2

1.4

4.43

7.00

g/l

3.57

Other bacterial diseases

1228

3226

2.55

179.97

1.4

6.86

6.68

g/l

0.64

897

2318

Anaemias

395

441

5.88

179.36

1.4

1.3

7.02

6.74

g/l

0.55

282

328

Examination and observation for other reasons

771

1301

3.39

175.11

1.5

1.3

6.35

6.92

g/l

3.06

658

801

Acute bronchitis

644

1883

3.42

174.94

1.5

1.4

6.37

6.79

g/l

1.81

491

1349

Other diseases of biliary tract

218

251

9.14

174.73

2.2

1.3

7.04

6.77

g/l

0.38

134

187

Tramadol

996

2141

2.83

172.96

1.4

6.49

6.89

g/l

2.24

732

1529

Other diseases of pleura

628

1591

3.49

170.91

1.5

1.4

6.74

6.90

g/l

0.43

442

1134

Suggestive for eosinophilic asthma

234

306

8.06

169.05

1.9

1.3

6.23

6.98

g/l

2.06

194

218

Acute upper respiratory infections of multiple and unspecified sites

995

2723

2.70

167.17

1.4

1.3

6.33

6.95

g/l

5.69

756

1911

Other bacterial diseases, including avohilmo

1273

3319

2.42

164.78

1.4

6.84

6.65

g/l

0.75

937

2378

Diseases of the respiratory system

654

881

3.76

164.13

1.4

1.3

6.51

7.15

g/l

2.86

474

573

Autoimmune diseases

1307

2737

2.45

163.16

1.4

7.08

6.48

g/l

4.66

943

1976

Used for control exclusion in common control thyroid runs

1225

2468

2.53

162.88

1.4

6.99

6.50

g/l

3.13

859

1803

Enlarged lymph nodes

314

577

5.62

162.51

1.6

1.3

7.29

6.56

g/l

1.63

231

423

Cholangitis (primary sclerosing, PSC)

178

175

10.81

160.77

2.0

1.2

7.67

6.83

g/l

1.47

106

135

Diseases of oesophagus, stomach and duodenum

1304

3284

2.37

158.77

1.4

6.57

6.79

g/l

1.15

952

2358

Headache

813

2214

2.87

155.84

1.5

1.3

6.37

6.74

g/l

2.13

624

1580

FESS (DNB20)

302

559

5.65

155.71

1.8

1.4

6.36

6.72

g/l

0.88

234

403

Ethmoidectomy

307

578

5.55

155.32

1.8

1.3

6.37

6.74

g/l

0.96

238

416

Pain in throat and chest

957

2121

2.70

151.92

1.4

6.41

6.93

g/l

4.11

721

1467

Other necrotizing vasculopathies

191

223

9.09

151.73

1.4

6.10

6.87

g/l

1.45

139

173

Other specified/unspecified systemic involvement of connective tissue

178

192

9.94

150.60

2.5

1.4

7.38

6.67

g/l

0.83

145

144

Abnormal findings on examination of blood, without diagnosis

661

1967

3.09

149.70

1.6

1.4

7.28

6.77

g/l

1.97

469

1412

Other diseases of upper respiratory tract

1220

2677

2.40

147.10

1.4

6.34

7.03

g/l

8.03

919

1838

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

671

2194

2.99

146.00

1.5

1.4

6.27

7.05

g/l

7.33

480

1511

Other necrotizing vasculopathies (FG)

164

166

10.49

145.11

1.5

1.3

6.19

7.01

g/l

1.20

119

125

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

190

233

8.58

144.85

1.7

1.4

8.13

6.80

g/l

1.96

124

169

Diseases of liver

535

1610

3.39

144.25

1.3

1.4

7.84

6.62

g/l

6.32

365

1176

Early onset COPD, excluding more controls

246

400

6.27

143.98

1.6

1.3

6.32

7.27

g/l

2.48

180

272

Finngen Rheumatological endpoints

1128

2682

2.41

141.29

1.5

1.3

6.94

6.63

g/l

1.55

819

1893

Any reimbursement code in KELA

650

982

3.35

139.50

1.4

1.3

6.48

6.88

g/l

1.63

479

718

Bacterial Sepsis

624

1686

3.11

139.38

1.4

6.88

6.76

g/l

0.22

443

1212

Other specific joint derangements/joint disorders

935

2294

2.57

136.98

1.4

6.54

6.77

g/l

0.96

698

1636

Vasomotor and allergic rhinitis

524

1571

3.31

135.83

1.5

1.4

6.37

7.02

g/l

4.12

433

1075

Polyarthropathies

841

2035

2.69

135.49

1.4

6.88

6.82

g/l

0.14

627

1452

Other diseases of pancreas

186

242

8.05

134.85

1.7

1.2

6.52

6.76

g/l

0.28

103

182

Septicaemia

556

1611

3.20

133.61

1.4

7.02

6.74

g/l

0.59

386

1169

L04AA Selective immunosuppressants

406

1080

3.87

132.42

1.5

1.3

6.53

6.57

g/l

0.08

305

771

Gastrointestinal diseases

626

961

3.30

131.22

1.4

1.3

6.57

6.69

g/l

0.32

446

737

Other soft tissue disorders, not elsewhere classified

1105

2703

2.35

130.89

1.4

6.45

6.92

g/l

3.83

828

1912

Codeine

1040

2344

2.42

129.63

1.4

6.47

6.87

g/l

2.77

743

1677

Explicit Sepsis

583

1804

2.99

124.92

1.4

7.03

6.72

g/l

0.73

408

1306

Opioids

1077

2384

2.35

124.82

1.4

6.60

6.87

g/l

1.28

770

1706

Explicit Sepsis, including avohilmo

595

1855

2.95

124.59

1.4

7.03

6.73

g/l

0.70

419

1341

Malaise and fatigue

604

1625

2.96

123.16

1.4

1.3

6.58

6.84

g/l

0.73

436

1172

Other immunodeficiencies

28.09

121.38

2.4

1.3

5.29

6.61

g/l

1.90

Implicit bacterial Sepsis

527

1461

3.14

121.13

1.5

1.4

6.60

6.81

g/l

0.47

378

1049

Infections, IBD-co-morbidities

226

242

6.70

121.11

1.5

1.2

6.79

6.72

g/l

0.07

162

169

Primary Sclerosing Cholangitis, IBD and UDCA required

101

17.96

120.84

1.5

1.3

8.63

6.78

g/l

2.56

Gastro-oesophageal reflux disease

827

2868

2.46

119.70

1.4

6.37

6.80

g/l

2.61

590

2071

Implicit viral Sepsis, including avohilmo

436

1304

3.40

118.22

1.4

6.44

6.73

g/l

0.72

323

951

Medical observation and evaluation for suspected diseases and conditions

714

1301

2.83

118.21

1.5

1.3

6.81

6.92

g/l

0.26

554

801

Other septicaemia, including avohilmo

493

1482

3.17

117.90

1.5

1.4

6.83

6.76

g/l

0.10

350

1069

Dermatitis

791

3190

2.45

117.47

1.5

1.4

6.78

6.75

g/l

0.07

588

2301

Implicit bacterial Sepsis, including avohilmo

566

1613

2.96

116.79

1.4

6.66

6.80

g/l

0.31

411

1159

Other septicaemia

482

1450

3.18

116.17

1.5

1.4

6.77

6.73

g/l

0.06

341

1045

Symptoms and signs involving the digestive system and abdomen

1062

2333

2.30

116.09

1.4

6.57

6.87

g/l

1.49

736

1716

Abdominal and pelvic pain

1059

2333

2.30

115.63

1.5

1.4

6.49

6.87

g/l

2.31

735

1716

Certain infectious and parasitic diseases

1033

2247

2.32

115.31

1.4

6.78

6.66

g/l

0.42

746

1589

Other and unspecified dermatitis

688

2694

2.59

114.76

1.6

1.4

6.81

6.79

g/l

0.05

516

1954

Sicca syndrome [Sjögren]

189

305

6.49

112.51

1.6

1.4

8.56

6.79

g/l

2.77

129

228

Implicit Sepsis

883

2797

2.35

112.19

1.4

6.64

6.70

g/l

0.14

625

2031

Low back pain

899

2609

2.35

111.78

1.5

1.4

6.39

6.93

g/l

3.86

663

1843

Other diseases of intestines

1203

3192

2.12

111.34

1.4

6.50

6.77

g/l

1.51

877

2289

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

335

357

4.75

110.98

1.3

6.35

6.67

g/l

0.67

241

247

Vocal cord dysfunction

200

290

6.20

110.20

1.6

1.2

6.36

6.82

g/l

0.86

140

205

Viral Sepsis

328

863

3.89

108.55

1.5

1.4

6.35

6.68

g/l

0.65

246

639

Implicit viral Sepsis

327

860

3.89

108.28

1.5

1.4

6.35

6.68

g/l

0.65

245

637

Nasal polyp

293

712

4.22

108.26

1.7

1.3

6.30

7.28

g/l

4.26

253

491

Haemorrhage from respiratory passages

400

1053

3.41

106.20

1.4

6.60

7.00

g/l

1.06

281

727

Noninfective enteritis and colitis

627

2451

2.59

104.78

1.4

6.89

6.69

g/l

0.53

439

1792

Primary_lymphoid and hematopoietic malignant neoplasms

351

997

3.60

103.81

1.4

6.95

6.77

g/l

0.19

257

708

Pain, not elsewhere classified

359

1073

3.40

97.85

1.7

1.3

6.31

6.80

g/l

1.80

296

774

Disorders of other endocrine glands

586

2256

2.59

97.80

1.5

1.4

6.35

6.73

g/l

1.54

354

1665

Cholelithiasis, broad definition with cholecystitis

895

2714

2.21

96.92

1.5

1.4

6.70

6.81

g/l

0.32

599

2080

Exclusions for E4_PCOS_BROAD

315

873

3.71

96.80

1.6

1.4

6.09

6.69

g/l

1.84

167

648

Other disorders of adrenal gland

135

179

8.04

96.80

1.8

1.3

6.05

7.01

g/l

1.35

137

All influenza

344

1011

3.46

96.32

1.5

1.4

6.54

6.70

g/l

0.30

259

721

Codeine or tramadol medication

1202

3278

2.01

96.26

1.4

6.49

6.84

g/l

2.41

858

2347

Other diseases of blood and blood-forming organs, wide

345

1020

3.46

96.05

1.4

7.13

6.72

g/l

0.65

237

733

Adrenocortical insufficiency

120

140

9.24

95.80

1.8

1.3

6.13

7.12

g/l

1.15

109

Disorders of lacrimal system

568

2175

2.61

95.74

1.5

1.4

6.61

6.78

g/l

0.43

416

1563

Dorsalgia

1057

2688

2.10

94.74

1.5

1.4

6.35

6.92

g/l

5.21

780

1900

Idiopathic pulmonary fibrosis

141

201

7.29

94.27

1.5

1.2

7.71

6.83

g/l

1.24

100

149

Diagnoses used for exclusion with ILD

358

1095

3.33

94.24

1.4

6.91

6.87

g/l

0.06

245

795

Pain in limb

900

2634

2.19

93.89

1.4

6.45

6.93

g/l

3.49

672

1865

Liquid cancers

396

1212

3.15

93.64

1.4

6.97

6.81

g/l

0.18

287

872

Implicit Sepsis, including avohilmo

906

3028

2.16

93.54

1.4

6.62

6.72

g/l

0.29

636

2213

Provisional assignment of new diseases of uncertain etiology

660

2767

2.39

93.17

1.5

1.4

6.21

6.85

g/l

4.72

503

1979

Codes for special purposes

660

2770

2.39

92.92

1.5

1.4

6.21

6.84

g/l

4.68

503

1982

Drug-induced adrenocortical insufficiency

15.48

92.70

2.0

1.4

6.02

6.57

g/l

0.47

Budesonide

198

398

5.09

92.66

1.4

1.2

7.51

6.69

g/l

1.53

141

279

Other special examinations and investigations of persons without complaint or reported diagnosis

659

1301

2.59

92.50

1.4

1.3

6.79

6.92

g/l

0.32

488

801

Other heart diseases

579

1430

2.66

92.41

1.5

1.4

6.85

6.57

g/l

0.86

410

1049

Nausea and vomiting

348

1029

3.35

92.12

1.5

1.3

6.45

6.96

g/l

1.62

258

777

Eosinophilic disease (BM)

23.05

91.23

1.6

1.2

6.93

8.50

g/l

0.50

Other disorders of lacrimal gland

486

1803

2.74

90.70

1.6

1.4

6.47

6.71

g/l

0.65

356

1290

Unspecified acute lower respiratory infection

257

647

4.08

90.68

1.5

1.4

6.71

6.75

g/l

0.04

194

468

Covid-19 confirmed case

474

1735

2.77

90.46

1.6

1.4

6.09

6.89

g/l

4.46

336

1229

General examination and investigation of persons without complaint and reported diagnosis

641

1301

2.58

90.21

1.5

1.3

6.38

6.92

g/l

2.77

532

801

Cardiovascular diseases

705

1543

2.45

89.80

1.4

1.3

6.57

6.62

g/l

0.12

501

1146

Other arthritis (FG)

395

1317

3.05

89.79

1.5

1.3

6.65

6.69

g/l

0.07

288

938

Parasetamol

732

1542

2.42

89.72

1.4

1.3

6.65

7.09

g/l

1.92

528

1070

Dermatitis and eczema

1207

3719

1.94

89.32

1.5

1.4

6.71

g/l

0.01

890

2656

Oedema, not elsewhere classified

373

1181

3.13

88.38

1.6

1.3

6.71

6.77

g/l

0.10

285

848

Cholelithiasis

844

2669

2.18

88.34

1.4

6.68

6.82

g/l

0.39

561

2046

Heart failure, not strict

805

2458

2.22

88.21

1.5

1.4

6.76

6.71

g/l

0.11

583

1761

Respiratory disorders in diseases classified elsewhere

18.71

88.16

1.8

1.4

5.99

6.63

g/l

0.62

Other disorders of white blood cells

133

193

7.27

87.83

1.5

1.4

6.66

6.75

g/l

0.05

143

Pneumonia due to other infectious organisms, not elsewhere classified

11.02

87.75

1.4

1.3

6.54

6.92

g/l

0.18

Osteoporosis

336

938

3.35

87.43

1.6

1.4

6.36

6.90

g/l

1.68

237

673

Biological medicines for asthma

11.95

87.36

1.4

1.3

6.20

6.58

g/l

0.40

Other disorders involving the immune mechanism, not elsewhere classified

102

110

10.00

86.49

2.8

1.3

6.07

6.75

g/l

1.12

Irritable bowel syndrome

383

1284

3.03

86.32

1.6

1.4

6.11

6.74

g/l

3.79

287

929

Viral pneumonia

206

456

4.64

86.01

1.4

1.3

6.30

6.54

g/l

0.34

146

327

Lower back pain or/and sciatica

1156

3751

1.93

85.81

1.5

1.4

6.34

6.85

g/l

4.76

858

2665

Other heart diseases, wide

1019

3082

2.02

85.11

1.4

6.95

6.57

g/l

1.93

726

2240

Complications of surgical and medical care, not elsewhere classified

1072

3670

1.96

85.04

1.4

6.57

6.77

g/l

0.86

789

2637

Other diseases of the respiratory system

282

795

3.62

84.42

1.5

1.4

6.35

6.96

g/l

1.34

202

577

Other respiratory disorders and diseases

282

795

3.62

84.42

1.5

1.4

6.35

6.96

g/l

1.34

202

577

Cardiovascular diseases (excluding rheumatic etc)

732

1830

2.31

84.15

1.4

1.3

6.65

6.62

g/l

0.07

512

1348

Sulfasalazine

294

852

3.50

84.13

1.4

1.2

6.74

6.77

g/l

0.04

211

589

Oxycodone

441

1360

2.81

83.61

1.5

1.4

6.37

6.99

g/l

2.40

314

974

Pain (limb, back, neck, head abdominally)

688

1446

2.40

83.01

1.4

6.58

6.94

g/l

1.53

494

1013

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

962

3241

2.02

82.73

1.4

6.66

6.69

g/l

0.06

684

2346

Defects in the complement system

29.45

82.71

2.7

1.4

5.12

6.92

g/l

1.92

Disorders of eyelid, lacrimal system and orbit

944

3474

2.01

81.32

1.5

1.4

6.58

6.77

g/l

0.76

696

2516

Diseases of salivary glands

442

1656

2.71

81.03

1.5

1.4

6.95

6.67

g/l

0.63

322

1188

Condition for Implicit Sepsis (Organ dysfunction codes)

905

3100

2.04

80.37

1.4

6.66

6.69

g/l

0.09

634

2263

Autoimmune hepatitis, wide definition

108

138

8.22

79.68

1.4

9.92

6.70

g/l

4.98

103

Allergic rhinitis

436

1614

2.71

79.56

1.5

1.4

6.26

6.79

g/l

3.15

368

1137

Cholangitis (primary sclerosing, PSC), with reimbursement 202

12.88

79.52

2.1

1.3

8.73

6.41

g/l

2.97

Other specified/unspecified arthritis

351

1174

3.04

79.45

1.4

1.5

6.72

6.83

g/l

0.19

253

847

Other inflammatory liver diseases

139

234

6.20

79.38

1.3

1.4

9.24

6.48

g/l

5.19

173

COPD (mode)

244

479

4.01

79.29

1.3

1.2

6.80

7.20

g/l

0.69

176

318

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

100

10.01

79.02

2.9

1.3

6.07

6.85

g/l

1.23

Childhood asthma (age<16), excluding more controls

166

236

5.59

78.93

1.3

6.38

6.99

g/l

1.30

127

153

Candidiasis, including avohilmo

415

1528

2.76

78.73

1.4

6.49

6.77

g/l

0.74

315

1103

Dental caries

331

1010

3.14

78.27

1.5

1.3

6.87

6.74

g/l

0.20

249

706

Wegener granulomatosis

17.62

78.11

1.8

1.4

6.23

6.35

g/l

0.07

Hernia of abdominal wall, postoperative

192

429

4.51

78.09

1.5

1.3

6.35

6.84

g/l

1.27

138

367

Childhood asthma (age<16)

166

240

5.49

77.60

1.3

6.38

7.01

g/l

1.36

127

155

5-aminosalicylic acid

245

665

3.74

77.49

1.4

1.2

7.76

6.62

g/l

3.59

165

460

Disorders of thyroid, IBD co-morbidities

193

268

5.00

77.48

1.4

1.3

6.45

6.68

g/l

0.44

145

189

Simple and mucopurulent chronic bronchitis

9.91

77.08

1.3

6.32

7.28

g/l

0.87

13.82

76.75

1.5

1.3

7.12

7.03

g/l

0.05

Intestinal infectious diseases

1018

3987

1.91

76.60

1.5

1.4

6.66

6.72

g/l

0.19

741

2872

Osteopathies and chondropathies

646

2681

2.23

75.98

1.5

1.4

6.41

6.83

g/l

1.68

460

1947

Spondylopathies

787

2199

2.13

75.79

1.4

6.37

6.98

g/l

4.19

559

1545

Neurological diseases, wide definition

310

430

3.66

75.57

1.4

1.2

6.44

6.64

g/l

0.36

221

305

COPD

419

1252

2.75

75.57

1.4

1.3

6.73

7.08

g/l

0.91

305

879

Other functional intestinal disorders

519

1957

2.44

75.10

1.5

1.4

6.27

6.79

g/l

2.27

383

1424

Diseases of the skin and subcutaneous tissue

968

2451

2.00

74.98

1.5

1.3

6.65

6.68

g/l

0.07

706

1706

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1065

3645

1.89

74.64

1.4

6.57

6.75

g/l

0.80

770

2610

Diarrhoea and gastroenteritis of presumed infectious origin

785

3447

2.05

74.62

1.4

6.50

6.70

g/l

0.75

565

2478

Symptoms and signs involving the skin and subcutaneous tissue

794

3755

2.01

72.54

1.5

1.4

6.67

6.74

g/l

0.20

612

2705

Aplastic and other anaemias

495

1872

2.45

72.45

1.4

6.83

6.84

g/l

0.01

321

1361

Eosinophilia

14.30

71.94

1.6

1.3

6.93

7.21

g/l

0.14

Episodal and paroxysmal disorders

1095

2973

1.88

71.83

1.4

6.53

6.86

g/l

1.89

775

2177

Other headache syndromes

487

2017

2.43

71.72

1.4

6.33

6.85

g/l

1.93

361

1488

Implicit fungal Sepsis, including avohilmo

134

240

5.79

71.67

1.4

5.86

6.55

g/l

1.16

182

Soft tissue disorders

1017

2724

1.92

71.66

1.4

6.50

6.92

g/l

2.98

740

1926

Caries of dentine

298

925

3.16

71.48

1.5

1.3

6.88

6.73

g/l

0.22

225

647

Rheumatoid arthritis

368

1168

2.83

71.35

1.5

1.4

6.86

6.89

g/l

0.04

282

840

Liquid cancers, including Hilmo

425

1447

2.62

71.27

1.4

7.08

6.79

g/l

0.39

310

1053

Other chronic obstructive pulmonary disease

399

1213

2.72

70.84

1.4

1.3

6.67

7.09

g/l

1.18

291

852

Other dorsopathies, not elsewhere classified

995

2699

1.93

70.67

1.4

6.46

6.91

g/l

2.99

731

1908

Respiratory insufficiency

119

8.13

70.58

1.4

1.3

6.30

6.84

g/l

0.44

Sleep apnoea

980

3266

1.91

70.49

1.4

6.58

6.80

g/l

1.13

671

2374

Sarcoidosis

210

554

3.89

69.61

1.4

1.3

7.07

6.87

g/l

0.27

139

406

L04AD Calcineurin inhibitors

205

534

3.97

69.35

1.4

6.78

6.65

g/l

0.16

145

393

Mycoses

372

1384

2.73

69.26

1.5

1.4

6.75

6.77

g/l

0.04

261

996

Migraine

582

2021

2.26

69.08

1.4

6.08

6.79

g/l

6.32

432

1504

Other joint disorders

885

2333

1.99

69.05

1.4

6.63

6.77

g/l

0.47

651

1662

Cardiac arrhythmias

660

1952

2.19

69.00

1.3

1.4

6.97

6.68

g/l

0.91

468

1448

Certain infectious and parasitic diseases, including avohilmo

667

1505

2.24

68.88

1.4

6.82

6.71

g/l

0.26

494

1044

Other noninfective gastroenteritis and colitis

330

1156

2.90

68.76

1.5

1.3

6.22

6.65

g/l

1.28

242

846

Neurological diseases

852

2129

2.02

68.66

1.4

6.45

6.97

g/l

3.05

602

1554

Other and unspecified anaemias

454

1746

2.47

68.14

1.4

6.83

6.84

g/l

0.02

295

1267

Intestinal infectious diseases, including avohilmo, including avohilmo

1158

3603

1.80

68.00

1.4

6.65

6.76

g/l

0.39

848

2575

Sciatica+with lumbago

552

2174

2.27

67.85

1.4

6.15

6.98

g/l

7.81

418

1537

All kidney diseases

1016

3713

1.85

67.23

1.5

1.4

6.90

6.65

g/l

0.90

714

2711

Other anaemias

455

1757

2.45

67.22

1.4

6.82

6.84

g/l

0.03

296

1277

Symptoms and signs concerning food and fluid intake

160

355

4.61

66.48

1.5

1.3

6.96

6.72

g/l

0.28

117

272

Dorsopathies

1008

2728

1.88

66.47

1.4

6.53

6.91

g/l

2.20

727

1934

Fibrosis and cirrhosis of liver

139

276

5.22

66.38

1.2

1.4

9.74

6.64

g/l

5.83

102

204

Hypertensive diseases (excluding secondary)

555

1394

2.34

66.07

1.5

1.3

6.48

6.65

g/l

0.44

383

1016

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

963

4083

1.85

66.07

1.5

1.4

6.51

6.75

g/l

1.07

718

2927

Diseases of the eye and adnexa

806

2000

2.03

65.82

1.4

1.3

6.42

6.90

g/l

3.22

594

1416

Diseases of the musculoskeletal system and connective tissue

519

1069

2.45

65.64

1.4

1.3

6.55

6.64

g/l

0.21

377

757

Fibromyalgia

153

333

4.72

65.40

1.6

1.3

6.30

6.83

g/l

0.88

117

238

Pleural effusion

192

496

3.95

65.40

1.6

1.4

7.19

6.80

g/l

0.65

127

365

Hypothyroidism, levothyroxine purchases

272

440

3.50

65.31

1.4

1.3

6.77

6.63

g/l

0.22

181

324

Hypothyroidism and >3 levothyroxin purchases

272

440

3.50

65.31

1.4

1.3

6.77

6.63

g/l

0.22

181

324

ILD-related respiratory insufficiency

9.39

64.60

1.2

8.88

7.46

g/l

0.64

Hypothyroidism (congenital or acquired)

272

444

3.47

64.36

1.4

1.3

6.72

6.69

g/l

0.04

181

328

Complications of medical and surgical care

771

3575

1.95

64.16

1.4

6.54

6.77

g/l

0.89

567

2591

Pneumocystosis, including avohilmo

11.49

63.96

1.6

1.4

6.09

8.01

g/l

1.05

Pneumocystosis

11.49

63.96

1.6

1.4

6.09

8.01

g/l

1.05

Complications of procedures, not elsewhere classified

836

3553

1.91

63.78

1.4

6.59

6.77

g/l

0.65

619

2550

Methotrexate

159

364

4.45

63.62

1.6

1.2

6.61

6.63

g/l

0.02

119

261

Persons encountering health services in other circumstances

480

2068

2.32

63.56

1.4

6.87

6.62

g/l

0.47

306

1461

Sleep apnoea, including avohilmo

1008

3360

1.83

63.13

1.4

6.57

6.78

g/l

1.06

689

2444

Diseases of the digestive system

491

2152

2.29

62.91

1.6

1.4

6.91

6.81

g/l

0.19

344

1538

Protozoal diseases, including avohilmo

109

8.32

62.78

1.5

1.4

6.40

7.31

g/l

0.52

Abnormalities of heart beat

349

1276

2.68

62.67

1.3

1.4

6.51

6.95

g/l

1.56

246

894

Inflammatory bowel disease

401

1629

2.50

62.36

1.3

1.4

7.32

6.63

g/l

2.26

272

1167

Infection due to other mycobacteria

15.77

62.04

1.4

6.92

6.47

g/l

0.39

Viral infections characterized by skin and mucous membrane lesions

497

2225

2.26

61.68

1.5

1.4

6.27

6.72

g/l

1.83

378

1607

Arthropathies

883

2344

1.92

61.33

1.3

1.4

6.59

6.77

g/l

0.77

655

1673

Sleep disorders (combined)

1074

3151

1.79

61.11

1.4

6.63

6.83

g/l

0.94

753

2294

Protozoal diseases

107

8.29

61.06

1.5

1.4

6.39

7.31

g/l

0.51

Urticaria and erythema

447

1924

2.35

61.04

1.5

1.4

6.60

6.70

g/l

0.23

348

1395

Cholecystectomy

720

3128

1.97

60.86

1.4

6.64

6.79

g/l

0.46

479

2299

Chronic laryngitis and laryngotracheitis

186

498

3.81

60.28

1.4

1.3

6.08

7.16

g/l

4.20

136

341

Other intervertebral disc disorders

787

2421

1.95

60.11

1.4

6.57

6.95

g/l

1.82

574

1702

Other diseases of liver

255

836

3.11

60.08

1.3

7.02

6.57

g/l

0.93

175

612

Colitis, primary sclerosing

12.13

60.08

1.4

1.3

9.13

6.47

g/l

2.94

Hypopituitarism

150

345

4.51

60.07

1.6

1.3

5.69

6.78

g/l

2.25

262

Biological medication for rheuma

275

943

2.98

59.91

1.3

1.4

6.74

6.51

g/l

0.50

188

675

Fungal Sepsis

136

7.08

59.72

1.5

1.3

6.63

6.87

g/l

0.13

102

Implicit fungal Sepsis

121

7.54

59.70

1.5

1.3

6.19

6.83

g/l

0.55

Other general symptoms and signs

105

178

6.06

58.74

1.7

1.3

6.38

6.69

g/l

0.43

141

Persons encountering health services in other circumstances, wide

1104

3253

1.75

58.45

1.5

1.4

6.86

6.63

g/l

1.07

825

2301

Voice disturbances

332

1272

2.65

58.42

1.4

6.23

6.77

g/l

1.86

249

917

Persons encountering health services for specific procedures and health care

1079

3665

1.75

58.23

1.4

6.60

6.73

g/l

0.48

784

2645

Depression medications

292

468

3.17

58.13

1.3

6.31

6.74

g/l

1.54

210

347

Functional dyspepsia

312

1164

2.72

57.81

1.5

1.4

6.46

6.72

g/l

0.59

230

827

Primary biliary cholangitis, wide definition

11.60

57.80

1.3

1.5

8.51

6.94

g/l

1.43

Dysphagia

266

913

2.95

57.62

1.4

1.3

6.33

7.05

g/l

2.86

186

676

Coagulation defects, purpura and other haemorrhagic conditions

267

924

2.94

57.16

1.6

1.4

6.59

6.66

g/l

0.10

203

668

Anxiety disorders, excluding more controls

848

2932

1.86

57.12

1.5

1.4

6.46

6.83

g/l

1.89

641

2097

Myalgia

292

1060

2.79

57.07

1.5

1.3

6.21

6.97

g/l

3.20

212

742

Persons encountering health services for examination and investigation

567

1301

2.20

56.60

1.4

1.3

6.69

6.92

g/l

0.70

439

801

Rheumatoid arthritis, including avohilmo

420

1827

2.33

56.04

1.5

1.4

6.94

6.72

g/l

0.46

313

1301

Constipation

893

3372

1.81

55.44

1.4

6.54

6.79

g/l

1.01

626

2480

Seropositive rheumatoid arthritis

263

911

2.91

55.43

1.5

1.3

6.87

6.71

g/l

0.27

206

642

Disorders of conjunctiva

873

3784

1.80

54.98

1.5

1.4

6.34

6.77

g/l

3.35

672

2704

Endocrine, nutritional and metabolic diseases

776

2045

1.93

54.98

1.4

1.3

6.46

6.75

g/l

1.30

531

1516

Renal failure

466

1795

2.23

54.78

1.5

1.4

7.07

6.84

g/l

0.50

316

1278

Antihypertensive medication - note that there are other indications

635

1619

2.06

54.73

1.4

1.3

6.48

6.75

g/l

1.05

455

1192

Infection due to other mycobacteria, including avohilmo

12.64

54.71

1.4

6.92

6.42

g/l

0.48

Ulcerative colitis

311

1194

2.65

54.53

1.3

7.79

6.64

g/l

3.97

213

860

All chronic kidney diseases

558

2153

2.08

54.46

1.5

1.4

6.98

6.73

g/l

0.73

393

1562

Chronic kidney disease

326

1227

2.59

54.41

1.5

1.4

7.00

6.83

g/l

0.25

223

886

Bleeding

815

3122

1.84

54.40

1.4

6.80

6.71

g/l

0.25

583

2253

Symptoms and signs involving the nervous and musculoskeletal systems

605

3077

1.98

53.67

1.6

1.4

6.30

6.83

g/l

3.50

447

2233

Primary biliary cholangitis (PBC)

11.44

53.54

1.2

8.52

7.06

g/l

1.16

Intestinal malabsorption

156

6.21

53.40

1.5

1.3

6.92

6.82

g/l

0.07

121

Other disorders of fluid, electrolyte and acid-base balance

338

1280

2.52

53.06

1.5

1.4

7.00

6.86

g/l

0.18

231

917

Purpura and other haemorrhagic conditions

197

599

3.36

52.73

1.6

1.4

6.58

6.69

g/l

0.15

147

436

Other pleural conditions

127

284

4.57

52.49

1.5

1.4

6.90

g/l

0.01

211

Rheumatism, unspecified

176

501

3.59

52.18

1.8

1.4

6.09

7.02

g/l

2.45

131

357

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

143

6.40

52.13

1.7

1.4

7.66

6.97

g/l

0.52

109

Symptoms and signs involving speech and voice

376

1612

2.36

51.96

1.4

6.26

6.87

g/l

2.36

279

1155

COPD, hospital admission 2, with asthma infections

322

1091

2.57

51.84

1.5

1.4

6.38

6.97

g/l

2.06

238

775

Renal tubulo-interstitial diseases

856

3540

1.78

51.80

1.5

1.4

6.95

6.66

g/l

0.94

598

2582

Other diseases of pericardium

140

6.38

50.86

1.5

1.2

6.91

6.69

g/l

0.14

101

Osteoporosis with pathological fracture (FG)

184

5.52

50.85

1.6

1.2

6.22

7.14

g/l

1.06

139

Other disorders of skin and subcutaneous tissue

721

3311

1.85

50.61

1.4

6.86

6.74

g/l

0.30

538

2391

Lumbar disc prolapse

613

2324

1.97

50.47

1.4

6.53

6.95

g/l

1.91

444

1636

Atrial fibrillation and flutter

313

768

2.66

50.12

1.3

7.36

6.73

g/l

1.20

223

548

COPD, hospital admissions 3, with asthma pneumonia sepsis

271

854

2.75

49.89

1.5

1.4

6.48

7.03

g/l

1.55

205

613

Drug-induced osteoporosis with pathological fracture

12.57

49.53

1.8

1.3

6.58

7.42

g/l

0.37

Nerve, nerve root and plexus disorders

1015

3616

1.69

49.48

1.4

6.41

6.81

g/l

3.08

721

2601

Mycoses, including avohilmo

918

4093

1.72

49.19

1.4

6.49

6.77

g/l

1.62

671

2938

Ulcerative colitis, NAS

203

656

3.16

49.17

1.3

1.4

7.94

6.64

g/l

3.31

143

478

Spondylosis

506

1915

2.08

49.13

1.5

1.4

6.35

7.04

g/l

3.81

341

1349

Non-Hodgkin lymphoma, all, including Hilmo

174

512

3.47

49.08

1.5

1.4

6.09

6.87

g/l

1.33

128

375

Polymyalgia rheumatica

152

409

3.79

48.98

1.6

1.3

6.93

6.91

g/l

0.02

111

299

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1032

3253

1.69

48.91

1.5

1.4

6.75

6.63

g/l

0.49

815

2301

Other symptoms and signs involving the nervous and musculoskeletal systems

457

2177

2.12

48.73

1.6

1.4

6.31

6.77

g/l

2.04

330

1565

Anxiety disorders

905

3616

1.73

48.53

1.5

1.4

6.45

6.74

g/l

1.41

686

2574

Erysipelas, including avohilmo

665

2629

1.89

48.40

1.5

1.4

6.84

6.68

g/l

0.50

493

1873

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

603

3112

1.91

48.22

1.4

6.62

6.82

g/l

0.59

445

2249

Abnormal results of function studies

136

343

4.07

48.16

1.5

1.3

7.28

6.60

g/l

0.74

253

Nutritional anaemias

500

2350

2.05

48.12

1.5

1.4

7.02

6.77

g/l

0.55

369

1690

Later onset COPD, excluding more controls

145

274

4.08

47.95

1.2

7.19

7.33

g/l

0.12

106

183

Other and unspecified iron deficiency

370

1627

2.30

47.95

1.4

6.84

6.74

g/l

0.17

268

1169

Neurotic, stress-related and somatoform disorders

896

3601

1.72

47.81

1.5

1.4

6.45

6.73

g/l

1.38

681

2560

Metabolic disorders

914

3191

1.73

47.78

1.5

1.4

6.70

6.75

g/l

0.11

653

2307

Neoplasms

750

2137

1.85

47.77

1.4

6.53

6.69

g/l

0.55

519

1561

Abnormal findings on diagnostic imaging of other body structures

179

546

3.34

47.66

1.5

1.3

6.85

6.60

g/l

0.37

120

401

Pneumonia due to Streptococcus pneumoniae

123

6.58

47.58

1.4

1.2

8.11

6.99

g/l

0.61

Conjunctivitis

786

3593

1.77

47.52

1.5

1.4

6.35

6.76

g/l

2.75

611

2570

Chronic hepatitis, not elsewhere classified

114

6.90

47.51

1.5

1.4

9.50

6.31

g/l

3.14

Pulmonary heart disease, diseases of pulmonary circulation

328

1378

2.41

47.45

1.4

6.86

6.90

g/l

0.05

247

981

Diaphragmatic hernia

367

1622

2.29

47.26

1.4

6.41

6.83

g/l

1.38

286

1163

Migraine without aura

246

907

2.75

46.76

1.4

6.23

6.87

g/l

2.53

182

677

Iron deficiency anaemia

440

2069

2.11

45.98

1.5

1.4

6.93

6.77

g/l

0.31

320

1488

Explicit bacterial Sepsis, including avohilmo

142

383

3.78

45.65

1.4

8.60

6.70

g/l

1.95

289

Abnormal serum enzyme levels

309

1238

2.44

45.61

1.6

1.4

7.11

6.87

g/l

0.45

233

902

Syncope and collapse

385

1449

2.23

45.47

1.4

6.58

6.85

g/l

0.83

269

1043

Explicit bacterial Sepsis

139

371

3.82

45.37

1.4

8.59

6.69

g/l

1.84

283

Tumor necrosis factor alpha inhibitors

233

851

2.79

45.30

1.3

1.4

6.66

6.60

g/l

0.09

160

601

Giant cell arteritis

104

6.99

45.19

1.2

1.5

6.22

7.27

g/l

0.98

Acute renal failure

243

907

2.72

45.15

1.5

1.4

7.14

6.87

g/l

0.40

154

657

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

429

1246

2.19

45.06

1.5

1.3

6.80

6.71

g/l

0.16

289

902

Other/unspecified dorsalgia

371

1661

2.23

44.77

1.3

1.4

6.17

7.01

g/l

5.19

271

1185

Benign neoplasm of colon, rectum, anus and anal canal

591

2660

1.89

44.54

1.5

1.4

6.70

6.83

g/l

0.38

455

1884

Inflammatory diseases of the central nervous system

130

337

3.96

44.37

1.4

6.79

6.78

g/l

0.01

101

240

Other chronic obstructive pulmonary disease, including avohilmo

491

2014

2.02

44.37

1.5

1.4

6.59

6.91

g/l

1.03

357

1444

Urticaria

354

1594

2.25

43.67

1.5

1.4

6.45

6.71

g/l

0.66

279

1158

Early onset COPD

246

941

2.65

43.59

1.6

1.4

6.32

6.90

g/l

1.63

180

666

Colitis, primary sclerosing, strict definition

10.97

43.57

1.4

1.3

8.93

6.28

g/l

2.84

Polyarthrosis

220

708

2.84

43.36

1.6

1.5

6.80

6.86

g/l

0.07

156

517

Diverticular disease of intestine

629

2103

1.87

43.33

1.6

1.4

6.47

6.84

g/l

1.65

480

1508

Mood disorders, excluding more controls

879

3057

1.70

43.15

1.4

6.43

6.85

g/l

2.59

633

2180

Chronic diseases of tonsils and adenoids

676

2353

1.82

42.83

1.4

1.3

6.25

6.97

g/l

5.15

523

1619

Diseases of middle ear and mastoid

598

2640

1.86

42.75

1.4

6.40

6.73

g/l

1.49

435

1889

Candidiasis

190

642

3.02

42.64

1.5

1.3

6.89

6.76

g/l

0.14

137

462

Heart failure,strict

456

1551

2.07

42.59

1.4

7.25

6.74

g/l

1.37

316

1097

Depression

925

3754

1.66

42.40

1.4

6.42

6.78

g/l

2.20

670

2695

Heart failure and antihypertensive medication

251

606

2.72

42.18

1.5

1.3

7.36

6.84

g/l

0.81

180

445

Migraine with aura

275

1129

2.46

41.92

1.4

5.85

6.81

g/l

6.65

210

829

Diseases of arteries, arterioles and capillaries (FINNGEN)

232

578

2.80

41.82

1.4

6.96

6.79

g/l

0.21

172

414

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

935

3600

1.65

41.74

1.4

6.80

6.69

g/l

0.32

666

2658

Other antidepressants

941

2897

1.67

41.69

1.4

6.38

6.89

g/l

3.92

663

2096

Spondyloarthritis

200

704

2.88

41.58

1.4

1.3

6.46

6.58

g/l

0.16

138

510

Other specified/unspecified necrotizing vasculopathies

13.01

41.51

1.4

6.27

6.04

g/l

0.12

Hypermobility syndrome

217

4.67

41.28

1.7

1.4

6.53

6.20

g/l

0.35

164

Ischemic heart diseases

763

2622

1.74

41.13

1.4

6.63

6.76

g/l

0.36

546

1890

Noninfectious colitis NAS

181

609

3.03

40.95

1.5

1.3

5.99

6.75

g/l

2.48

140

450

Benign neoplasms

912

2996

1.66

40.89

1.4

6.57

6.85

g/l

1.46

648

2141

COPD, hospital admissions

396

1592

2.11

40.75

1.4

6.64

6.95

g/l

0.81

289

1125

Drug-induced cataract

7.94

40.72

1.5

1.3

5.99

6.86

g/l

0.60

IBD patients in KELA-register

275

1146

2.43

40.71

1.2

1.4

7.65

6.59

g/l

3.69

182

826

Benign neoplasm: Colon

501

2460

1.93

40.64

1.5

1.4

6.60

6.90

g/l

1.16

387

1749

Infections of the skin and subcutaneous tissue

598

3266

1.81

40.55

1.4

6.83

6.69

g/l

0.37

454

2330

Pulmonary eosinophilia, not elsewhere classified

14.23

40.45

1.7

1.4

6.26

6.39

g/l

0.07

COPD, early/later onset

399

1607

2.10

40.44

1.4

6.67

6.95

g/l

0.69

291

1136

Visual disturbances and blindness

523

2789

1.89

40.37

1.5

1.4

6.35

6.79

g/l

2.33

401

2004

Visual disturbances

495

2597

1.92

40.34

1.6

1.4

6.37

6.76

g/l

1.78

380

1869

Hypothyroidism, drug reimbursement

141

267

3.73

40.23

1.8

1.3

6.95

6.68

g/l

0.43

103

201

Personal history of allergy to drugs, medicaments and biological substances

11.18

40.13

1.6

1.1

6.34

6.14

g/l

0.16

Recurrent or chronic depression

414

1381

2.10

40.10

1.3

1.4

6.38

6.98

g/l

2.57

301

1004

Atopic dermatitis, strict definition with reimbursement

339

1488

2.21

40.06

1.4

1.3

6.67

6.70

g/l

0.04

262

1069

Disorders of orbit

153

5.42

40.03

1.7

1.4

6.37

6.64

g/l

0.26

113

Hypertension, essential

722

2331

1.76

39.91

1.4

6.51

6.78

g/l

1.14

511

1674

Ulcerative colitis (strict) with PSC

14.86

39.79

1.3

9.69

6.57

g/l

2.18

Erysipelas

486

2175

1.94

39.72

1.5

1.4

6.80

6.75

g/l

0.10

364

1543

Percutaneous Coronary Intervention

717

2504

1.75

39.58

1.4

6.62

6.77

g/l

0.42

529

1810

Pulmonary embolism

292

1264

2.34

39.58

1.5

1.4

6.56

6.91

g/l

0.81

217

904

Care involving use of rehabilitation procedures

622

3151

1.79

39.54

1.4

6.49

6.75

g/l

1.00

447

2291

Hypertensive diseases

747

2437

1.74

39.53

1.4

6.58

6.79

g/l

0.74

528

1758

IBD (strict) with PSC

12.28

39.53

1.3

10.07

6.43

g/l

2.99

Streptococcal septicaemia, including avohilmo

120

319

3.84

39.50

1.5

1.3

8.47

6.63

g/l

1.67

248

Spondylopathies (FG)

166

543

3.11

39.43

1.5

1.3

6.28

6.71

g/l

0.85

118

377

Herpesviral [herpes simplex] infections

165

539

3.13

39.37

1.5

1.4

6.36

6.68

g/l

0.49

127

391

Other gastritis (incl. Duodenitis)

224

861

2.63

39.31

1.5

1.4

6.86

7.02

g/l

0.22

176

612

Disorders of sclera, cornea, iris and ciliary body

548

2995

1.84

39.29

1.5

1.4

6.74

6.71

g/l

0.08

394

2164

Multiple myeloma, including Hilmo

127

5.86

39.26

1.4

10.03

7.24

g/l

1.19

Non-invasive ventilation

229

756

2.64

39.20

1.3

1.4

6.18

7.01

g/l

2.58

560

Unspecified jaundice

127

5.83

39.20

2.0

1.2

7.46

7.19

g/l

0.17

104

Shoulder lesions

652

2186

1.80

39.14

1.4

6.27

7.01

g/l

5.96

486

1532

Pulmonary heart disease

292

1271

2.32

39.08

1.5

1.4

6.56

6.93

g/l

0.88

217

912

Nonsuppurative otitis media

274

995

2.42

38.97

1.5

1.3

6.01

6.77

g/l

3.38

207

720

Hypertension

744

2435

1.73

38.92

1.4

6.56

6.79

g/l

0.86

526

1757

Suppurative and unspecified otitis media

404

1760

2.05

38.81

1.4

6.41

6.66

g/l

0.78

299

1260

Crohn disease

181

629

2.93

38.71

1.2

1.3

6.83

6.70

g/l

0.15

124

458

Streptococcal septicaemia

117

310

3.86

38.71

1.5

1.3

8.45

6.62

g/l

1.55

242

Gout

239

808

2.56

38.52

1.4

1.5

6.74

7.16

g/l

0.68

166

569

Hypothyroidism, strict autoimmune

583

2092

1.84

38.46

1.4

6.79

6.52

g/l

0.98

417

1535

Pollen allergy

250

1009

2.48

38.44

1.5

1.4

6.38

6.51

g/l

0.33

216

725

Concussion

459

1820

1.97

38.41

1.5

1.4

6.60

6.96

g/l

1.03

332

1326

Dialysis, with operation codes

163

537

3.10

38.33

1.4

6.61

6.76

g/l

0.13

117

395

Unspecified chronic bronchitis

7.56

38.30

1.3

7.37

7.16

g/l

0.10

Mood disorders

959

3846

1.60

38.28

1.4

6.46

6.79

g/l

1.93

692

2768

Intracranial trauma

516

1840

1.91

38.21

1.5

1.4

6.63

6.95

g/l

0.97

370

1342

Mood [affective] disorders

956

3845

1.60

38.00

1.4

6.46

6.79

g/l

1.87

690

2768

Emergency coronary revascularization (for ACS)

753

2678

1.71

37.93

1.4

6.61

6.78

g/l

0.54

555

1921

Glomerular diseases

211

803

2.67

37.89

1.7

1.3

6.68

6.70

g/l

0.02

146

582

Nephropathy related operations

159

520

3.12

37.88

1.5

1.4

6.75

6.73

g/l

0.01

114

386

Spinal stenosis

428

1577

2.01

37.83

1.4

6.22

7.10

g/l

5.87

316

1111

Coronary revascularization (ANGIO or CABG)

711

2508

1.73

37.76

1.4

6.59

6.77

g/l

0.51

525

1812

Inflammatory bowel disease, strict (require KELA)

275

1186

2.35

37.72

1.2

1.4

7.65

6.56

g/l

3.87

182

858

Disturbances of skin sensation

312

1419

2.22

37.67

1.3

6.40

6.72

g/l

0.83

234

1010

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

368

1785

2.08

37.63

1.6

1.3

6.30

6.69

g/l

1.36

221

1299

Hard cardiovascular diseases

762

2665

1.70

37.56

1.4

6.60

6.74

g/l

0.42

559

1904

Depression or dysthymia

614

1855

1.82

37.47

1.4

6.48

6.96

g/l

2.58

435

1339

Benzodiazepine use

931

3950

1.60

37.22

1.4

6.62

6.75

g/l

0.47

662

2849

Multiple myeloma and malignant plasma cell neoplasms

141

5.42

37.16

1.4

1.3

10.50

7.20

g/l

1.50

103

Acute suppurative otitis media

315

1342

2.21

37.05

1.4

6.35

6.65

g/l

0.78

233

964

Zoster [herpes zoster], including avohilmo

486

2512

1.88

36.94

1.5

1.4

6.48

6.79

g/l

0.92

373

1794

Temporomandibular joint disorders, including avohilmo

472

2429

1.90

36.84

1.5

1.4

6.49

6.63

g/l

0.35

345

1777

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

549

2926

1.81

36.82

1.6

1.3

6.25

6.74

g/l

3.44

433

2103

All influenza (not pneumonia)

168

576

2.96

36.74

1.4

1.3

6.46

6.59

g/l

0.17

120

407

Other nutritional deficiencies

663

3554

1.71

36.62

1.4

6.36

6.77

g/l

2.60

483

2591

Nonsuppurative otitis media, including avohilmo

353

1458

2.11

36.55

1.5

1.3

6.19

6.74

g/l

2.68

273

1043

Transplanted organ and tissue status

139

431

3.30

36.25

1.5

1.4

6.78

6.67

g/l

0.08

100

328

SLE (Finngen)

6.39

36.24

1.5

1.4

7.32

6.68

g/l

0.54

Benign neoplasm of other and ill-defined parts of digestive system

201

764

2.67

36.21

1.5

1.4

6.29

6.80

g/l

1.10

152

543

Alcohol-induced acute pancreatitis

134

5.52

36.14

1.3

5.67

6.75

g/l

1.90

Major coronary heart disease event

743

2643

1.69

36.13

1.4

6.60

6.77

g/l

0.52

544

1895

Anxiety (asthma-related co-morbidities)

614

2669

1.76

36.07

1.4

6.52

6.80

g/l

1.07

479

1931

Collagenous colitis

127

375

3.46

35.82

1.4

6.63

6.73

g/l

0.08

271

Polyarteritis nodosa and related conditions

10.72

35.78

1.6

1.3

6.58

6.00

g/l

0.28

Cholecystitis

140

440

3.23

35.56

2.1

1.2

6.64

6.86

g/l

0.41

320

Personal history of allergy to analgesic agent

15.86

35.45

1.4

1.1

6.29

6.73

g/l

0.30

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

535

2988

1.80

35.43

1.4

6.63

6.78

g/l

0.36

391

2153

Corticotropin deficiency

12.16

35.28

2.0

1.4

5.96

7.06

g/l

0.45

Other bacterial intestinal infections

198

759

2.64

35.05

1.4

1.3

6.91

6.64

g/l

0.32

146

543

Urinary track infection

564

1545

1.84

35.01

1.5

1.4

6.51

6.69

g/l

0.51

419

1131

Other reaction to severe stress, and adjustment disorders

383

1933

2.00

34.98

1.6

1.4

6.36

6.67

g/l

0.93

286

1385

Pneumonia derived septicemia

106

6.07

34.98

1.5

1.3

9.52

7.01

g/l

1.17

Other and unspecified disorders of white blood cells

131

5.46

34.84

1.4

1.3

6.36

6.92

g/l

0.27

COPD related to multimorbidity

335

1350

2.11

34.69

1.4

6.60

6.99

g/l

0.97

240

948

DVT of lower extremities and pulmonary embolism

376

1884

2.00

34.66

1.4

6.58

6.87

g/l

0.75

271

1352

Abnormal weight loss

122

359

3.47

34.59

1.4

7.34

6.76

g/l

0.63

270

Heart failure, strict

482

1793

1.88

34.55

1.4

7.24

6.76

g/l

1.32

335

1285

Other complications of surgical and medical care, not elsewhere classified

130

401

3.31

34.19

1.3

1.4

6.95

6.83

g/l

0.08

103

290

Diseases of the ear and mastoid process

1030

3342

1.55

34.14

1.4

6.48

6.81

g/l

2.25

736

2428

Herpesviral [herpes simplex] infections, including avohilmo

290

1334

2.20

34.11

1.4

6.53

6.73

g/l

0.32

218

949

Viral pneumonia (unknown virus, not influenza)

247

4.02

34.03

1.2

1.3

6.32

6.72

g/l

0.36

182

All anxiety disorders

624

2832

1.72

34.03

1.4

6.53

6.78

g/l

0.93

487

2017

Polypectomy (DHB20)

252

4.00

33.96

2.0

1.3

6.25

6.82

g/l

0.99

180

Any mental disorder

969

3108

1.57

33.70

1.4

6.56

6.84

g/l

1.34

701

2221

Allergic conjunctivitis

570

3169

1.74

33.66

1.6

1.3

6.25

6.72

g/l

3.28

451

2277

Mucosal proctocolitis

167

600

2.83

33.64

1.4

1.3

8.22

6.63

g/l

4.59

111

441

Enterocolitis due to Clostridium difficile

121

361

3.41

33.52

1.4

6.56

6.64

g/l

0.07

270

Seropositive rheumatoid arthritis, wide

263

1171

2.27

33.51

1.5

1.4

6.87

6.68

g/l

0.32

206

834

Disorders of synovium and tendon

479

2219

1.84

33.51

1.5

1.4

6.25

6.94

g/l

4.74

345

1567

Venous thromboembolism

476

2516

1.83

33.50

1.5

1.4

6.51

6.81

g/l

0.99

343

1808

Other and unspecified tonsillitis

327

1300

2.11

33.50

1.4

6.33

6.82

g/l

2.06

246

892

All-cause Heart Failure

473

1770

1.87

33.41

1.4

7.26

6.78

g/l

1.29

330

1272

Weight loss

131

412

3.24

33.39

1.4

7.13

6.68

g/l

0.48

308

Atrial fibrillation and flutter with reimbursement

226

565

2.54

33.29

1.4

7.59

6.89

g/l

1.04

158

408

Cerebrovascular diseases (FINNGEN)

276

854

2.28

33.17

1.3

6.85

6.71

g/l

0.18

202

610

Suppurative and necrotic conditions of lower respiratory tract

192

4.45

33.12

1.4

1.2

7.35

7.10

g/l

0.15

138

Postviral fatigue syndrome

12.92

32.99

2.0

1.4

5.97

6.28

g/l

0.23

Rotator cuff syndrome

521

1996

1.81

32.97

1.4

6.19

7.03

g/l

6.43

394

1398

Other symptoms and signs involving the digestive system and abdomen

167

606

2.79

32.91

1.4

1.3

6.03

6.91

g/l

2.11

111

464

Drug-induced osteoporosis

9.58

32.88

2.3

1.4

5.79

7.10

g/l

0.72

Congenital malformations of the respiratory system, including avohilmo

6.79

32.80

1.5

1.4

5.97

6.04

g/l

0.05

Pain in thoracic spine

167

609

2.78

32.64

1.4

1.3

5.87

6.89

g/l

4.08

132

426

Migraine with aura and triptan purchases

199

793

2.55

32.60

1.4

5.97

6.74

g/l

3.27

154

578

Thrombocytopenia, unspecified

100

269

3.81

32.49

1.7

1.3

6.47

6.79

g/l

0.34

193

Conjunctivitis (acute, non atopic), including avohilmo

902

3500

1.56

32.21

1.5

1.4

6.61

6.84

g/l

0.99

677

2468

Other disorders of urethra and urinary system

628

2585

1.70

32.18

1.4

6.59

6.84

g/l

0.91

451

1887

Continuous positive airway pressure

171

518

2.78

32.16

1.4

1.3

6.96

6.93

g/l

0.03

149

387

Sequelae with surgical and medical care as external cause

220

924

2.41

32.15

1.4

6.74

6.69

g/l

0.05

165

650

Disorders of skin appendages

498

2804

1.78

31.87

1.3

1.4

6.45

6.72

g/l

0.97

374

2022

Somatoform disorder

188

738

2.58

31.78

1.4

1.3

6.12

6.70

g/l

2.07

139

513

Bacterial intestinal infections, IBD co-morbidities

197

792

2.52

31.66

1.4

1.3

6.94

6.67

g/l

0.32

146

566

Systemic lupus erythematosus

113

5.59

31.66

1.5

1.3

7.32

6.59

g/l

0.58

Other/unspecified seropositive rheumatoid arthritis

256

1156

2.24

31.56

1.5

1.4

6.88

6.67

g/l

0.34

202

821

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

625

3427

1.67

31.50

1.4

6.49

6.68

g/l

0.76

448

2474

Secondary hypertension

243

3.88

31.43

1.3

1.2

6.17

6.59

g/l

0.40

179

COPD, hospital admissions 1, only main diagnosis

288

1159

2.15

31.42

1.3

1.4

6.50

7.00

g/l

1.25

212

823

Adalimumab

143

492

2.97

31.29

1.3

1.4

6.67

6.58

g/l

0.11

102

355

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

253

1147

2.23

30.91

1.5

1.4

6.85

6.70

g/l

0.24

199

815

Cervicobrachial syndrome

219

934

2.37

30.89

1.6

1.3

6.11

6.97

g/l

2.73

176

657

Iridocyclitis

243

1085

2.27

30.83

1.5

1.4

6.59

6.69

g/l

0.14

180

778

Polyneuropathies and other disorders of the peripheral nervous system

220

942

2.36

30.79

1.4

6.74

6.93

g/l

0.26

169

674

Symptoms and signs involving cognition, perception, emotional state and behaviour

869

3759

1.55

30.68

1.4

6.56

6.76

g/l

0.89

631

2719

Hypo-osmolality and hyponatraemia

178

687

2.60

30.58

1.4

6.90

6.87

g/l

0.03

113

494

Disorders of lens

577

2086

1.73

30.53

1.4

6.57

6.78

g/l

0.65

414

1542

Paralytic ileus and intestinal obstruction

230

1007

2.30

30.43

1.4

6.60

6.92

g/l

0.51

157

713

Other and unspecified polyneuropathies, also in other diseases

195

796

2.48

30.37

1.4

6.78

6.85

g/l

0.08

151

573

Alcohol-induced chronic pancreatitis

259

3.77

30.35

1.3

6.01

6.87

g/l

1.75

190

Congenital malformations, deformations and chromosomal abnormalities

569

3206

1.69

30.30

1.5

1.4

6.47

6.69

g/l

0.85

407

2321

Nonorganic sleeping disorders, excluding more controls

219

943

2.35

30.24

1.4

6.26

6.89

g/l

2.31

157

671

Congenital malformations of the respiratory system

6.91

30.17

1.5

1.4

6.03

6.00

g/l

0.02

Other bacterial intestinal infections, including avohilmo

236

1051

2.27

30.11

1.3

6.90

6.69

g/l

0.29

177

748

Temporal arteritis

6.08

30.10

1.2

1.5

6.19

6.98

g/l

0.60

Migraine without aura and triptan purchases

200

830

2.44

30.06

1.4

6.20

6.72

g/l

1.59

149

607

Pericarditis

5.85

30.03

1.4

1.2

6.65

6.76

g/l

0.06

Other Crohn's disease

103

299

3.53

29.93

1.2

1.3

6.94

6.59

g/l

0.37

217

Non-follicular lymphoma

112

343

3.33

29.87

1.5

1.4

5.94

6.86

g/l

1.26

250

Deviated nasal septum

284

1364

2.10

29.79

1.3

1.4

6.35

7.10

g/l

3.39

194

920

Paroxysmal tachycardia

207

715

2.43

29.70

1.5

1.3

6.60

6.69

g/l

0.15

147

511

Gout, FINNGEN

239

1069

2.24

29.61

1.4

6.74

7.05

g/l

0.47

166

759

Factors influencing health status and contact with health services

218

437

2.52

29.57

1.3

1.4

6.66

7.17

g/l

0.96

161

291

Other specified/unspecified inflammatory spondylopathies

172

4.42

29.38

1.6

1.4

6.32

6.91

g/l

0.61

121

Other arthrosis

434

1586

1.84

29.22

1.3

1.5

6.60

6.86

g/l

0.76

320

1125

Other encephalitis

5.93

29.18

1.3

6.84

7.33

g/l

0.25

Other diseases of lip and oral mucosa

409

2245

1.84

29.14

1.4

6.74

6.68

g/l

0.10

307

1615

Sequelae of external causes of morbidity and mortality

260

1221

2.15

29.11

1.5

1.4

6.62

6.75

g/l

0.18

192

866

Disorders of oesophagus in diseases classified elsewhere

7.79

29.08

1.5

1.2

6.80

7.50

g/l

0.33

Non-Hodgkin lymphoma, all

111

5.36

28.99

1.5

1.4

5.84

7.05

g/l

0.93

Other (seronegative) rheumatoid arthritis, wide

191

791

2.45

28.85

1.5

1.4

6.79

6.75

g/l

0.04

146

559

Cervical disc disorders

310

1560

2.00

28.74

1.4

6.15

7.04

g/l

4.14

219

1103

Use of hypnotics and sedatives

936

3549

1.51

28.69

1.4

6.51

6.79

g/l

1.35

679

2549

COPD-related respiratory insufficiency

116

372

3.17

28.63

1.4

6.48

6.81

g/l

0.41

274

Other ulcerative colitis

233

3.83

28.53

1.4

1.3

8.00

6.70

g/l

1.47

164

Other anxiety disorders

459

2215

1.77

28.49

1.4

1.3

6.45

6.68

g/l

0.68

367

1571

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

164

637

2.61

28.43

1.4

9.45

6.87

g/l

4.95

111

464

Glomerulonephritis

122

407

3.06

28.22

1.8

1.4

6.67

6.57

g/l

0.07

297

Other skin changes

202

867

2.36

28.17

1.7

1.3

6.42

6.77

g/l

0.66

151

606

Giant cell arteritis with polymyalgia rheumatica

5.70

28.17

1.2

1.5

6.19

7.18

g/l

0.84

Other arrhythmias

557

2482

1.68

28.10

1.4

6.68

6.64

g/l

0.10

388

1808

Zoster [herpes zoster]

187

777

2.44

28.05

1.5

1.4

6.13

6.74

g/l

1.21

149

551

Exposure to unspecified factor

914

4158

1.50

27.87

1.4

6.68

6.71

g/l

0.09

605

3056

Vasculitis limited to skin, not elsewhere classified

6.24

27.85

1.5

1.2

6.08

7.82

g/l

1.67

Cirrhosis of liver, NAS

188

4.15

27.83

1.3

10.46

6.51

g/l

4.68

133

Insulin, combination of fast acting with intermediate-acting or long-acting

537

2912

1.68

27.83

1.5

1.4

6.81

6.80

g/l

0.02

360

2103

Follow-up examination after treatment for conditions other than malignant neoplasms

331

1117

1.98

27.72

1.4

1.3

6.50

6.95

g/l

1.37

261

701

Encephalitis

105

5.44

27.68

1.3

6.81

7.11

g/l

0.15

Dentofacial anomalies [including malocclusion]

670

3305

1.59

27.43

1.4

6.56

6.70

g/l

0.43

477

2404

Non-rheumatic valve diseases

384

1474

1.87

27.41

1.5

1.4

7.05

6.63

g/l

0.99

268

1064

Valvular heart disease excluding rheumatic fever

387

1492

1.86

27.32

1.5

1.4

7.03

6.63

g/l

0.92

270

1079

Disorders of the thyroid gland

816

3468

1.53

27.22

1.5

1.4

6.66

6.72

g/l

0.17

565

2544

Pneumococcal septicemia

118

5.09

27.16

1.5

1.3

10.05

6.62

g/l

1.69

Obesity and other hyperalimentation

598

3482

1.62

27.14

1.4

6.37

6.77

g/l

2.31

435

2541

Acute and subacute iridocyclitis

202

883

2.32

27.04

1.5

1.3

6.59

6.71

g/l

0.14

146

632

Systemic sclerosis (FG)

6.93

26.95

1.3

8.18

6.84

g/l

0.50

Insulin medication

537

2678

1.67

26.91

1.5

1.4

6.81

6.78

g/l

0.05

360

1939

Obesity

594

3466

1.62

26.90

1.4

6.38

6.77

g/l

2.20

431

2532

Papulosquamous disorders

372

2034

1.84

26.90

1.5

1.4

6.50

6.78

g/l

0.97

281

1451

159

625

2.58

26.89

1.6

1.4

7.05

6.48

g/l

0.56

432

Presence of other functional implants

489

1947

1.73

26.73

1.4

6.48

6.81

g/l

1.11

295

1444

GI-bleeding

272

1342

2.04

26.68

1.4

7.02

6.88

g/l

0.17

193

961

Hypoparathyroidism

117

5.03

26.41

2.4

1.4

6.45

7.14

g/l

0.57

L04AC Interleukin inhibitors

295

3.37

26.27

1.4

1.3

7.02

6.59

g/l

0.53

208

Convulsions, not elsewhere classified

204

894

2.27

26.22

1.4

1.3

6.83

6.67

g/l

0.27

149

633

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

6.21

26.08

1.3

12.31

7.53

g/l

1.57

Multiple myeloma

6.21

26.08

1.3

12.31

7.53

g/l

1.57

Pain and other conditions associated with female genital organs and menstrual cycle

211

785

2.27

26.08

1.4

6.50

6.91

g/l

0.80

154

564

Otitis media, unspecified

137

464

2.76

26.01

1.4

1.3

5.83

6.70

g/l

3.42

100

354

Ulcerative colitis (strict definition, require KELA)

193

842

2.32

26.00

1.3

1.4

7.88

6.58

g/l

4.26

128

604

Adverse effects, not elsewhere classified

220

1014

2.20

25.93

1.6

1.3

6.25

6.61

g/l

0.93

169

740

Viral pneumonia (known virus, not influenza)

5.78

25.85

1.5

1.3

6.27

7.48

g/l

0.82

Anterior Iridocyclitis

211

958

2.23

25.82

1.5

1.3

6.59

6.73

g/l

0.17

153

684

Unknown and unspecified causes of morbidity

221

3.73

25.81

1.3

5.83

6.80

g/l

1.91

171

Mixed connective tissue disease

8.14

25.74

1.7

1.3

8.55

5.96

g/l

1.39

Asthma mixed form (mode), excluding more controls

5.67

25.70

1.5

1.3

6.10

7.30

g/l

1.23

Other or unspecified ileus, impaction or obstruction

166

681

2.46

25.60

1.3

1.4

6.82

6.94

g/l

0.11

108

482

Gastroduodenal ulcer

202

901

2.25

25.51

1.4

6.93

7.13

g/l

0.30

135

634

Hypogonadotropic hypogonadism

129

4.75

25.42

1.2

1.3

5.94

6.90

g/l

0.88

Arthrosis

551

1816

1.67

25.38

1.3

1.4

6.75

6.84

g/l

0.22

403

1288

Other viral diseases, including avohilmo

385

2143

1.79

25.38

1.5

1.3

6.68

6.65

g/l

0.05

289

1549

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

187

814

2.33

25.34

1.3

1.4

7.92

6.57

g/l

4.29

124

587

Other and unspecified vasculitis limited to skin

6.19

25.32

1.4

1.2

6.24

7.97

g/l

1.48

Hypokalaemia

132

488

2.74

25.28

1.6

1.3

7.10

6.69

g/l

0.48

353

Other specified/unspecified soft tissue disorders

129

4.67

25.28

1.5

1.3

6.05

7.17

g/l

1.39

Non-selective monoamine reuptake inhibitors

325

1664

1.89

25.22

1.5

1.4

6.16

6.90

g/l

4.01

227

1210

Other enthesopathies

267

1337

2.01

25.17

1.7

1.4

6.15

6.98

g/l

3.34

206

953

Nonalcoholic fatty liver disease

136

513

2.70

25.13

1.3

1.4

6.68

6.81

g/l

0.18

102

365

Lung cancer and mesothelioma

111

310

3.06

25.11

1.2

1.3

6.67

7.28

g/l

0.77

209

Disorders of parathyroid gland

183

782

2.34

25.06

1.8

1.3

6.49

6.89

g/l

0.73

129

551

Agranulocytosis

129

474

2.77

25.05

1.4

1.3

6.98

6.63

g/l

0.35

340

Seronegative rheumatoid arthritis

112

381

2.98

25.02

1.4

1.3

6.88

6.73

g/l

0.10

263

Other diseases of urinary system

838

3146

1.50

24.74

1.4

6.70

6.80

g/l

0.31

590

2304

Atopic dermatitis

542

2661

1.63

24.48

1.4

6.66

6.70

g/l

0.12

419

1928

Thyroiditis, ILD-related definition

127

469

2.75

24.41

1.5

1.3

7.16

6.51

g/l

1.17

347

Other and unspecified effects of external causes

282

1457

1.95

24.37

1.5

1.3

6.39

6.64

g/l

0.65

215

1045

Heart failure and coronary heart disease

320

1180

1.91

24.37

1.3

1.4

7.29

7.01

g/l

0.42

233

809

Cervicalgia

190

846

2.27

24.36

1.7

1.4

6.40

7.03

g/l

1.56

146

593

Hypothyroidism, other/unspecified

747

3240

1.52

24.28

1.4

6.71

6.73

g/l

0.05

518

2380

Asthma mixed form (mode)

5.36

24.20

1.5

1.3

6.10

7.25

g/l

1.21

Cutaneous abscess, furuncle and carbuncle

263

1330

2.00

24.20

1.3

7.01

6.62

g/l

0.90

198

954

Cystitis

708

2740

1.54

24.06

1.4

6.59

6.83

g/l

0.93

519

2009

Other and unspecified urticaria

212

995

2.16

23.92

1.5

1.3

6.64

6.63

g/l

0.01

161

711

Acute tubulo-interstitial nephritis

526

2740

1.63

23.89

1.4

6.84

6.70

g/l

0.27

383

2004

Dermatitis due to substances taken internally

187

3.88

23.87

1.5

6.26

6.93

g/l

0.41

137

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

109

376

2.95

23.83

1.5

1.3

5.68

6.76

g/l

2.75

272

Psoriatic and enteropathic arthropathies

122

447

2.77

23.80

1.3

6.74

6.65

g/l

0.10

316

Secondary right heart disease

112

4.85

23.71

1.3

8.44

7.09

g/l

0.63

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

197

902

2.21

23.67

1.3

1.4

7.82

6.59

g/l

3.97

131

649

Other inflammation of eyelid

152

623

2.47

23.61

1.5

1.3

6.69

6.71

g/l

0.02

113

449

Diseases of spleen

6.92

23.60

1.8

1.3

7.45

6.72

g/l

0.42

Triptan medication for migraine, min. 3 purchases

533

2463

1.63

23.59

1.4

6.15

6.77

g/l

5.27

397

1785

Triptan medication for migraine, single purchase ok

695

3083

1.53

23.56

1.4

6.53

6.72

g/l

0.80

499

2236

Migraine, single triptan purchase ok & required. ICD-code if available is included

695

3083

1.53

23.56

1.4

6.53

6.72

g/l

0.80

499

2236

Other diseases of the digestive system

263

1342

1.97

23.55

1.4

6.97

6.89

g/l

0.09

190

964

Emphysema

184

3.87

23.54

1.2

1.3

6.99

7.11

g/l

0.07

136

Chronic gastritis

211

994

2.14

23.50

1.3

1.4

6.78

6.98

g/l

0.34

172

706

Other pulmonary heart/vessel disease

133

4.47

23.48

1.4

1.2

8.37

7.23

g/l

0.54

Myocarditis

137

4.39

23.45

1.5

1.2

7.01

6.44

g/l

0.51

Hernia

800

3588

1.49

23.38

1.4

6.66

6.71

g/l

0.13

587

2563

Recurrent aphthous stomatitis , including avohilmo

161

681

2.40

23.35

1.4

6.31

6.68

g/l

0.69

130

488

Stomatitis and related lesions

210

992

2.14

23.31

1.4

6.63

6.67

g/l

0.04

168

711

Glomerular disorders in diseases classified elsewhere

123

460

2.72

23.10

1.5

1.4

6.29

6.75

g/l

0.65

336

Diseases of arteries, arterioles and capillaries

529

2405

1.62

23.07

1.4

6.89

6.77

g/l

0.25

386

1708

Acute laryngitis and tracheitis

128

480

2.66

23.06

1.3

6.10

6.90

g/l

2.18

332

Systemic sclerosis

5.90

23.06

1.3

8.18

6.77

g/l

0.57

Psychiatric diseases

819

2759

1.49

23.03

1.3

1.4

6.47

6.89

g/l

2.28

581

1987

Dizziness and giddiness

642

3255

1.54

22.77

1.4

6.51

6.78

g/l

1.13

463

2365

Persons with potential health hazards related to communicable diseases

375

2143

1.75

22.70

1.4

6.27

6.66

g/l

1.47

236

1582

Non-ischemic cardiomyopathy

253

1010

2.00

22.60

1.4

7.06

6.92

g/l

0.22

175

710

Hypothyreosis and Thyroxine purchase for inclusion criteria

770

3400

1.49

22.60

1.4

6.68

6.71

g/l

0.06

533

2497

Diabetes mellitus

881

3510

1.45

22.46

1.4

6.52

6.76

g/l

0.96

610

2568

Pyothorax

138

4.31

22.42

1.4

1.3

6.86

6.95

g/l

0.06

Haemorrhoids and perianal venous thrombosis

277

1452

1.91

22.40

1.3

1.4

7.10

6.91

g/l

0.31

191

1034

Symptoms and signs involving the urinary system

643

3172

1.54

22.37

1.5

1.4

6.80

6.74

g/l

0.13

470

2270

Care involving dialysis

315

3.07

22.32

1.4

5.90

6.66

g/l

1.14

233

Deforming dorsopathies

243

1233

1.99

22.14

1.5

1.4

6.26

6.97

g/l

2.85

184

873

Obesity due to excess calories

442

2690

1.65

21.93

1.3

1.4

6.43

6.79

g/l

1.52

318

1956

Other viral diseases, not elsewhere classified

202

960

2.12

21.91

1.5

1.4

6.73

6.63

g/l

0.12

156

708

Lymphoid leukaemia

185

3.76

21.87

1.5

1.2

6.36

6.95

g/l

0.36

136

Other disorders of eye and adnexa

159

689

2.34

21.86

1.4

5.97

6.74

g/l

3.30

124

489

Diabetes, varying definitions

873

3505

1.45

21.86

1.4

6.53

6.76

g/l

0.92

602

2564

Other inflammation of eyelid, including avohilmo

408

2434

1.69

21.85

1.4

6.25

6.74

g/l

2.34

303

1756

Other abnormal immunological findings in serum

5.87

21.82

1.7

1.3

7.07

6.16

g/l

1.00

Subjective visual disturbances

241

1227

1.98

21.82

1.5

1.3

6.34

6.72

g/l

1.04

181

864

6-mercaptopurine

5.17

21.72

2.1

1.2

8.55

6.59

g/l

0.81

Benign neoplasm: Transverse colon

115

430

2.72

21.65

1.6

1.4

6.28

7.03

g/l

1.63

310

Other viral diseases

298

1626

1.84

21.58

1.5

1.3

6.84

6.54

g/l

0.58

225

1180

Insulin, fast-acting

321

1797

1.80

21.56

1.5

1.3

6.55

6.76

g/l

0.40

220

1299

Other symptoms and signs involving the circulatory and respiratory systems

196

3.63

21.53

1.5

1.3

6.32

6.47

g/l

0.12

144

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

809

3513

1.46

21.47

1.4

6.93

6.70

g/l

0.76

563

2553

Gonarthrosis [arthrosis of knee](FG)

531

1908

1.61

21.45

1.4

1.3

6.75

6.74

g/l

0.03

397

1347

Dermatographic urticaria

287

3.13

21.30

1.8

1.4

6.05

6.48

g/l

0.80

207

Total colectomy operation

148

4.09

21.30

1.6

1.3

7.63

6.90

g/l

0.48

109

Total colectomy

148

4.09

21.30

1.6

1.3

7.63

6.90

g/l

0.48

109

Other diseases of hard tissues of teeth

432

1320

1.70

21.23

1.4

1.3

6.68

6.78

g/l

0.20

302

929

Bronchitis, not specified as acute or chronic

272

3.17

21.18

1.6

1.3

6.42

6.97

g/l

0.93

195

Other medical care

407

2038

1.69

21.17

1.3

1.4

6.52

6.75

g/l

0.53

283

1474

Other viral diseases, not elsewhere classified, including avohilmo

277

1486

1.87

21.01

1.4

6.59

6.54

g/l

0.09

215

1076

Chronic iridocyclitis

172

3.81

20.97

1.5

1.3

6.80

6.94

g/l

0.07

129

Extracorporeal dialysis

229

3.39

20.97

1.5

1.3

5.44

6.87

g/l

2.27

167

Ovarian cyst

296

901

1.89

20.97

1.3

1.4

6.47

6.81

g/l

0.75

218

635

Crohn's disease of small intestine

295

3.08

20.96

1.2

1.3

6.57

6.63

g/l

0.05

216

Idiopathic thrombocytopenic purpura

108

4.69

20.92

1.4

1.3

7.63

7.18

g/l

0.21

Soft tissue disorders related to use, overuse and pressure

232

1183

1.98

20.90

1.4

6.54

7.04

g/l

1.41

179

834

Lung diseases due to external agents

122

479

2.58

20.78

1.3

6.88

6.72

g/l

0.19

359

Volume depletion

318

2.96

20.67

1.3

6.31

6.65

g/l

0.42

221

Type 2 diabetes

821

3291

1.45

20.60

1.4

6.55

6.77

g/l

0.80

574

2394

Intestinal stricture

264

1416

1.88

20.45

1.4

6.49

6.90

g/l

0.81

184

1005

Other metabolic disorders

143

611

2.37

20.34

1.7

1.3

6.43

6.65

g/l

0.31

438

Selective serotonin reuptake inhibitors

816

2930

1.45

20.31

1.4

6.35

6.89

g/l

3.88

584

2125

Heart failure and bmi 25plus

256

886

1.94

20.26

1.4

7.41

6.68

g/l

1.31

169

583

Internal derangement of knee

298

1648

1.80

20.17

1.5

1.4

6.36

6.83

g/l

1.46

211

1177

Enthesopathies of lower limb, excluding foot

203

1003

2.04

20.03

1.4

1.3

6.62

6.89

g/l

0.54

158

708

Conjunctivitis (acute, non atopic)

272

1477

1.85

20.00

1.4

1.3

6.71

6.77

g/l

0.09

208

1068

Secondary and unspecified malignant neoplasm of lymph nodes

303

2.99

19.99

1.4

6.53

7.01

g/l

0.38

222

Viral infections of the central nervous system, including avohilmo

325

2.91

19.95

1.4

6.10

6.65

g/l

0.68

233

Other diseases of stomach and duodenum

202

3.48

19.89

1.4

1.3

6.58

7.09

g/l

0.57

148

Hyperkinetic disorders, excluding more controls

143

572

2.36

19.89

1.3

6.25

6.71

g/l

1.17

112

409

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

5.51

19.86

1.4

1.3

5.60

6.09

g/l

0.69

Type 2 diabetes, wide definition

588

2428

1.53

19.77

1.5

1.4

6.69

6.85

g/l

0.41

440

1820

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

788

3243

1.45

19.71

1.4

6.58

6.76

g/l

0.54

543

2369

Acute pharyngitis

146

632

2.31

19.63

1.3

1.4

6.14

6.93

g/l

2.27

101

443

Insulin, fast-acting or short human

322

1862

1.74

19.39

1.5

1.3

6.55

6.80

g/l

0.52

221

1338

Seropositive rheumatoid arthritis, strict definition

145

637

2.30

19.37

1.5

1.3

6.96

6.73

g/l

0.26

113

448

Viral infections of the central nervous system

293

2.99

19.33

1.4

5.73

6.66

g/l

2.11

206

Diseases of tongue

192

3.50

19.21

1.6

1.3

6.67

6.91

g/l

0.14

137

Ocular pain

103

388

2.70

19.19

1.5

5.98

6.59

g/l

1.57

278

Pruritus

116

463

2.54

19.17

1.6

1.4

7.17

6.97

g/l

0.18

332

Ascites

222

3.29

19.12

1.3

1.2

8.42

6.78

g/l

1.60

168

Other diseases of intestine

139

604

2.33

19.02

1.4

6.81

6.83

g/l

0.01

424

SLE, strict definition

134

4.08

19.00

1.6

1.4

7.13

6.75

g/l

0.24

105

SLE, ICD10

134

4.08

19.00

1.6

1.4

7.13

6.75

g/l

0.24

105

Atopic dermatitis, strict definition

295

1641

1.77

18.82

1.4

6.78

6.64

g/l

0.22

228

1185

Other and unspecified types of non-Hodgkin lymphoma, hilmo

126

4.15

18.81

1.6

1.3

5.92

6.87

g/l

0.78

Behavioural syndromes associated with physiological disturbances and physical factors

806

3850

1.42

18.80

1.3

1.4

6.49

6.76

g/l

1.26

585

2787

Coxibs

220

571

2.03

18.77

1.3

6.32

7.26

g/l

2.88

156

406

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

122

4.21

18.76

1.5

1.3

7.68

7.24

g/l

0.21

Radiculopathy

133

571

2.35

18.71

1.4

1.3

6.10

7.12

g/l

3.43

408

Systemic sclerosis, icd10

4.84

18.61

1.3

8.18

6.93

g/l

0.49

Insulin, intermediate and long-acting

444

2717

1.58

18.55

1.4

6.70

6.77

g/l

0.14

302

1965

Congenital malformations of the musculoskeletal system, not elsewhere classified

5.57

18.47

1.4

1.3

5.59

6.02

g/l

0.55

Coronary atherosclerosis

479

1920

1.58

18.45

1.4

6.74

6.83

g/l

0.18

347

1366

Sleep disorders

775

3758

1.42

18.42

1.3

1.4

6.48

6.76

g/l

1.51

560

2710

Localized swelling, mass and lump of skin and subcutaneous tissue

279

1576

1.78

18.32

1.7

1.3

7.07

6.73

g/l

0.70

230

1120

Cluster headache, strict

120

4.18

18.29

1.2

1.3

6.26

6.76

g/l

0.70

Genitourinary diseases

473

1489

1.60

18.28

1.3

1.4

6.62

6.84

g/l

0.70

350

1058

Heartburn

104

403

2.61

18.27

1.4

1.3

6.11

6.88

g/l

1.84

297

Abnormal findings on diagnostic imaging of central nervous system

189

3.46

18.27

1.6

1.4

6.56

g/l

0.00

143

Psoriasis

256

1412

1.83

18.23

1.3

1.4

6.59

6.78

g/l

0.41

191

1008

Gout, idiopatic and unspecified

199

1011

1.98

18.22

1.4

6.58

7.04

g/l

0.69

135

731

Other disorders of ear

763

3464

1.43

18.16

1.5

1.4

6.46

6.79

g/l

1.71

549

2524

Exposure to other specified factors

698

4178

1.44

18.14

1.5

1.4

6.63

6.72

g/l

0.27

523

3002

Senile cataract

474

1832

1.58

18.13

1.4

6.62

6.81

g/l

0.44

340

1362

Excessive, frequent and irregular menstruation

313

945

1.78

18.08

1.4

1.3

6.25

6.80

g/l

2.02

219

672

Rare circulating lymphoid malignancy, including Hilmo

4.70

18.07

2.0

1.2

6.14

6.78

g/l

0.25

Meniscus derangement

403

1643

1.63

18.04

1.3

1.4

6.65

6.85

g/l

0.51

271

1163

Other CVD (FINNGEN)

261

2.80

18.03

1.4

1.3

6.08

6.94

g/l

0.98

182

Insomnia

762

3738

1.42

18.02

1.3

1.4

6.48

6.77

g/l

1.55

552

2696

Other cataract

346

1530

1.69

17.93

1.5

1.4

6.70

6.85

g/l

0.28

249

1135

Panhypopituitarism

5.83

17.89

1.9

1.3

5.16

7.37

g/l

2.75

Gastric ulcer

135

596

2.28

17.81

1.4

7.03

7.10

g/l

0.07

422

Chronic apical periodontitis

927

3773

1.38

17.80

1.4

6.58

6.73

g/l

0.59

649

2732

Viral and other specified intestinal infections, including avohilmo

262

1408

1.80

17.78

1.5

1.3

6.38

6.55

g/l

0.43

191

1017

Type 2 diabetes, definitions combined

766

3135

1.43

17.78

1.5

1.4

6.53

6.78

g/l

0.90

538

2288

Other and unspecified drugs and medicaments

353

2.71

17.65

1.4

5.66

6.71

g/l

2.42

256

Other infectious diseases, including avohilmo

342

2.73

17.60

1.4

1.3

6.76

6.90

g/l

0.11

248

Cluster headache, wide

128

3.99

17.59

1.2

1.3

6.18

6.79

g/l

0.93

Malignant neoplasm of pancreas, including Hilmo

276

2.94

17.58

1.6

1.4

6.80

6.99

g/l

0.17

202

Gonarthrosis

453

1616

1.59

17.56

1.3

1.5

6.84

6.86

g/l

0.03

337

1151

Ehlers-Danlos syndrome, including avohilmo

6.31

17.51

1.4

1.3

5.41

6.28

g/l

1.37

Ulcerative enterocolitis

107

4.32

17.49

1.4

1.3

7.67

6.52

g/l

0.94

Disorders of ocular muscles, binocular movement, accommodation and refraction

431

2739

1.57

17.32

1.5

1.4

6.44

6.69

g/l

0.98

318

1988

Other meningitis

5.98

17.25

1.6

1.3

5.75

6.39

g/l

0.59

Fissure and fistula of anal and rectal regions

199

1031

1.94

17.23

1.3

1.4

6.63

6.87

g/l

0.39

134

734

Nonorganic sleeping disorders

219

1172

1.89

17.23

1.4

6.26

6.59

g/l

0.95

157

837

Hepatic failure, not elsewhere classified

113

4.17

17.12

1.4

1.3

8.10

6.51

g/l

1.46

Misadventures to patients during surgical and medical care

135

607

2.25

17.12

1.5

1.3

6.53

6.81

g/l

0.36

436

Type 2 diabetes, strict (exclude DM1)

769

3173

1.41

17.09

1.5

1.4

6.54

6.78

g/l

0.88

541

2306

Abscess of lung

5.88

16.96

1.3

1.4

8.02

6.97

g/l

0.32

Diffuse large B-cell lymphoma, helper endpoint

150

3.67

16.92

1.5

4.86

7.09

g/l

4.47

116

Diffuse large B-cell lymphoma

150

3.67

16.92

1.5

4.86

7.09

g/l

4.47

116

Diffuse large B-cell lymphoma, including Hilmo

150

3.67

16.92

1.5

4.86

7.09

g/l

4.47

116

Ulcerative ileocolitis

155

3.64

16.91

1.3

8.30

6.43

g/l

1.76

113

Diabetes medication

862

3648

1.38

16.90

1.4

6.60

6.75

g/l

0.49

603

2665

Inflammatory diseases of female pelvic organs

526

2393

1.51

16.88

1.4

6.48

6.67

g/l

0.58

391

1750

Ehlers-Danlos syndrome

6.82

16.86

1.4

1.2

5.38

6.19

g/l

1.11

Congenital malformations and deformations of the musculoskeletal system

110

454

2.45

16.81

1.6

1.4

6.27

6.35

g/l

0.11

353

Other abnormalities of plasma proteins

6.68

16.78

2.1

1.4

7.29

6.30

g/l

0.33

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

5.60

16.77

1.5

1.2

8.00

7.26

g/l

0.28

Substance abuse, excluding more controls

443

2392

1.55

16.75

1.3

1.4

6.49

6.91

g/l

1.59

305

1694

Polyarthritis, unspecified

111

4.15

16.66

1.8

1.4

6.62

7.00

g/l

0.19

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

130

579

2.26

16.65

1.5

1.4

6.44

6.54

g/l

0.14

443

Keratitis

311

1861

1.68

16.65

1.5

1.4

6.84

6.71

g/l

0.26

217

1326

Chronic nephritic syndrome

134

3.82

16.54

2.0

1.3

7.39

6.81

g/l

0.22

Reactive arthropathies, FINNGEN

259

2.94

16.50

1.4

1.3

6.41

6.62

g/l

0.23

180

Other infectious diseases

270

2.90

16.48

1.5

1.3

7.03

6.92

g/l

0.07

200

Cardiomyopathy

138

636

2.19

16.43

1.3

7.34

6.82

g/l

0.73

101

467

Crohn's disease NAS

266

2.91

16.35

1.2

1.3

6.99

6.68

g/l

0.28

193

Crohn's disease of large intestine

203

3.22

16.34

1.3

7.16

6.74

g/l

0.28

149

Missing teeth due to accident, extraction or parodontitis

494

2943

1.51

16.30

1.5

1.4

6.81

6.76

g/l

0.10

356

2119

Brachial plexus disorders

104

428

2.47

16.21

1.5

1.4

6.21

6.54

g/l

0.34

305

Obesity, other/unspecified

306

1838

1.68

16.17

1.5

1.4

6.59

6.74

g/l

0.31

241

1331

Other diseases of oesophagus

306

2.75

16.15

1.2

1.3

6.46

6.95

g/l

0.70

220

Exclusions for E4_PCOS_CONSORTIUM

620

2675

1.45

16.12

1.5

1.4

6.26

6.75

g/l

2.83

394

1991

Postprocedural disorders of nervous system

308

2.74

16.00

1.5

1.4

6.07

6.51

g/l

0.53

229

Ischaemic heart disease, wide definition

589

2484

1.46

15.98

1.5

1.4

6.63

6.80

g/l

0.46

421

1784

Acute generalized exanthematous pustulosis

171

3.41

15.94

1.5

1.3

6.41

6.91

g/l

0.24

127

Personality disorders, excluding more controls

217

1184

1.84

15.93

1.3

1.4

6.30

6.86

g/l

2.27

154

841

Dental operations

434

1422

1.58

15.93

1.4

6.78

6.71

g/l

0.12

307

1037

Oxicams

176

490

2.05

15.82

1.3

6.19

7.32

g/l

3.60

135

350

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

397

2.50

15.81

1.4

7.01

6.67

g/l

0.22

296

Other/unspecified rheumatoid arthritis

106

445

2.41

15.80

1.6

1.4

6.37

6.86

g/l

0.87

309

Complications of internal orthopaedic prosthetic devices, implants and grafts

173

883

1.97

15.71

1.4

6.40

6.96

g/l

1.30

123

630

Gout, unspecified

161

802

2.02

15.68

1.4

6.56

6.96

g/l

0.48

110

588

Pneumothorax

208

3.12

15.66

1.3

7.41

6.87

g/l

0.47

157

Trochanteric bursitis

125

566

2.23

15.61

1.6

1.4

6.12

6.99

g/l

2.41

401

Substance use, excluding alcohol

192

1018

1.90

15.60

1.3

1.4

6.39

6.66

g/l

0.53

139

731

Chronic ulcer of skin, not elsewhere classified

214

3.08

15.56

1.9

1.4

6.79

7.13

g/l

0.28

158

Haemolytic anaemias

117

3.94

15.55

1.6

1.3

7.57

6.99

g/l

0.17

Other neurological diseases

558

2975

1.46

15.50

1.4

6.26

6.86

g/l

3.70

400

2136

Exophthalmic conditions

7.33

15.41

1.7

1.3

6.13

5.70

g/l

0.24

Type 2 diabetes, definitions combined, including avohilmo

760

3168

1.39

15.39

1.4

6.53

6.78

g/l

0.87

530

2303

Diabetes, insulin treatment (Kela reimbursement)

815

3541

1.37

15.37

1.4

6.58

6.75

g/l

0.51

566

2580

Endocarditis

109

4.03

15.37

1.3

1.2

8.64

6.39

g/l

1.07

Disorders of mineral metabolism

332

2.63

15.34

1.3

7.10

6.87

g/l

0.18

240

Algoneurodystrophy

123

3.84

15.30

1.6

1.4

6.01

6.87

g/l

0.85

Injuries to the knee and lower leg

976

3954

1.34

15.26

1.5

1.4

6.57

6.75

g/l

0.82

724

2834

Other and unspecified visual disturbances

108

465

2.35

15.24

1.6

1.3

6.38

6.87

g/l

0.68

326

Acetic acid derivatives and related substances

205

552

1.93

15.22

1.5

1.3

6.19

7.32

g/l

3.14

146

391

Pleural plaque

249

2.88

15.19

1.3

7.31

7.06

g/l

0.21

186

Disease of hard tissues of teeth, NOS

394

1301

1.59

15.18

1.4

1.3

6.68

6.79

g/l

0.25

270

915

Diseases of oral cavity, salivary glands and jaws

404

1320

1.58

15.16

1.4

1.3

6.53

6.78

g/l

0.66

296

929

Covid-19 suspected case

203

1106

1.85

15.16

1.3

6.47

6.69

g/l

0.49

180

776

Ulcerative colitis (strict definition, all Crohn cases excluded)

145

705

2.08

15.14

1.2

1.4

7.95

6.56

g/l

3.64

515

Crohn disease (strict definition, require KELA, min 2 HDR)

278

2.78

15.10

1.2

1.4

6.95

6.69

g/l

0.19

200

Marginal zone B-cell lymphoma, including Hilmo

5.59

15.09

1.6

1.2

6.44

6.49

g/l

0.01

STROKE

419

1830

1.55

15.07

1.3

1.4

6.89

6.77

g/l

0.21

309

1312

Small fibre neuropathy

111

3.98

15.04

1.7

1.3

5.94

7.22

g/l

1.48

Autonomic disorders

4.67

15.03

1.4

1.3

5.58

6.90

g/l

1.32

Invasive ventilation

273

2.79

15.02

1.3

5.71

6.73

g/l

1.48

204

Carrier of infectious disease

4.21

15.02

1.6

1.3

6.27

6.53

g/l

0.20

Postprocedural endocrine and metabolic disorders, not elsewhere classified

121

550

2.22

15.01

1.8

1.3

6.37

6.54

g/l

0.22

397

Chorioretinal inflammation

4.19

14.99

1.5

1.3

7.22

6.98

g/l

0.07

Carpal tunnel syndrome

485

2840

1.49

14.99

1.5

1.4

6.54

6.81

g/l

0.96

359

2050

Injuries to the abdomen, lower back, lumbar spine and pelvis

330

2029

1.61

14.98

1.3

1.4

6.39

6.80

g/l

1.57

242

1449

Spondylolisthesis/Spondylolysis

147

721

2.06

14.96

1.7

1.3

5.95

6.96

g/l

3.76

109

514

Benign neoplasm: Colon, unspecified

198

1075

1.86

14.94

1.5

1.4

6.65

6.95

g/l

0.50

146

765

Nephrotic syndrome

116

3.90

14.94

1.9

1.3

5.14

6.74

g/l

1.93

Retention of urine

255

1194

1.74

14.92

1.5

1.4

6.79

6.93

g/l

0.22

180

844

Viral and other specified intestinal infections

192

1007

1.87

14.89

1.6

1.3

6.42

6.58

g/l

0.26

136

730

Ankylosing spondylitis

343

2.57

14.88

1.3

6.40

6.93

g/l

0.97

243

Disorders of muscles

397

2.45

14.82

1.3

6.32

6.86

g/l

0.70

280

Crohn disease (strict definition, require KELA)

281

2.75

14.80

1.2

1.3

6.95

6.66

g/l

0.21

202

Generalized skin eruption due to drugs and medicaments

150

3.48

14.74

1.5

1.3

6.41

6.92

g/l

0.22

111

Other disorders of skin and subcutaneous tissue, not elsewhere classified

127

593

2.16

14.73

1.8

1.4

6.40

6.80

g/l

0.69

426

Alcohol use disorder, Swedish definition

438

2649

1.51

14.73

1.3

1.4

6.62

6.78

g/l

0.36

277

1897

Faecal incontinence

270

2.77

14.73

1.4

1.3

6.43

6.99

g/l

0.57

192

465

2797

1.49

14.69

1.3

1.4

6.63

6.78

g/l

0.33

295

2008

Etanercept

294

2.70

14.64

1.5

1.3

6.98

6.38

g/l

0.80

218

Acquired haemolytic anaemia

4.56

14.58

1.6

1.4

6.59

6.83

g/l

0.06

Psoriatic arthropathies

407

2.41

14.52

1.3

1.4

6.48

6.85

g/l

0.49

287

Cerebral cysts

218

2.99

14.50

1.8

1.3

6.44

6.73

g/l

0.23

164

Disorders of optic nerve and visual pathways

414

2.40

14.47

1.6

1.4

6.05

6.54

g/l

0.78

304

Unspecified kidney failure

324

2.59

14.47

1.3

7.19

6.66

g/l

0.43

238

Reactive arthropathies

336

2.56

14.47

1.4

6.88

7.02

g/l

0.11

233

488

2897

1.47

14.39

1.3

1.4

6.61

6.79

g/l

0.45

313

2072

Vascular disorders of the intestines

182

3.17

14.38

1.2

1.3

7.32

7.30

g/l

0.01

129

Coeliac disease

116

528

2.22

14.37

1.7

1.4

7.05

6.73

g/l

0.29

380

Chronic lymphocytic leukaemia

4.39

14.36

1.2

1.4

6.99

7.23

g/l

0.07

Chronic lymphocytic leukaemia, helper endpoint

4.39

14.36

1.2

1.4

6.99

7.23

g/l

0.07

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

4.39

14.36

1.2

1.4

6.99

7.23

g/l

0.07

Other disorders of bone

177

940

1.90

14.35

1.5

1.3

6.10

6.71

g/l

1.65

134

683

Diplopia

123

574

2.17

14.32

1.8

1.3

5.91

6.91

g/l

3.40

414

Secondary uncertain malignant neoplasm

113

510

2.24

14.28

1.4

7.12

6.86

g/l

0.16

371

Sacroiliitis, not elsewhere classified

163

3.31

14.25

1.3

1.4

6.46

6.63

g/l

0.12

113

Postmenopausal osteoporosis with pathological fracture

179

3.17

14.13

1.3

1.4

5.93

6.89

g/l

1.22

132

Persons encountering health services for specific procedures, not carried out

376

2.45

14.12

1.4

6.11

6.71

g/l

1.35

270

Cardiac murmurs and other cardiac sounds

325

2.55

14.02

1.3

6.68

6.74

g/l

0.05

241

Tonsillectomy and adenotomy

501

2389

1.47

14.00

1.4

1.3

6.29

6.67

g/l

1.57

391

1696

Viral warts

104

459

2.30

13.91

1.4

6.26

6.51

g/l

0.31

328

Other diseases of anus and rectum

222

1270

1.75

13.89

1.2

1.4

6.55

6.92

g/l

0.85

165

904

Coxarthrosis [arthrosis of hip](FG)

352

1541

1.58

13.88

1.3

6.48

6.82

g/l

1.09

278

1085

Other bursopathies

110

497

2.23

13.88

1.5

1.3

6.75

6.98

g/l

0.29

346

Extreme obesity with alveolar hypoventilation

142

3.45

13.76

1.4

1.3

7.26

6.86

g/l

0.20

101

Otalgia

381

2.42

13.73

1.8

1.3

6.38

6.74

g/l

0.36

277

Cluster headache, strict, including avohilmo

209

2.97

13.71

1.3

5.90

6.64

g/l

1.33

147

Oesophagitis

157

3.30

13.70

1.4

1.2

6.03

6.87

g/l

1.03

111

Panic disorder

143

719

2.01

13.65

1.3

6.67

6.73

g/l

0.09

111

505

Hyperlipidaemia, other/unspecified

283

1560

1.64

13.63

1.5

1.4

6.68

6.91

g/l

0.37

207

1122

Other peripheral vascular diseases

317

2.56

13.58

1.3

1.4

6.30

6.51

g/l

0.16

234

Disorders of calcium metabolism

232

2.84

13.55

1.3

1.4

7.20

6.72

g/l

0.33

170

Gout, strict definition

140

701

2.01

13.52

1.4

6.29

7.07

g/l

1.84

511

Erythema nodosum

4.01

13.50

1.7

1.4

7.32

6.90

g/l

0.16

Meningitis

195

3.03

13.48

1.5

1.3

6.05

6.77

g/l

1.06

144

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

307

2.58

13.46

1.2

1.4

6.90

6.63

g/l

0.20

220

Pyogenic arthritis

211

2.93

13.45

1.4

7.99

7.09

g/l

0.78

152

Other autoimmune haemolytic anaemias

6.55

13.40

1.8

1.3

7.46

6.82

g/l

0.10

Unspecified/other endometriosis

389

2.37

13.37

1.5

1.4

5.68

6.81

g/l

2.55

276

Other noninfective disorders of lymphatic vessels and lymph nodes

116

3.70

13.35

1.5

1.3

6.38

6.35

g/l

0.01

Other enthesopathy of foot (+metatarsalgia)

392

2.37

13.34

1.6

1.3

5.79

6.85

g/l

2.18

277

Other external causes of accidental injury

654

2352

1.40

13.31

1.4

1.3

6.49

6.83

g/l

1.67

471

1707

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

191

3.02

13.29

1.5

1.4

7.70

7.01

g/l

0.43

144

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

277

1055

1.66

13.27

1.3

1.4

6.44

6.45

g/l

0.01

207

784

Lichen simplex chronicus and prurigo

224

2.86

13.23

1.2

1.4

7.79

6.81

g/l

0.96

164

Hypersensitivity pneumonitis due to organic dust

5.63

13.16

1.3

1.5

8.60

6.94

g/l

0.96

Coxarthrosis

333

1364

1.58

13.15

1.3

1.5

6.57

6.94

g/l

1.18

264

981

Phlebitis and thrombophlebitis (not including DVT)

184

1019

1.82

13.10

1.4

6.10

6.68

g/l

1.54

134

748

Acute lymphadenitis

248

2.75

13.07

1.9

1.3

6.54

6.34

g/l

0.17

186

Hypothyroidism, strict autoimmune, 3 medication purchases required

646

3149

1.38

13.05

1.3

1.4

6.95

6.73

g/l

0.67

466

2315

Open wound of lower leg

138

697

2.00

13.04

1.4

1.3

6.24

6.64

g/l

0.80

498

Cluster headache, wide,, including avohilmo

221

2.86

12.99

1.3

5.84

6.68

g/l

1.65

156

Neuralgia and neuritis, unspecified

173

3.11

12.96

1.4

1.3

6.50

7.06

g/l

0.46

124

Other and unspecified nerve root and plexus disorders, also in other diseases

179

987

1.83

12.94

1.5

1.3

6.58

6.87

g/l

0.42

109

699

Childhood allergy (age < 16)

141

586

2.00

12.93

1.4

6.27

6.42

g/l

0.28

110

427

Falls/tendency to fall

876

3314

1.33

12.92

1.3

1.4

6.53

6.75

g/l

0.91

627

2382

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

212

1066

1.75

12.86

1.3

6.21

6.61

g/l

1.42

165

772

Disturbance of activity and attention

142

710

1.97

12.84

1.3

1.4

6.21

6.63

g/l

1.12

111

515

Psoriasis vulgaris

162

870

1.88

12.76

1.3

6.61

6.78

g/l

0.27

121

624

Benign neoplasm: Small intestine

135

3.40

12.65

1.2

1.4

6.98

7.06

g/l

0.04

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

219

1271

1.71

12.65

1.2

1.3

6.14

6.85

g/l

3.31

156

910

Other obstetric conditions, not elsewhere classified

281

1092

1.63

12.57

1.3

1.4

6.43

g/l

0.01

211

811

Menorrhagia

257

858

1.68

12.48

1.4

6.31

6.76

g/l

1.15

182

607

Cytomegalovirus infection, IBD co-morbidity

4.12

12.47

1.4

1.3

6.19

6.99

g/l

0.30

Irregular menses

404

2047

1.49

12.46

1.5

1.4

6.19

6.71

g/l

3.09

299

1519

Injuries to the ankle and foot

609

3791

1.38

12.45

1.4

6.61

6.71

g/l

0.26

465

2717

Cardiomyopathy, other and unspecified

260

2.65

12.44

1.3

7.61

6.52

g/l

1.05

197

Fall on same level

933

3817

1.31

12.44

1.3

1.4

6.71

g/l

0.00

681

2750

Diseases of the myoneural junction and muscle

105

488

2.17

12.42

1.5

1.4

6.25

6.73

g/l

0.80

353

Benign neoplasm: Stomach

374

2.36

12.42

1.8

1.4

5.96

6.87

g/l

1.96

270

Raynaud syndrome

400

2.31

12.35

1.4

6.56

6.58

g/l

0.01

294

Benign neoplasm: Duodenum

4.06

12.27

1.2

1.3

7.39

7.28

g/l

0.04

Rosacea

124

617

2.03

12.26

1.3

1.4

6.56

6.74

g/l

0.25

436

Supplementary factors related to causes of morbidity and mortality classified elsewhere

262

1629

1.62

12.23

1.7

1.3

6.48

6.69

g/l

0.42

194

1156

Other coagulation defects

310

2.49

12.20

1.5

1.4

6.65

6.56

g/l

0.07

224

Systemic lupus erythematosus, unspecified

114

3.60

12.19

1.4

7.60

6.51

g/l

0.82

Viral warts, including avohilmo

197

1140

1.74

12.12

1.5

1.4

6.49

6.63

g/l

0.24

149

814

Disorders of vestibular function (Vertigo)

358

2327

1.51

12.12

1.3

1.4

6.52

6.75

g/l

0.60

248

1688

Fentanyl

286

2.53

12.11

1.7

1.2

6.50

6.86

g/l

0.31

213

Diseases of pulp and periapical tissues, including avohilmo

819

3202

1.33

12.11

1.4

6.81

6.70

g/l

0.31

586

2307

Cervicocranial syndrome

391

2.30

12.07

1.6

1.2

5.70

6.87

g/l

4.38

280

Rash and other nonspecific skin eruption

404

2.28

12.07

1.4

6.49

6.88

g/l

0.50

302

Erythema multiforme

4.30

12.06

1.2

1.3

8.22

6.75

g/l

0.80

External causes of morbidity and mortality

513

1801

1.43

12.05

1.4

1.3

6.48

6.97

g/l

2.39

371

1308

Myelodysplastic syndrome, including Hilmo

4.27

12.03

1.3

1.4

7.04

7.34

g/l

0.16

Chronic tubulo-interstitial nephritis

110

3.61

12.03

1.3

1.4

8.02

6.79

g/l

0.90

Oter anti-inflammatory and antirheumatic agents, non-steroids

156

445

1.94

12.02

1.4

1.3

6.71

7.37

g/l

0.90

119

317

Lesion of ulnar nerve

127

642

2.00

12.02

1.5

1.3

6.44

6.92

g/l

0.73

459

Superficial injury of lower leg

223

1338

1.68

12.00

1.3

1.4

6.22

6.67

g/l

1.33

177

956

Hernia of abdominal wall

351

2341

1.51

11.99

1.5

1.4

6.64

6.78

g/l

0.31

261

1679

Dermatophytosis

122

609

2.02

11.96

1.4

6.65

6.93

g/l

0.39

445

Other and unspecified rosacea

412

2.26

11.96

1.3

1.4

6.48

6.90

g/l

0.54

294

Cellulitis

189

1086

1.75

11.93

1.4

1.3

6.66

g/l

0.00

149

778

Chronic suppurative otitis media, including avohilmo

326

2.42

11.88

1.8

1.4

6.27

6.65

g/l

0.64

242

Other disorders of conjunctiva

117

577

2.05

11.86

1.5

1.3

6.37

6.86

g/l

0.94

412

Post-traumatic stress disorder

363

2.34

11.86

1.3

6.18

6.56

g/l

0.73

254

Metatarsalgia

363

2.34

11.85

1.6

1.3

5.68

6.89

g/l

2.39

253

Hyperkinetic disorders

147

764

1.89

11.85

1.3

1.4

6.22

6.58

g/l

0.91

116

564

Scleritis and episcleritis

267

2.59

11.85

1.6

1.5

6.67

6.49

g/l

0.17

203

Synovial cyst of popliteal space [Baker]

227

2.72

11.79

1.3

6.47

7.21

g/l

0.87

160

Vitamin deficiency

173

3.00

11.71

1.5

1.3

6.79

6.83

g/l

0.02

126

Vitamin deficiency, wide

173

3.00

11.71

1.5

1.3

6.79

6.83

g/l

0.02

126

Ulcerative rectosigmoiditis

353

2.35

11.70

1.3

7.49

6.66

g/l

0.92

251

Demyelinating diseases of the central nervous system

397

2.27

11.70

1.4

6.14

6.50

g/l

0.48

289

Abnormal involuntary movements

119

594

2.02

11.68

1.4

1.3

5.88

6.71

g/l

2.94

430

Cerebral palsy and other paralytic syndromes

104

494

2.13

11.67

1.5

1.4

6.08

6.63

g/l

0.78

362

Accidents

641

2352

1.37

11.65

1.4

1.3

6.55

6.83

g/l

1.20

465

1707

Dental caries, including avohilmo

537

1956

1.41

11.65

1.4

6.60

6.75

g/l

0.40

366

1414

Hyperparathyroidism

130

662

1.96

11.63

1.5

1.3

6.51

6.86

g/l

0.47

468

Adenocarcinoma and ductal carcinoma of pancreas

104

3.62

11.49

1.2

1.4

6.09

7.19

g/l

0.92

Benign neoplasm: Pancreas

3.78

11.47

1.4

1.3

6.09

7.27

g/l

0.88

Disorders of vitreous body

377

2446

1.47

11.44

1.4

6.79

6.78

g/l

0.01

288

1765

Disorders of lipoprotein metabolism and other lipidaemias

604

2689

1.37

11.41

1.5

1.4

6.79

6.78

g/l

0.01

448

1929

Dystonia

220

2.73

11.40

1.5

1.4

6.29

6.46

g/l

0.07

159

Cytomegaloviral disease

3.84

11.38

1.4

1.3

6.19

6.85

g/l

0.26

Fibroblastic disorders

159

881

1.82

11.36

1.4

1.3

6.77

7.21

g/l

0.61

112

625

Disorders of vitreous body and globe

386

2505

1.46

11.34

1.4

6.76

6.80

g/l

0.06

297

1809

Other CVD

142

761

1.88

11.29

1.4

1.3

6.46

6.91

g/l

0.56

557

Tongue abnormality

222

2.70

11.20

1.6

1.5

6.70

6.90

g/l

0.10

167

Cytomegaloviral disease, including avohilmo

3.80

11.20

1.4

1.3

6.19

6.84

g/l

0.26

Injuries to the thorax

349

2357

1.49

11.19

1.5

1.4

7.11

6.81

g/l

0.81

269

1668

Injury, poisoning and certain other consequences of external causes

418

1433

1.47

11.19

1.5

1.3

6.72

6.92

g/l

0.48

305

1013

Disorders of continuity of bone

463

2.14

11.18

1.4

1.3

6.35

6.77

g/l

0.52

329

Other retinal disorders

465

2501

1.42

11.17

1.4

6.61

6.86

g/l

0.84

329

1807

Cramp and spasm

189

2.85

11.16

1.4

1.3

5.88

6.91

g/l

1.66

139

Other follicular disorders

342

2.34

11.16

1.4

6.44

6.68

g/l

0.30

241

Hyperkalaemia

178

2.90

11.13

1.6

1.4

6.98

6.95

g/l

0.02

135

Allergic urticaria

355

2.31

11.11

1.3

1.4

6.55

6.56

g/l

0.01

258

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

5.91

11.09

1.4

1.3

6.73

6.65

g/l

0.04

Caries of dentine, including avohilmo

582

2165

1.38

11.08

1.4

6.42

6.75

g/l

1.35

403

1579

Special screening examination for infectious and parasitic diseases

171

700

1.79

11.07

1.5

1.3

6.40

6.75

g/l

0.63

135

434

Umbilical hernia

213

1291

1.66

11.07

1.6

1.4

6.80

6.73

g/l

0.11

156

924

Colectomy operation

129

676

1.92

11.03

1.4

1.3

7.49

6.78

g/l

0.96

485

Bullous disorders

191

2.82

10.93

1.4

7.32

6.97

g/l

0.31

141

Postprocedural disorders of digestive system, not elsewhere classified

108

3.49

10.88

1.9

1.3

6.43

7.09

g/l

0.53

CR(E)ST syndrome

4.86

10.80

1.3

1.4

7.29

7.69

g/l

0.07

Hepatomegaly and splenomegaly, not elsewhere classified

8.37

10.76

1.3

6.66

6.31

g/l

0.13

Combined immunodeficiencies

8.34

10.74

1.4

1.2

4.93

6.57

g/l

2.26

Ulcer of lower limb, not elsewhere classified

111

558

2.01

10.71

1.3

1.4

6.85

6.88

g/l

0.02

404

Paracetamol or NSAID medication

120

296

2.06

10.70

1.4

1.3

6.64

7.37

g/l

1.28

227

Fracture of rib(s), sternum and thoracic spine

230

1434

1.61

10.69

1.5

1.4

7.18

6.83

g/l

0.70

178

1007

Injuries to the wrist and hand

812

4165

1.30

10.68

1.4

6.53

6.75

g/l

0.89

600

2998

Mouth breathing

317

2123

1.50

10.61

1.4

6.46

6.72

g/l

0.71

223

1537

Conductive and sensorineural hearing loss

583

2860

1.36

10.61

1.5

1.4

6.45

6.80

g/l

1.54

404

2085

Vasomotor rhinitis (mode)

270

2.48

10.58

1.9

1.4

5.86

6.65

g/l

1.58

195

Sensorineural hearing loss

546

2664

1.37

10.57

1.5

1.4

6.39

6.80

g/l

1.96

375

1941

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

4.08

10.56

1.4

5.85

6.97

g/l

1.00

Other diseases of arteries and capillaries

332

2.31

10.52

1.7

1.4

6.80

6.76

g/l

0.03

245

Paralytic ileus

3.60

10.50

1.3

1.2

5.82

7.73

g/l

2.02

Other (not insulin) diabetes medications

744

3338

1.31

10.50

1.4

6.63

6.77

g/l

0.37

522

2425

Abnormal findings on examination of urine, without diagnosis

157

2.98

10.50

1.4

1.3

5.99

6.93

g/l

1.24

115

Other congenital malformations

416

2.16

10.46

1.3

1.4

6.50

6.35

g/l

0.20

314

Benign neoplasm of major salivary glands

371

2.23

10.45

1.7

1.4

7.01

6.87

g/l

0.12

276

Other disorders of kidney and ureter

108

543

2.01

10.45

1.4

6.68

6.90

g/l

0.26

398

Neuromuscular dysfunction of bladder

346

2.28

10.42

1.3

6.16

6.98

g/l

1.13

255

Benign neoplasm: Caecum

430

2.14

10.41

1.6

1.4

6.46

6.99

g/l

0.82

310

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

142

3.07

10.36

1.5

1.3

7.96

7.32

g/l

0.28

111

Polyuria

171

996

1.73

10.36

1.4

6.76

6.92

g/l

0.21

129

707

conjunctival haemorrhage

273

2.45

10.34

1.6

1.3

6.32

7.10

g/l

0.98

203

Endometriosis

245

889

1.61

10.32

1.3

1.4

6.31

6.79

g/l

1.28

184

627

Hypotension

117

607

1.94

10.31

1.3

6.51

6.81

g/l

0.29

441

Endometriosis of pelvic peritoneum

134

658

1.87

10.30

1.4

6.23

6.91

g/l

1.26

467

Artrosis, including avohilmo

624

2550

1.34

10.29

1.4

6.61

6.82

g/l

0.83

461

1798

Malignant neoplasm of pancreas

209

2.66

10.25

1.2

1.5

6.18

7.05

g/l

1.15

154

Benign neoplasm: salivary glands, exclude unknown (D119)

336

2.29

10.25

1.7

1.4

7.04

6.81

g/l

0.20

247

Type of accident

239

1520

1.58

10.25

1.8

1.3

6.49

6.71

g/l

0.43

176

1078

Diseases of external ear

280

1845

1.53

10.23

1.4

6.73

6.79

g/l

0.12

207

1327

Other demyelinating diseases of the central nervous system

165

2.91

10.23

1.5

1.4

6.26

6.67

g/l

0.33

115

Other disorders starting during childhood or adolecense, excluding more controls

199

2.67

10.21

1.4

1.3

5.82

6.41

g/l

1.07

151

Oesophageal varices

128

3.18

10.19

1.7

1.3

10.96

6.43

g/l

3.25

Chronic suppurative otitis media

233

2.56

10.19

1.8

1.3

6.30

6.87

g/l

0.89

168

Subacute thyroiditis

118

3.28

10.17

1.5

6.17

6.95

g/l

0.85

Nummular dermatitis

306

2.35

10.15

1.5

1.4

6.48

6.90

g/l

0.51

226

Calcific aortic valvular stenosis, diagnosis (helper)

181

1034

1.69

10.15

1.5

1.4

7.93

6.93

g/l

1.68

134

737

Operations 2 for CAVS

181

1034

1.69

10.15

1.5

1.4

7.93

6.93

g/l

1.68

134

737

Other/unspecified reactive arthropathies

282

2.41

10.13

1.4

6.54

6.60

g/l

0.06

202

Failure and rejection of transplanted organs and tissues

4.61

10.12

1.4

6.09

7.08

g/l

0.46

Viral meningitis

134

3.12

10.10

1.4

1.3

5.59

6.23

g/l

0.85

101

Procreative management

295

1614

1.51

10.08

1.5

1.4

6.70

6.56

g/l

0.29

199

1149

Episcleritis

217

2.62

10.08

1.6

1.4

6.48

6.59

g/l

0.08

166

Diseases of inner ear

402

2723

1.42

10.06

1.3

1.4

6.64

6.84

g/l

0.52

276

1968

Dipeptidyl peptidase 4 (DPP-4) inhibitors

388

2131

1.43

10.02

1.4

7.00

6.86

g/l

0.24

280

1537

Other/unspecified synovitis and tenosynovitis

437

2.10

9.98

1.5

1.3

5.61

6.79

g/l

3.28

310

Calcific aortic valvular stenosis

181

1039

1.68

9.98

1.5

1.4

7.93

6.92

g/l

1.68

134

742

Calcific aortic valvular stenosis, operated

181

1039

1.68

9.98

1.5

1.4

7.93

6.92

g/l

1.68

134

742

Calcific aortic valvular stenosis, including rheumatic fever

181

1038

1.68

9.97

1.5

1.4

7.93

6.92

g/l

1.69

134

740

Disorders of choroid and retina

596

3129

1.34

9.95

1.5

1.4

6.62

6.77

g/l

0.46

426

2259

Speech and linguistic disorders, excluding more controls

318

2.26

9.91

1.2

1.3

6.46

6.67

g/l

0.24

231

Cutaneous lupus erythematosus

3.98

9.91

1.2

1.3

8.41

7.07

g/l

0.45

Hordeolum and other deep inflammation of eyelid

243

2.50

9.86

1.6

1.4

6.26

6.71

g/l

0.51

176

Fenamates

107

363

2.02

9.84

1.5

1.3

6.59

7.55

g/l

1.80

266

Other or ill-defined heart diseases

185

2.74

9.84

1.5

1.2

7.55

6.61

g/l

0.96

131

Viral meningitis, including avohilmo

147

2.98

9.81

1.4

1.3

5.71

6.26

g/l

0.71

110

Restless leg syndrome

122

654

1.88

9.80

1.7

1.3

5.86

6.81

g/l

3.70

469

Allergic purpura

3.50

9.79

1.4

1.3

5.45

6.24

g/l

0.87

Adhesive capsulitis of shoulder

123

661

1.87

9.79

1.4

1.3

6.43

7.12

g/l

1.48

472

Peritonsillar abscess

144

812

1.78

9.78

1.3

1.4

6.34

7.12

g/l

2.16

107

548

Vitamin D deficiency

3.94

9.75

1.3

6.25

6.64

g/l

0.19

Viral encephalitis, not elsewhere classified/unspecified

3.94

9.75

1.4

5.52

6.97

g/l

1.72

Nonspecific lymphadenitis

251

2.46

9.71

1.4

1.3

7.02

6.38

g/l

0.65

191

Elevated blood glucose level

319

2.28

9.68

1.9

1.3

6.91

6.57

g/l

0.32

226

Iron deficiency anaemia secondary to blood loss (chronic)

116

614

1.90

9.68

1.4

1.3

7.01

6.78

g/l

0.17

431

Injuries to the head

880

4125

1.27

9.67

1.5

1.4

6.62

6.73

g/l

0.36

641

2974

Unspecified haematuria

294

1603

1.50

9.66

1.6

1.4

6.93

6.84

g/l

0.13

227

1131

Ankylosing spondylitis, ICD10

397

2.14

9.65

1.3

6.40

6.66

g/l

0.37

283

Kidney transplant status

222

2.56

9.65

1.7

1.3

5.69

6.67

g/l

1.07

161

Dialysis

154

2.91

9.64

1.3

6.02

6.90

g/l

0.75

111

Anaemia in chronic diseases classified elsewhere

4.00

9.64

1.5

1.3

5.35

7.75

g/l

1.54

Aortic aneurysm

152

858

1.75

9.59

1.5

1.4

7.15

6.92

g/l

0.21

620

Achalasia of cardia

4.89

9.59

1.3

1.4

6.25

6.75

g/l

0.26

Other/unspecified cytomegaloviral diseases

3.89

9.57

1.4

1.3

6.12

6.69

g/l

0.19

Isolated proteinuria

113

3.26

9.51

1.4

1.3

6.20

6.52

g/l

0.29

Other specified and unspecified retinal disorders

113

3.24

9.49

1.5

1.2

7.06

7.03

g/l

0.02

Spontaneous rupture of synovium and tendon

278

2.36

9.48

1.7

1.3

6.46

6.98

g/l

0.47

201

Problems related to lifestyle

453

2.05

9.47

1.3

6.90

6.48

g/l

0.50

312

Other diseases of gallbladder

108

3.28

9.46

1.3

5.95

6.86

g/l

0.92

Other noninflammatory disorders of vulva and perineum

407

2.11

9.43

1.4

7.76

6.89

g/l

0.90

287

Adult respiratory distress syndrome

7.14

9.42

1.0

1.3

4.17

6.64

g/l

2.45

Substance abuse

443

2996

1.38

9.40

1.3

1.4

6.49

6.78

g/l

0.96

305

2140

Chronic hepatitis NAS

4.83

9.38

1.2

8.41

6.50

g/l

0.79

Other and unspecified iridocyclitis

173

2.76

9.38

1.8

1.3

7.34

6.74

g/l

0.38

129

Hodgkin lymphoma, hilmo

3.47

9.37

1.6

1.3

6.05

6.58

g/l

0.30

Prurigo nodularis

4.02

9.36

1.1

1.4

7.44

7.29

g/l

0.08

Malignant neoplasm of other and unspecified parts of biliary tract

4.80

9.36

1.3

7.73

6.58

g/l

0.43

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

369

2.16

9.35

1.3

1.4

6.29

g/l

0.00

279

Haemorrhage, not elsewhere classified

3.38

9.33

1.4

1.2

6.39

7.47

g/l

0.67

Disorders of refraction and accommodation

244

1589

1.54

9.30

1.4

1.3

6.46

6.62

g/l

0.41

183

1154

Smoking dependency

390

2.13

9.29

1.3

1.4

6.69

6.63

g/l

0.06

280

Gingivitis and periodontal diseases

755

3030

1.29

9.28

1.4

6.66

6.71

g/l

0.14

557

2157

Atherosclerosis, excluding cerebral and coronary sclerosis

248

1268

1.54

9.27

1.6

1.4

6.89

6.93

g/l

0.06

191

900

Dental pulpitis, including avohilmo

738

3681

1.29

9.27

1.4

6.76

6.69

g/l

0.16

516

2663

Other localized connective tissue disorders

4.24

9.23

1.6

1.3

8.75

6.97

g/l

0.35

Other specified/unspecified bacterial intestinal infections

245

2.44

9.22

1.2

1.4

7.69

6.72

g/l

0.57

179

Polycystic ovarian syndrome, consortium definition

548

2346

1.34

9.21

1.4

6.34

6.69

g/l

1.72

401

1724

Other disorders of eyelid

298

1916

1.47

9.20

1.5

1.4

6.58

6.89

g/l

0.84

220

1382

Viral hepatitis, IBD co-morbidity

110

3.21

9.17

1.1

1.3

6.88

6.66

g/l

0.14

Mental and behavioural disorders due to tobacco

392

2.12

9.17

1.3

1.4

6.69

6.66

g/l

0.03

282

Primary adrenocortical insufficiency

4.75

9.16

2.0

1.3

6.28

6.47

g/l

0.09

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

240

1551

1.54

9.14

1.5

1.4

6.09

6.68

g/l

3.39

189

1129

Any death

452

2306

1.38

9.11

1.2

1.5

7.36

6.67

g/l

1.83

322

1633

Mental and behavioural disorders due to psychoactive substance use

455

3064

1.36

9.08

1.3

1.4

6.51

6.79

g/l

0.90

309

2191

Optic neuritis

182

2.68

9.07

1.5

1.4

5.85

6.80

g/l

1.20

133

Special screening examination for other diseases and disorders

406

2.08

9.07

1.3

6.72

7.01

g/l

0.30

254

Conduction disorders

194

962

1.62

9.04

1.4

1.3

7.04

6.75

g/l

0.43

128

701

Colonic or urogenital fistula

208

1322

1.58

9.02

1.3

1.4

6.58

6.75

g/l

0.28

143

947

Tuberculosis, IBD comorbidity

188

2.63

9.01

2.2

1.3

7.50

6.79

g/l

0.57

138

Other and unspecified disorders of vitreous body

310

2094

1.45

8.98

1.4

6.76

6.77

g/l

0.02

240

1514

Osteonecrosis

236

2.45

8.97

1.4

1.3

7.02

6.75

g/l

0.08

170

Benign neoplasm: Descending colon

255

2.38

8.92

1.4

6.73

6.79

g/l

0.04

184

Benign neoplasm: Ascending colon

108

575

1.89

8.91

1.5

1.3

6.82

6.89

g/l

0.07

411

Tuberculosis, wide, including avohilmo

207

2.54

8.88

2.2

1.3

7.60

7.06

g/l

0.43

155

Superficial injury of abdomen, lower back and pelvis

132

749

1.78

8.85

1.2

1.3

6.26

6.69

g/l

1.17

548

Idiopathic gout

332

2.19

8.83

1.3

6.57

6.87

g/l

0.29

241

Perforation of tympanic membrane

378

2.11

8.82

1.3

1.4

6.26

6.78

g/l

0.78

277

Nonischemic cardiomyopathy

345

2.16

8.80

1.2

1.4

7.20

6.79

g/l

0.41

253

Hypertensive heart and/or renal disease

168

735

1.68

8.77

1.4

6.66

7.24

g/l

0.84

124

507

Ulcer of oesophagus

197

2.57

8.73

1.3

1.2

6.97

7.14

g/l

0.10

142

Appendectomy

503

3599

1.33

8.72

1.3

1.4

6.31

6.76

g/l

2.40

353

2601

Other keratitis

101

530

1.92

8.72

1.6

1.4

6.50

6.66

g/l

0.19

384

Myeloid leukaemia

3.61

8.72

1.4

1.3

5.57

7.55

g/l

1.58

Adenocarcinoma of pancreas

3.61

8.71

1.2

1.3

5.89

7.39

g/l

1.17

Other sleep disorders

454

2.00

8.70

1.4

6.12

6.87

g/l

2.06

329

Infective dermatitis

482

1.97

8.68

1.4

1.3

7.08

6.97

g/l

0.08

351

Pemphigoid

3.78

8.65

1.5

1.3

7.01

7.26

g/l

0.16

Cardiodefibrillation

227

1481

1.54

8.65

1.3

1.4

7.32

6.96

g/l

0.50

138

1067

Arthropathic psoriasis

100

525

1.92

8.63

1.3

1.4

6.49

6.76

g/l

0.35

379

Malignant neoplasm, including Hilmo

667

3010

1.29

8.62

1.3

1.4

6.86

6.67

g/l

0.46

464

2199

Malignant neoplasm, wide definition

668

3014

1.29

8.61

1.3

1.4

6.87

6.68

g/l

0.48

464

2201

Hallux valgus (acquired)

217

995

1.57

8.58

1.5

6.54

6.84

g/l

0.54

167

721

Other endocrine disorders

242

2.37

8.58

1.3

6.99

6.44

g/l

0.57

194

Acute bronchiolitis

255

2.29

8.57

1.4

1.3

6.56

6.26

g/l

0.19

207

Pleural plaque with presence of asbestos

211

2.49

8.55

1.3

1.2

7.18

6.98

g/l

0.14

158

Hyperhidrosis

3.46

8.52

1.4

1.3

6.32

7.01

g/l

0.48

Ganglion

152

908

1.68

8.48

1.5

1.4

6.08

6.81

g/l

2.85

116

651

Ulcerative proctitis

255

2.34

8.47

1.4

1.3

7.00

6.62

g/l

0.34

188

Portal vein thrombosis

4.40

8.46

2.1

1.2

6.45

7.07

g/l

0.30

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

160

2.73

8.45

1.3

1.4

6.33

6.10

g/l

0.16

121

Atypical facial pain

189

2.57

8.42

1.6

1.4

6.59

6.74

g/l

0.07

143

Other disorders of central nervous system

4.78

8.42

1.4

5.30

6.76

g/l

0.78

Thyroiditis

314

2.19

8.35

1.5

6.61

6.71

g/l

0.09

232

Nail disorders

380

2.07

8.34

1.2

1.4

6.25

6.66

g/l

0.59

268

Stenosis and insufficiency of lacrimal passages

340

2.14

8.34

1.3

6.83

7.01

g/l

0.12

241

Infliximab

3.41

8.26

1.3

6.60

6.59

g/l

0.00

Female infertility, cervical, vaginal, other or unspecified origin

193

774

1.60

8.25

1.4

6.22

6.90

g/l

2.01

150

552

Olecranon bursitis

215

2.45

8.24

1.4

1.2

7.08

7.18

g/l

0.05

152

Cardiomyopathies, Primary/intrinsic

443

1.98

8.22

1.4

7.12

6.79

g/l

0.38

329

Lichen planus

527

1.89

8.21

1.9

1.3

6.47

6.77

g/l

0.45

378

Squamous cell neoplasms and carcinomas of the skin

277

2.25

8.20

1.1

1.5

6.36

7.10

g/l

0.80

201

Other abnormal findings of blood chemistry

174

2.62

8.20

1.6

1.4

6.71

6.63

g/l

0.06

128

Non-allergic asthma

329

2.15

8.20

1.9

1.5

6.31

6.83

g/l

0.69

233

Abnormal blood-pressure reading, without diagnosis

140

2.82

8.18

1.7

1.4

5.69

6.70

g/l

1.20

104

Other and unspecified coagulation defects

216

2.44

8.18

1.6

1.4

7.09

6.62

g/l

0.34

154

Other congenital malformations, including avohilmo

116

650

1.80

8.16

1.3

1.4

6.61

6.41

g/l

0.32

477

Autoimmune hyperthyroidism

216

2.43

8.16

1.4

6.61

6.53

g/l

0.07

158

Seborrhoeic keratosis

180

1134

1.60

8.15

1.5

1.4

6.16

6.90

g/l

2.60

146

814

Other bullous disorders

3.29

8.12

1.3

7.54

6.78

g/l

0.54

Generalized anxiety disorder

137

806

1.71

8.08

1.3

6.31

6.74

g/l

0.93

106

567

Psoriatic arthropathies, ICD10

502

1.91

8.08

1.3

1.4

6.48

6.69

g/l

0.25

360

Inflammation of lacrimal passages (acute and unspecified)

4.21

8.04

1.7

1.2

6.10

6.23

g/l

0.09

Phobic anxiety disorders

115

644

1.79

8.04

1.5

1.3

6.64

6.59

g/l

0.05

455

Juvenile rheumatoid arthirtis

3.49

7.99

1.3

1.4

7.16

6.55

g/l

0.43

Vascular diseases of the intestine

104

3.12

7.99

1.1

1.2

8.23

7.02

g/l

0.50

Pure hypercholesterolaemia

519

2501

1.32

7.98

1.4

6.83

6.79

g/l

0.07

389

1794

Peripheral artery disease

262

1410

1.47

7.96

1.5

1.4

7.03

6.90

g/l

0.19

205

998

Excessive attrition of teeth

484

3635

1.32

7.96

1.5

1.4

6.55

6.71

g/l

0.50

356

2644

Juvenile arthritis (FINNGEN)

183

2.55

7.93

1.3

1.4

7.43

6.37

g/l

1.24

136

Other symptoms and signs involving cognitive functions and awareness

326

2059

1.41

7.92

1.5

1.4

6.65

6.83

g/l

0.37

236

1470

Disorders resulting from impaired renal tubular function

132

2.85

7.89

1.2

1.3

6.26

6.96

g/l

0.42

Other extrapyramidal and movement disorders in other diseases

183

1169

1.57

7.84

1.5

1.4

6.24

6.71

g/l

1.39

144

835

Tuberculosis, wide

202

2.45

7.82

2.2

1.3

7.50

7.08

g/l

0.29

150

Angina pectoris

355

1695

1.39

7.78

1.5

1.4

6.47

6.81

g/l

0.93

244

1200

Other aneurysm

167

2.60

7.78

1.6

1.2

6.93

7.03

g/l

0.05

122

Barrett oesophagus

150

2.70

7.75

1.5

1.3

6.97

7.08

g/l

0.07

103

Other diseases of blood and blood-forming organs

241

2.31

7.68

1.3

7.99

6.94

g/l

0.42

174

Female infertility

205

794

1.55

7.65

1.4

1.3

6.26

6.90

g/l

1.89

157

566

Iron deficiency

140

2.76

7.64

1.3

5.73

6.48

g/l

1.29

105

Diseases of peritoneum

407

1.98

7.62

1.5

1.4

7.21

6.75

g/l

0.25

297

Fracture of lumbar spine and pelvis

152

933

1.63

7.61

1.3

1.4

6.34

6.75

g/l

0.82

108

662

Vulvovaginal ulceration/inflammation in other diseases

320

2.12

7.59

1.5

1.4

6.26

6.54

g/l

0.33

235

Desensitization to allergens

268

2.23

7.59

1.4

6.54

6.24

g/l

0.33

192

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

356

2.04

7.55

1.1

1.4

6.36

7.06

g/l

0.94

260

Cardiomyopathy (excluding other)

464

1.91

7.54

1.4

1.3

7.08

6.80

g/l

0.31

344

Other obstructive and reflux uropathy

141

2.73

7.52

1.2

1.3

8.19

6.60

g/l

1.66

105

Later onset COPD

154

759

1.64

7.52

1.2

1.4

7.24

7.18

g/l

0.07

112

540

Dislocation, sprain and strain of joints and ligaments of knee

476

3281

1.31

7.51

1.4

6.45

6.74

g/l

1.29

345

2354

Diseases of pulp and periapical tissues and dental caries

456

1749

1.34

7.50

1.4

1.3

6.54

6.74

g/l

0.51

314

1261

Other psoriatic arthropathies

487

1.89

7.48

1.3

1.4

6.51

6.69

g/l

0.22

352

Other specified and unspecified disorders of eyelid

4.50

7.48

2.0

1.3

5.51

6.73

g/l

0.88

Acne

520

1.85

7.45

1.3

6.56

6.47

g/l

0.09

378

Other/unspecified enthesopathies, not elsewhere classified

296

2.15

7.43

1.9

1.3

5.96

7.09

g/l

1.90

215

Pacemaker

218

1357

1.50

7.43

1.3

1.4

7.07

6.96

g/l

0.14

139

971

Hypertensive Heart Disease

148

683

1.65

7.42

1.4

6.59

7.24

g/l

0.90

107

469

Glaucoma

376

2354

1.36

7.41

1.4

6.45

6.88

g/l

1.69

255

1711

Symptoms and signs involving emotional state

120

2.88

7.41

1.2

1.3

6.87

6.23

g/l

0.49

Allergic contact dermatitis

104

582

1.80

7.40

1.4

1.3

5.98

6.87

g/l

2.73

415

Acute myeloid leukaemia and myelodysplastic syndromes

3.79

7.38

1.5

1.2

6.18

7.16

g/l

0.52

Unspecified misadventure during surgical and medical care

208

2.38

7.37

1.5

1.3

6.48

6.86

g/l

0.34

151

Benign paroxysmal vertigo

209

1394

1.51

7.37

1.3

1.4

6.46

6.75

g/l

0.53

141

1005

Testicular dysfunction

172

2.54

7.36

1.3

1.2

6.31

6.95

g/l

0.34

120

Trigeminal neuralgia

227

2.32

7.35

1.8

1.4

5.69

6.64

g/l

2.14

168

Atrophic disorders of skin

121

709

1.72

7.34

1.5

1.4

7.04

6.73

g/l

0.33

507

Disorders of plasma-protein metabolism, not elsewhere classified

7.66

7.30

1.5

1.3

6.56

5.97

g/l

—

Other and unspecified follicular disorders

161

2.58

7.29

1.6

1.3

6.71

6.62

g/l

0.06

114

Acute peritonitis

228

2.31

7.27

1.5

1.3

7.15

7.04

g/l

0.04

167

Complications following infusion, transfusion and therapeutic injection

4.39

7.26

1.7

1.2

7.62

6.72

g/l

0.17

Diabetes insipidus

4.65

7.26

2.1

1.3

6.38

6.18

g/l

—

Follicular lymphoma, hilmo

144

2.68

7.25

1.6

1.4

5.14

7.04

g/l

1.94

105

Lateral epicondylitis

542

1.82

7.25

1.5

1.3

6.50

7.04

g/l

0.65

378

Anogenital herpesviral [herpes simplex] infection, including avohilmo

550

1.81

7.23

1.4

6.43

6.46

g/l

0.02

397

256

1600

1.44

7.22

1.5

1.4

6.63

6.92

g/l

0.61

192

1139

Otitis externa

182

1185

1.54

7.21

1.4

1.3

6.63

6.74

g/l

0.21

142

856

Other epidermal thickening

156

2.60

7.21

1.4

6.17

7.13

g/l

1.17

120

Acute nasopharyngitis (common cold)

475

1.87

7.18

1.3

1.4

7.09

7.02

g/l

0.05

318

Oral lichen planus

3.17

7.17

2.0

1.3

6.06

7.13

g/l

0.93

Myocardial infarction

295

1461

1.41

7.17

1.3

1.4

6.74

6.82

g/l

0.16

213

1022

Appendicitis, broad definition

556

3907

1.28

7.15

1.4

6.55

6.76

g/l

0.75

386

2826

Diseases of appendix

560

3925

1.28

7.15

1.4

6.52

6.76

g/l

0.88

389

2840

Testicular hypofunction

157

2.59

7.14

1.3

1.2

6.48

6.97

g/l

0.22

111

Impingement syndrome of shoulder

155

975

1.60

7.13

1.4

6.16

7.13

g/l

2.38

123

695

Disorders of adult personality and behaviour

231

1584

1.47

7.12

1.3

1.4

6.36

6.69

g/l

1.01

166

1133

Gluteal tendinitis

146

2.64

7.06

1.3

6.46

7.13

g/l

0.47

107

Amyloidosis

3.67

7.06

1.5

1.3

8.94

7.74

g/l

0.25

Eustachian salpingitis and obstruction

398

1.95

7.05

1.6

1.3

6.48

6.81

g/l

0.39

285

Acute epiglottitis

4.28

7.05

1.7

1.3

6.70

7.56

g/l

—

Acute appendicitis, no complications

426

3216

1.32

7.04

1.4

6.52

6.71

g/l

0.55

296

2327

Scar conditions and fibrosis of skin

158

2.57

7.04

1.2

1.4

7.84

6.73

g/l

0.55

117

Nonpyogenic thrombosis of intracranial venous system

4.52

7.03

1.3

6.40

6.49

g/l

0.03

Personality disorders

217

1475

1.48

7.01

1.3

1.4

6.30

6.67

g/l

1.26

154

1051

Morphin

3.91

7.00

1.6

1.2

7.11

7.67

g/l

0.24

Other disorders of optic [2nd] nerve and visual pathways

252

2.21

6.95

1.7

1.3

6.32

6.67

g/l

0.28

188

Paralytic strabismus

252

2.20

6.95

1.6

1.4

5.99

6.87

g/l

1.19

184

Unspecific neurodegenerative disorder

105

1226

0.58

6.93

1.2

1.4

6.75

7.10

g/l

0.40

870

Decubitus ulcer and pressure area

171

2.48

6.92

1.6

1.2

8.05

7.40

g/l

0.37

127

Other contact dermatitis

305

2.08

6.91

1.6

1.4

6.38

6.79

g/l

0.52

225

Intracranial injury

435

3092

1.31

6.91

1.5

1.4

6.68

6.75

g/l

0.15

318

2222

Other shoulder lesions

366

1.98

6.91

1.3

6.26

6.80

g/l

0.71

260

Intestinal adhesions without obstruction

279

2.13

6.88

1.7

1.4

6.24

7.06

g/l

1.09

202

Fracture of foot, except ankle

196

1311

1.50

6.86

1.4

1.3

6.86

6.61

g/l

0.40

150

933

Contact with and exposure to communicable diseases

253

1770

1.43

6.84

1.4

6.32

6.62

g/l

0.67

136

1304

Other embolism and thrombosis

524

1.81

6.81

1.7

1.3

6.67

6.63

g/l

0.04

386

Golimumab

161

2.53

6.79

1.2

1.3

7.04

6.51

g/l

0.40

123

Unspecified fall

376

2769

1.34

6.78

1.5

1.4

6.31

6.78

g/l

2.27

262

2013

Thoracic aortic aneurysm

103

591

1.76

6.77

1.6

1.4

6.64

6.79

g/l

0.19

431

Skin changes due to chronic exposure to nonionizing radiation

237

1489

1.45

6.77

1.5

1.4

6.52

6.95

g/l

1.23

176

1051

Abnormal findings in nipple discharge synovial fluid wound secretions

3.98

6.76

1.5

1.3

7.49

6.24

g/l

0.68

Alcoholic liver disease

390

1.94

6.76

1.2

1.4

8.25

6.57

g/l

2.11

290

Noninflammatory disorders of female genital tract

271

950

1.44

6.74

1.5

1.3

6.47

6.81

g/l

0.93

195

675

Other specified and unspecified disorders of eye and adnexa

138

2.65

6.74

1.2

1.4

6.05

6.85

g/l

0.85

106

Duodenal ulcer

322

2.03

6.70

1.2

1.3

7.20

7.00

g/l

0.15

234

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

109

638

1.72

6.68

1.4

6.95

6.75

g/l

0.14

463

Benign neoplasm: Parotid gland

296

2.08

6.67

1.5

1.4

7.15

6.85

g/l

0.21

218

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

303

2.07

6.66

1.6

1.4

6.53

6.65

g/l

0.06

221

Lichen simplex chronicus

105

2.90

6.66

1.3

8.34

7.02

g/l

0.69

150

2.55

6.64

1.2

7.35

6.59

g/l

0.65

110

Other/unspecified enthesopathies of lower limb, excluding foot

270

2.13

6.64

1.2

1.3

6.78

6.93

g/l

0.10

194

Hidradenitis suppurativa

169

2.46

6.63

1.3

1.4

6.46

6.27

g/l

0.20

121

Benign neoplasm of mouth and pharynx

464

1.85

6.61

1.4

1.3

5.64

6.85

g/l

3.03

332

Other disorders of patella

122

738

1.66

6.61

1.2

1.4

6.91

6.70

g/l

0.31

519

Localized scleroderma [morphea]

4.24

6.59

1.4

1.3

6.76

7.01

g/l

0.07

Fracture at wrist and hand level

269

1919

1.40

6.58

1.3

1.4

6.79

6.71

g/l

0.11

182

1368

Other and unspecified acquired haemolytic anaemias

6.39

6.54

1.9

1.3

4.97

6.33

g/l

—

Superficial injury of wrist and hand

172

1132

1.53

6.53

1.4

6.06

6.61

g/l

2.06

135

817

Acne vulgaris

387

1.92

6.53

1.2

1.3

6.60

6.36

g/l

0.24

275

Major coronary heart disease event excluding revascularizations

368

1812

1.34

6.51

1.3

1.4

6.72

6.84

g/l

0.22

268

1272

Injuries to the shoulder and upper arm

638

3956

1.25

6.51

1.4

6.54

6.78

g/l

0.92

463

2841

Other juvenile arthritis

177

2.41

6.48

1.3

1.4

7.59

6.48

g/l

1.20

129

Malignant neoplasm

631

2956

1.25

6.45

1.3

1.4

6.77

6.68

g/l

0.18

432

2163

Corneal ulcer

142

898

1.59

6.45

1.6

1.3

6.71

6.68

g/l

0.04

645

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

281

2.08

6.43

1.4

1.3

5.78

6.17

g/l

0.69

219

Plantar fascial fibromatosis

369

1.94

6.42

1.4

1.3

6.68

6.96

g/l

0.19

261

MS-disease / Multiple Sclerosis

328

2.00

6.42

1.4

5.85

6.46

g/l

1.07

243

Malignant neoplasm

629

2948

1.25

6.41

1.3

1.4

6.75

6.68

g/l

0.12

431

2157

Occupational exposure to risk-factors

119

2.73

6.37

1.7

1.2

6.16

6.85

g/l

0.65

Myocardial infarction, strict

269

1359

1.40

6.36

1.4

6.61

6.88

g/l

0.64

197

945

Disorders of lacrimal system and orbit in diseases classified elsewhere

3.14

6.35

1.3

6.67

6.80

g/l

0.06

Pneumonitis due to solids and liquids

255

2.13

6.35

1.3

1.2

6.48

6.93

g/l

0.43

190

Benign neoplasm: Rectum

125

770

1.63

6.33

1.5

1.4

6.65

6.88

g/l

0.29

104

551

Unspecified nephritic syndrome

3.22

6.33

1.6

1.3

8.08

6.38

g/l

0.72

Use of pramipexole

151

973

1.56

6.33

1.4

5.95

6.85

g/l

3.06

108

696

Endocrine disorders, other/unspecified

3.40

6.32

1.2

1.3

5.55

6.71

g/l

—

Haemorrhage in early pregnancy

212

1423

1.45

6.31

1.2

1.5

6.14

6.70

g/l

1.90

162

1054

Urethritis and urethral syndrome

3.39

6.30

1.4

7.03

7.07

g/l

0.02

Alzheimer disease, including avohilmo

1006

0.56

6.30

1.4

6.82

7.17

g/l

0.38

707

Hypercalcemia

149

2.52

6.29

1.2

1.4

7.07

7.05

g/l

0.01

108

Actinic keratosis

227

1443

1.44

6.29

1.5

1.4

6.52

6.95

g/l

1.15

168

1019

Hypertrophic disorders of skin

237

2.18

6.26

1.3

1.4

6.42

6.61

g/l

0.17

173

Other hearing loss

174

1121

1.51

6.26

1.5

1.4

6.10

7.08

g/l

3.58

116

799

Impetigo

205

2.27

6.26

1.4

1.3

7.03

6.51

g/l

0.45

161

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

223

1561

1.43

6.23

1.3

1.4

6.65

6.77

g/l

0.17

160

1108

Recurrent dislocation of patella

199

2.28

6.23

1.1

1.4

7.06

6.40

g/l

0.59

142

Other and unspecified diseases of blood and blood-forming organs

3.10

6.22

1.4

1.3

9.40

7.26

g/l

0.51

Radial styloid tenosynovitis [de Quervain]

199

2.28

6.22

1.7

1.4

6.16

6.81

g/l

0.56

148

Ingrowing nail

225

2.20

6.21

1.2

1.3

6.26

6.82

g/l

0.63

165

Extrapyramidal and movement disorders

261

1879

1.39

6.20

1.6

1.4

6.39

6.83

g/l

1.07

191

1355

DVT of lower extremities

126

782

1.62

6.20

1.4

1.3

6.76

6.55

g/l

0.24

569

Alopecia areata

104

2.84

6.19

1.4

7.53

6.08

g/l

0.73

Thyrotoxicosis, other and/or unspecified

146

939

1.56

6.18

1.3

1.4

6.48

6.71

g/l

0.40

105

672

Glucagon-like peptide-1 (GLP-1) analogues

233

1649

1.42

6.13

1.2

1.4

6.50

6.74

g/l

0.48

169

1193

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

233

1649

1.42

6.13

1.2

1.4

6.50

6.74

g/l

0.48

169

1193

Allergic colitis

116

2.72

6.11

1.4

5.67

6.07

g/l

0.50

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

229

1617

1.42

6.10

1.2

1.4

6.33

6.76

g/l

1.14

171

1165

Diabetic maculopathy, excluding more controls

426

1.84

6.09

1.4

6.68

6.85

g/l

0.18

302

Abscess of anal and rectal regions

349

1.94

6.05

1.3

6.13

6.74

g/l

0.79

247

Other dialysis

117

2.69

6.02

1.2

1.3

6.13

6.76

g/l

0.57

Epilepsy

204

1409

1.45

6.02

1.3

1.4

7.06

6.88

g/l

0.21

160

1040

Other abnormal uterine and vaginal bleeding

154

717

1.55

5.99

1.3

1.4

6.46

6.75

g/l

0.40

108

505

Hypersplenism

8.54

5.95

1.3

6.52

5.53

g/l

—

Acute appendicitis

515

3802

1.26

5.95

1.4

6.47

6.77

g/l

1.24

361

2747

Type 1 diabetes

185

1260

1.47

5.95

1.4

1.3

6.73

6.78

g/l

0.06

130

911

Arthropathies in other diseases classified elsewhere

112

2.71

5.94

1.3

1.4

6.36

7.36

g/l

0.71

Disorders of psychological development

102

562

1.69

5.90

1.3

1.4

6.23

6.50

g/l

0.43

408

Other and unspecified psoriasis

263

2.07

5.90

1.2

1.4

7.35

6.68

g/l

0.61

196

Autoimmune thyroiditis

3.35

5.89

1.2

1.3

7.32

6.54

g/l

0.32

Benign neoplasm: Rectum, anus and anal canal

135

863

1.57

5.89

1.4

6.79

6.82

g/l

0.04

109

620

Other disorders of bladder

460

1.79

5.88

1.3

7.09

6.94

g/l

0.10

334

Degenerative diseases of the nervous system

1050

0.58

5.87

1.2

1.4

6.66

7.17

g/l

0.66

742

Statin medication

513

2283

1.27

5.82

1.4

6.64

6.78

g/l

0.34

367

1605

Alcohol abuse, main dg, excluding more controls

108

656

1.66

5.82

1.3

1.4

6.26

6.78

g/l

0.93

460

Artificial opening status

186

2.28

5.82

1.5

6.96

6.83

g/l

0.06

141

Superficial injury of hip and thigh

101

603

1.68

5.80

1.4

1.3

6.71

6.77

g/l

0.06

426

Heterophoria

376

1.88

5.79

1.6

1.4

6.47

6.49

g/l

0.02

267

Benign neoplasm: Sigmoid colon

128

812

1.58

5.79

1.6

1.4

6.55

6.82

g/l

0.40

586

Mature T/NK-cell lymphomas, hilmo

4.00

5.75

1.3

6.78

6.90

g/l

—

Adjustment and management of implanted device

108

658

1.65

5.75

1.1

1.4

7.62

6.99

g/l

0.70

477

Acute posthaemorrhagic anaemia

2.94

5.74

1.3

7.47

7.26

g/l

0.07

Bell's palsy

509

1.74

5.70

1.4

1.3

5.80

6.84

g/l

2.06

362

Trigger finger

584

1.69

5.69

1.4

1.3

6.67

6.98

g/l

0.50

416

Other and unspecified glaucoma

207

2.19

5.69

1.5

1.3

6.58

7.09

g/l

0.35

151

Abnormalities of gait and mobility

458

1.78

5.67

1.4

1.3

6.59

6.86

g/l

0.31

336

Convalescence

201

2.21

5.67

1.5

6.40

6.59

g/l

0.14

144

Endometriosis of rectovaginal septum and vagina

288

2.00

5.65

1.6

1.4

5.99

6.81

g/l

1.16

201

Strabismus

201

1404

1.43

5.64

1.6

1.4

6.36

6.57

g/l

0.43

140

1020

Injuries to the neck

177

1212

1.47

5.61

1.4

6.43

6.64

g/l

0.33

135

862

Ventral hernia

158

1058

1.50

5.60

1.4

6.31

6.76

g/l

0.93

121

757

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

144

948

1.53

5.54

1.4

6.45

6.64

g/l

0.27

104

681

Other and unspecified aplastic anaemias

4.74

5.54

1.5

1.3

7.77

6.32

g/l

—

Excessive vomiting in pregnancy

382

1.85

5.53

1.4

1.5

6.11

6.56

g/l

0.69

282

Infections with a predominantly sexual mode of transmission, including avohilmo

307

2112

1.33

5.51

1.3

1.4

6.63

6.66

g/l

0.06

226

1511

Female genital prolapse

186

704

1.47

5.51

1.8

1.3

6.60

6.82

g/l

0.30

131

502

Bruxism

2.95

5.50

1.4

6.53

6.05

g/l

0.35

Endometriosis ASRM stages 1,2

137

894

1.54

5.50

1.4

6.27

6.66

g/l

0.62

644

Valvular operations

492

1.74

5.49

1.5

1.4

7.86

6.78

g/l

0.90

368

Spasmodic torticollis

123

2.56

5.48

1.7

1.4

7.78

6.63

g/l

0.26

Presence of cardiac and vascular implants and grafts

253

1353

1.38

5.47

1.5

1.4

7.25

6.93

g/l

0.50

187

991

AV-block

501

1.68

5.47

1.3

1.4

7.48

6.86

g/l

0.62

366

Familial hypercholesterolemia

561

1.68

5.45

1.6

1.4

6.59

6.99

g/l

0.42

403

Crohn disease (strict definition, all UC cases excluded)

218

2.13

5.43

1.1

1.3

5.86

6.65

g/l

0.88

157

Otitis externa, unspecified

555

1.69

5.41

1.3

1.4

6.67

6.64

g/l

0.04

409

Neovascular glaucoma

124

2.53

5.38

1.5

1.3

6.66

6.82

g/l

0.08

Thyrotoxicosis

181

1256

1.45

5.37

1.5

1.4

6.40

6.69

g/l

0.65

130

901

Erosion of teeth , including avohilmo

210

1497

1.41

5.37

1.3

1.4

7.21

6.58

g/l

1.03

150

1072

Speech and linguistic disorders

446

1.75

5.37

1.4

1.3

6.32

6.35

g/l

0.02

335

Persistent mood disorders

136

891

1.53

5.37

1.3

1.4

6.26

6.76

g/l

1.31

107

619

Drug-induced neutropenia

287

1.97

5.36

1.5

1.4

6.55

6.74

g/l

0.12

209

Amyloidosis, other/unspecified

3.60

5.35

1.4

1.3

9.54

6.75

g/l

0.57

Glaucoma suspect

237

1726

1.38

5.31

1.4

6.64

6.89

g/l

0.51

157

1247

Other disorders starting during childhood or adolescence

278

1.98

5.31

1.4

5.82

6.12

g/l

0.44

218

Other erythematous conditions

125

2.51

5.31

1.3

1.4

6.71

6.86

g/l

0.09

Dermatophytosis, including avohilmo

470

3682

1.25

5.29

1.4

6.46

6.73

g/l

1.10

339

2633

Lichen ruber planus, wide definition including periferal and oral lichen planus

160

1088

1.48

5.29

1.8

1.4

6.66

6.82

g/l

0.22

121

783

Poisoning by drugs, medicaments and biological substances

182

1269

1.44

5.28

1.3

1.4

6.21

6.65

g/l

0.89

131

909

Biguanides

680

3390

1.21

5.26

1.4

6.63

6.78

g/l

0.38

483

2449

Benign neoplasm of other and unspecified endocrine glands

100

613

1.64

5.26

1.4

1.3

6.71

6.76

g/l

0.05

446

Pure hyperglyceridaemia

2.92

5.22

1.4

6.84

6.51

g/l

0.10

Papilloedema, unspecified

2.92

5.22

1.4

1.3

5.61

6.71

g/l

1.64

Tubulo-interstitial nephritis, not specified as acute or chronic

215

2.11

5.20

1.3

1.4

9.24

6.65

g/l

1.68

162

Congenital malformations of the urinary system

256

2.01

5.19

1.2

1.3

6.68

6.63

g/l

0.03

190

Other hammer toe(s) (acquired)

100

558

1.64

5.15

1.6

1.5

6.45

6.86

g/l

0.76

404

Other condition

111

702

1.59

5.14

1.8

1.3

6.50

6.65

g/l

0.14

505

Tuberculosis

164

2.27

5.14

2.2

1.3

7.31

7.02

g/l

0.18

122

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

327

1.88

5.13

1.3

5.98

6.58

g/l

0.62

228

Artificial joint operation, meniscal resection

627

3300

1.22

5.09

1.4

6.59

6.80

g/l

0.82

447

2371

Striking against or struck by other objects

256

1899

1.35

5.09

1.4

6.45

6.69

g/l

0.52

173

1361

Malignant neoplasm of eye, brain and central nervous system

146

2.35

5.09

1.4

6.01

6.90

g/l

0.78

112

Mantle cell lymphoma, including Hilmo

4.55

5.09

1.9

1.3

5.12

6.55

g/l

—

Specific personality disorders

182

1279

1.43

5.08

1.3

1.4

6.27

6.63

g/l

1.09

135

912

Calculus of kidney and ureter

195

1387

1.41

5.07

1.4

6.54

6.90

g/l

0.77

139

996

Alzheimer disease

849

0.57

5.06

1.2

1.4

6.57

7.13

g/l

0.59

601

Glaucoma secondary to other eye disorders

128

2.45

5.06

1.5

1.3

6.66

6.80

g/l

0.07

Right bundle-branch block

116

2.53

5.05

1.1

1.2

7.40

6.79

g/l

0.34

Propionic acid derivatives

182

630

1.46

5.03

1.4

1.3

6.23

7.25

g/l

2.63

135

458

Anti-inflammatory and antirheumatic products, non-steroids

182

630

1.46

5.03

1.3

6.51

7.25

g/l

1.43

133

458

Oral lichen planus, including avohilmo , including avohilmo

294

1.92

5.02

1.5

6.43

6.80

g/l

0.36

208

Amenorrhoea

294

1.92

5.01

1.8

1.5

6.58

6.85

g/l

0.26

213

Other and unspecified epidermal thickening

2.67

5.01

1.3

6.00

7.26

g/l

1.00

Specific development disorders of scholastic skills

234

2.03

5.00

1.4

1.3

5.83

6.33

g/l

0.62

175

Sleep disorders, other/unspecified

160

2.28

5.00

1.2

1.4

6.21

g/l

0.00

115

Lesion of lateral popliteal nerve

180

2.19

4.95

1.5

1.3

6.78

6.93

g/l

0.09

127

Pleural plaque without asbestos

2.69

4.92

1.4

1.2

7.21

7.24

g/l

0.02

Spondylopathies in diseases classified elsewhere

4.66

4.90

1.2

1.3

10.81

9.33

g/l

—

Maternal care for other conditions predominantly related to pregnancy

162

1094

1.45

4.88

1.2

1.4

6.52

6.74

g/l

0.39

115

815

Vitamin B12 deficiency anaemia

318

1.87

4.88

1.3

1.4

7.80

6.85

g/l

0.53

233

Abrasion of teeth

266

2003

1.33

4.86

1.3

1.4

6.81

g/l

0.01

196

1446

Other female pelvic inflammatory diseases

112

720

1.56

4.86

1.3

1.4

6.35

6.64

g/l

0.35

515

Other maternal disorders predominantly related to pregnancy

410

2027

1.27

4.85

1.3

1.4

6.36

6.69

g/l

1.33

301

1502

Disorders of tooth development and eruption

108

556

1.59

4.85

1.4

1.3

6.05

6.68

g/l

1.59

397

Hypocalcemia

2.87

4.84

1.4

1.3

7.48

7.37

g/l

0.04

Other disorders of the musculoskeletal system and connective tissue

105

666

1.59

4.83

1.5

1.4

6.20

6.82

g/l

1.16

483

Ptosis of eyelid

414

1.75

4.83

1.8

1.3

6.75

6.87

g/l

0.10

297

Contusion of toe(s) without damage to nail

101

2.61

4.82

1.5

1.2

5.41

6.51

g/l

1.01

Other problems related to primary support group, including family circumstances

587

1.62

4.82

1.4

6.00

6.54

g/l

1.36

438

Diseases of male genital organs

347

1347

1.30

4.80

1.4

6.63

6.83

g/l

0.50

255

944

Poisoning by medicine

164

1144

1.44

4.79

1.3

1.4

6.03

6.56

g/l

1.16

114

813

Congenital malformations of the urinary system, including avohilmo

271

1.94

4.78

1.2

1.3

6.76

6.66

g/l

0.07

202

Suppurative otitis media, unspecified

2.91

4.77

1.7

1.4

6.49

6.58

g/l

0.03

Tobacco use

223

2.04

4.77

1.3

7.25

6.74

g/l

0.41

159

Other and unspecified injuries of lower leg

357

1.81

4.77

1.4

1.3

7.33

6.66

g/l

0.77

251

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

219

1607

1.37

4.76

1.2

1.4

6.14

6.75

g/l

2.71

156

1157

Other and unspecified nail disorders

2.83

4.74

1.3

5.72

7.32

g/l

1.11

Flat foot [pes planus] (acquired)

365

1.79

4.73

1.2

1.6

6.94

6.86

g/l

0.06

266

Osteomyelitis

224

2.03

4.71

1.5

1.2

7.17

6.76

g/l

0.27

165

Gonarthrosis,primary

594

2956

1.21

4.69

1.4

6.72

6.79

g/l

0.16

444

2122

Idiopathic urticaria

2.68

4.68

1.3

5.92

6.34

g/l

0.50

Chronic Coagulation defects

2.68

4.68

1.7

1.3

5.99

6.79

g/l

0.63

Any dementia

106

1128

0.65

4.68

1.2

1.4

7.16

7.12

g/l

0.03

798

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

374

1.78

4.67

1.3

1.4

7.67

6.83

g/l

0.64

269

Other nonscarring hair loss

4.40

4.67

1.1

1.4

6.00

6.04

g/l

—

Oesophageal obstruction

2.66

4.66

1.3

1.2

6.86

7.46

g/l

0.28

Achilles tendinitis

411

1.74

4.66

1.7

1.3

6.41

6.97

g/l

0.90

297

Other and unspecified myopathies

309

1.86

4.65

1.4

1.3

6.41

6.95

g/l

0.67

229

Malignant neoplasm of digestive organs, including Hilmo

271

1506

1.33

4.63

1.4

1.5

6.86

6.85

g/l

0.02

182

1103

Artificial joint re-operation

226

2.01

4.60

1.3

1.5

7.20

7.15

g/l

0.04

170

Benign neoplasm: Pituitary gland, craniopharyngeal duct

206

2.06

4.59

1.4

1.3

6.41

6.81

g/l

0.26

153

Carcinoma in situ of skin of other and unspecified parts of face

240

1.97

4.58

1.3

6.74

7.04

g/l

0.18

184

Schizophrenia

799

0.51

4.58

1.1

1.4

6.18

6.67

g/l

0.67

561

Superficial injury of ankle and foot

100

637

1.58

4.55

1.5

1.3

6.60

6.54

g/l

0.06

460

Type 1 diabetes, wide definition, subgroup 1

141

965

1.47

4.55

1.4

1.3

6.72

6.79

g/l

0.07

105

731

Graves ophthalmopathy, strict

2.76

4.54

1.3

1.4

6.43

7.06

g/l

0.40

Mixed conductive and sensorineural hearing loss

452

1.69

4.54

1.4

1.3

6.80

6.82

g/l

0.02

324

Tinnitus

159

1115

1.43

4.54

1.4

6.58

6.81

g/l

0.43

119

802

Acne, including avohilmo

170

972

1.42

4.51

1.3

6.50

6.70

g/l

0.37

131

709

Infections with a predominantly sexual mode of transmission

228

1695

1.35

4.51

1.4

6.61

6.69

g/l

0.13

172

1198

Hyperaldosteronism

2.68

4.51

1.6

1.2

6.06

6.84

g/l

0.63

Convergence insufficiency and excess

3.48

4.49

1.2

1.3

6.14

6.03

g/l

—

Arterial embolism and thrombosis

161

2.19

4.49

1.3

1.2

5.54

7.07

g/l

2.20

122

Excessive earwax

439

3220

1.24

4.47

1.5

1.4

6.68

6.77

g/l

0.21

301

2339

Degeneration of macula and posterior pole

279

1646

1.31

4.45

1.4

6.76

6.89

g/l

0.28

205

1193

Medial epicondylitis

130

2.33

4.44

1.4

6.04

6.88

g/l

0.96

Other chondrocalcinosis

4.15

4.44

1.6

1.4

5.45

7.02

g/l

1.72

KRA_PSY_EATING, excluding more controls

318

1.82

4.44

1.3

6.04

6.83

g/l

1.44

226

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

129

846

1.49

4.44

1.2

1.4

6.93

6.69

g/l

0.27

100

635

Injuries to the hip and thigh

314

2193

1.29

4.44

1.4

6.69

6.84

g/l

0.32

246

1561

Any event in cancer register

667

3267

1.19

4.44

1.3

1.4

6.86

6.69

g/l

0.40

464

2395

Sudden idiopathic hearing loss

395

1.73

4.44

1.9

1.3

6.39

6.86

g/l

0.51

290

Perioral dermatitis

2.59

4.41

1.5

1.3

6.42

6.17

g/l

0.17

Visual impairment including blindness (binocular or monocular)

223

1.99

4.40

1.3

6.09

6.87

g/l

0.87

160

Cauda equina syndrome

3.27

4.37

1.2

1.4

5.10

6.78

g/l

—

Bacterial, viral and other infectious agents, including avohilmo

412

1.71

4.37

1.4

6.72

6.57

g/l

0.15

287

Dementia, including avohilmo

148

1436

0.70

4.37

1.2

1.4

6.88

6.97

g/l

0.09

1015

Thyrotropin deficiency

3.42

4.36

1.5

1.3

5.84

6.37

g/l

—

Discitis, unspecified

3.25

4.36

1.4

1.2

9.35

7.81

g/l

—

Transport accidents

335

2193

1.27

4.35

1.5

1.3

6.60

6.83

g/l

0.65

246

1591

Leisure time condition

131

894

1.47

4.34

1.8

1.3

6.41

6.74

g/l

0.58

639

Speech therapy

171

1227

1.40

4.31

1.6

1.4

6.48

6.69

g/l

0.32

159

871

Myopia

103

670

1.55

4.30

1.3

1.4

6.20

6.53

g/l

0.63

476

Tuberculosis of other organs, strict, including avohilmo

2.99

4.30

1.9

1.3

7.95

7.64

g/l

0.09

Use of anticholinesterases

1044

0.63

4.29

1.3

1.4

6.58

7.21

g/l

0.80

741

N06DA Anticholinesterases

1044

0.63

4.29

1.3

1.4

6.58

7.21

g/l

0.80

741

Thyrotoxicosis with diffuse goitre

639

1.56

4.28

1.5

1.3

6.42

6.64

g/l

0.35

459

Obsessive-compulsive disorder

275

1.87

4.26

1.5

1.3

5.83

6.63

g/l

1.68

191

D07AA Corticosteroids, weak (group I)

118

791

1.50

4.25

1.5

1.4

6.45

6.62

g/l

0.28

588

Other specified/unspecified dorsopathies

2.58

4.23

1.6

1.4

6.93

7.08

g/l

0.05

Mantle cell lymphoma

4.93

4.22

1.8

1.2

5.92

6.56

g/l

—

Anogenital herpesviral [herpes simplex] infection

298

1.83

4.21

1.5

1.4

6.12

6.50

g/l

0.30

218

Urolithiasis

204

1512

1.35

4.21

1.4

6.51

6.92

g/l

0.99

142

1083

Scoliosis

313

1.80

4.18

1.3

6.87

6.73

g/l

0.11

227

Event of undetermined intent

292

1.83

4.16

1.2

1.3

6.82

6.64

g/l

0.12

211

Other disorders of nervous system

249

1.90

4.16

1.3

1.5

5.57

6.63

g/l

1.57

188

Acute gastritis

235

1.93

4.15

1.5

1.3

6.07

6.84

g/l

1.20

172

Unspecified privation

464

1.65

4.15

1.6

1.4

6.65

6.61

g/l

0.04

337

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

133

892

1.45

4.15

1.2

1.4

6.94

6.69

g/l

0.29

102

665

Other specified and unspecified personality disorders

411

1.69

4.14

1.3

1.4

6.18

6.48

g/l

0.37

294

Lichen planus, including avohilmo

130

896

1.46

4.12

1.8

1.4

6.58

6.79

g/l

0.29

100

635

Other and unspecified disorders of skin and subcutaneous tissue

222

1.95

4.11

1.6

1.4

5.81

6.92

g/l

1.80

164

Ankylosing spondylitis, strict definition

188

2.04

4.10

1.2

1.3

6.67

6.53

g/l

0.10

137

Respiratory tuberculosis, confirmed and not-confirmed

148

2.18

4.09

2.3

1.3

7.54

6.90

g/l

0.43

109

Respiratory tuberculosis

148

2.18

4.09

2.3

1.3

7.54

6.90

g/l

0.43

109

Other disorders of bone density and structure

2.66

4.08

1.3

6.95

6.60

g/l

0.21

Dislocation, sprain and strain of joint and ligaments of hip

123

2.30

4.05

1.3

6.71

7.17

g/l

0.25

Dementia

136

1322

0.70

4.03

1.2

1.4

7.03

6.97

g/l

0.06

937

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

318

2180

1.27

4.02

1.5

1.4

6.50

6.66

g/l

0.38

242

1607

Cerebrovascular diseases

476

2717

1.22

4.02

1.3

1.4

7.07

6.74

g/l

0.87

355

1927

Deep endometriosis

407

1.68

4.02

1.5

1.4

6.18

6.57

g/l

0.41

294

Viral conjunctivitis, including avohilmo

156

2.14

4.01

1.5

1.3

7.33

6.57

g/l

0.38

120

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

143

2.19

4.00

1.5

1.3

6.14

6.35

g/l

0.16

109

Open wound of ankle and foot

492

1.62

4.00

1.3

6.23

6.58

g/l

0.45

349

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

105

2.41

4.00

1.3

1.5

5.55

6.65

g/l

1.20

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

289

2237

1.28

3.98

1.4

6.39

6.64

g/l

0.81

231

1598

Injury of muscle and tendon at forearm level

2.86

3.98

1.3

8.20

7.11

g/l

0.36

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

170

2.08

3.97

1.3

1.4

6.63

6.80

g/l

0.10

119

Necrosis of pulp, including avohilmo

428

3467

1.22

3.96

1.4

6.94

6.70

g/l

0.54

294

2516

Other acquired deformities of musculoskeletal system and connective tissue

177

2.05

3.96

1.9

1.3

7.08

6.79

g/l

0.16

124

Molar incisor enamel hypoplasia

215

1.93

3.95

1.4

6.17

6.37

g/l

0.11

175

Follicular cysts of skin and subcutaneous tissue

127

879

1.45

3.95

1.4

1.3

5.84

6.82

g/l

2.98

624

Dilated cardiomyopathy

463

1.63

3.94

1.4

1.3

7.13

6.83

g/l

0.30

337

Cyst of kidney

254

1.86

3.94

1.5

1.3

7.48

7.02

g/l

0.41

184

Exposure to other and unspecified inanimate mechanical forces

357

1.72

3.93

1.4

1.3

6.53

6.68

g/l

0.14

257

Status epilepticus

106

2.38

3.91

1.4

1.3

5.57

6.68

g/l

1.20

Spirochaetal infections, other/unspecified

380

1.70

3.91

1.2

1.4

6.57

6.97

g/l

0.34

269

Use of other anti-dementia drugs

756

0.58

3.90

1.4

6.76

7.14

g/l

0.33

545

Use of memantine

756

0.58

3.90

1.4

6.76

7.14

g/l

0.33

545

Other symptoms and signs involving the urinary system

418

1.66

3.90

1.5

1.3

6.89

6.82

g/l

0.05

299

Diabetic retinopathy, excluding more controls

177

717

1.39

3.90

1.4

1.5

6.46

6.55

g/l

0.11

115

486

Inflammatory disease of uterus

102

678

1.51

3.89

1.4

5.64

6.53

g/l

2.69

485

Early lumbar disc prolapse, operated

426

1.65

3.89

1.2

1.3

6.55

6.48

g/l

0.07

288

Other disorders of veins

274

2107

1.28

3.89

1.3

1.4

7.24

6.73

g/l

0.86

190

1544

Other bursitis of elbow

5.39

3.85

1.2

6.04

7.95

g/l

—

Visual field defects

307

1.77

3.85

1.5

1.3

6.34

6.98

g/l

0.63

222

Mental and behavioural disorders due to alcohol

343

2625

1.25

3.83

1.3

1.4

6.64

6.78

g/l

0.27

225

1864

Injury of nerves at forearm level

3.12

3.83

1.3

1.4

5.77

6.75

g/l

—

Other superficial mycoses

2.63

3.82

1.6

1.3

6.27

6.64

g/l

0.24

Dislocation, sprain and strain of joints and ligaments at neck level

117

803

1.46

3.82

1.5

1.4

6.30

6.55

g/l

0.47

567

Chronic mastoiditis

2.63

3.82

2.3

1.2

7.62

7.60

g/l

0.01

Other facial nerve disorders

2.45

3.82

1.6

1.3

8.25

7.08

g/l

0.31

Other disorders of binocular movement

2.57

3.82

1.4

1.3

6.47

5.80

g/l

0.55

Other misadventures during surgical and medical care

2.57

3.82

1.4

1.3

6.24

6.59

g/l

0.23

Dissection of aorta

2.45

3.81

1.8

1.3

6.66

6.62

g/l

0.02

Hypertrophic scar

215

1.92

3.78

1.4

6.42

6.59

g/l

0.13

158

Tooth eruption problems

114

753

1.47

3.77

1.4

6.06

6.58

g/l

1.30

564

Pain associated with micturition

524

1.57

3.75

1.4

6.31

6.79

g/l

0.40

379

Respiratory conditions due to other external agents

2.95

3.75

1.6

1.3

4.96

6.63

g/l

2.90

Tuberculosis of other organs

2.95

3.75

2.1

1.3

7.85

7.12

g/l

—

Other peripheral vertigo

362

1.70

3.75

1.5

1.4

6.33

6.73

g/l

0.43

266

Graves ophthalmopathy

2.43

3.75

1.3

1.4

6.35

6.89

g/l

0.38

Myocardial infarction, without ST-elevation

219

1505

1.32

3.75

1.4

6.79

7.05

g/l

0.51

173

1062

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

134

2.19

3.74

2.1

1.3

6.64

6.92

g/l

0.18

Hyperfunction of pituitary gland

202

1.95

3.73

1.4

1.3

6.27

6.74

g/l

0.41

146

Other specified disorders of muscle

2.59

3.73

1.5

1.2

5.84

7.19

g/l

0.88

Presbycusis

388

1.66

3.71

1.6

1.2

5.65

7.23

g/l

2.64

280

Mental and behavioural disorders due to sedatives or hypnotics

296

1.77

3.71

1.3

1.4

6.04

6.66

g/l

0.88

214

Tuberculosis of other organs, strict

2.82

3.70

2.0

1.3

8.00

7.64

g/l

0.10

Herpesviral keratitis and keratoconjunctivitis

148

2.11

3.69

1.6

1.3

7.43

6.92

g/l

0.23

110

Chromosomal abnormalities, not elsewhere classified

122

2.25

3.68

1.4

1.3

6.95

6.07

g/l

0.86

Left hemicolectomy

2.72

3.67

1.4

1.2

6.84

7.82

g/l

0.20

Benign lipomatous neoplasm of other sites/unspecified

297

1.76

3.66

1.2

1.4

6.29

6.84

g/l

0.47

219

Sequelae of injuries, of poisoning and of other consequences of external causes

164

1205

1.37

3.65

1.4

1.3

6.98

6.69

g/l

0.26

115

861

Dislocation, sprain and strain of joints and ligaments of head

176

2.01

3.65

1.5

1.3

5.56

6.66

g/l

1.18

128

Benign neoplasm of eye and adnexa

434

1.62

3.65

1.7

1.4

6.07

6.88

g/l

1.40

323

Hypertrophy of breast in women and men

141

1011

1.40

3.64

1.4

1.3

6.21

6.72

g/l

1.20

726

Dissociative [conversion] disorders

149

2.10

3.64

1.2

1.3

5.64

6.45

g/l

1.18

103

Benign neoplasm of middle ear and respiratory system

283

1.78

3.64

1.8

1.3

6.82

6.72

g/l

0.07

202

Left ventricular outflow tract obstruction (LVOTO), broad definition

497

1.58

3.63

1.6

1.3

7.39

6.60

g/l

0.49

368

Other and unspecified nonscarring hair loss

4.11

3.63

1.1

1.4

6.01

6.02

g/l

—

Hemiplegia

163

2.04

3.60

1.3

6.73

6.88

g/l

0.06

120

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

143

2.11

3.59

1.6

1.2

7.26

7.30

g/l

0.02

109

Caries of enamel

708

3988

1.16

3.59

1.4

6.79

6.67

g/l

0.40

560

2828

Any dementia, excluding more controls

999

0.68

3.58

1.2

1.4

7.25

7.07

g/l

0.16

702

Delirium, not induced by alcohol and other psychoactive substances

412

1.63

3.57

1.4

1.3

6.81

6.79

g/l

0.01

298

Alzheimer’s disease, strict definition

707

0.59

3.54

1.1

1.4

6.63

7.12

g/l

0.42

506

Other secondary gonarthrosis

199

1.93

3.54

1.3

1.4

6.03

6.88

g/l

0.86

146

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

111

767

1.45

3.53

1.2

1.4

6.93

6.84

g/l

0.06

564

Examination and encounter for administrative purposes

271

1.78

3.53

1.2

6.91

7.15

g/l

0.16

164

Disorder of lipoprotein metabolism, unspecified

493

1.57

3.52

1.3

1.4

6.37

6.91

g/l

0.72

351

Medicines for HER+ breast cancer

137

1758

0.72

3.52

1.2

1.4

6.70

6.66

g/l

0.04

1297

Primary open-angle glaucoma

173

1240

1.35

3.50

1.4

6.30

6.94

g/l

1.98

113

884

Disorder of the sleep-wake schedule

2.65

3.49

1.5

1.3

7.22

6.54

g/l

0.48

Female infertility, associated with anovulation

332

1.70

3.48

1.5

1.4

6.34

6.80

g/l

0.70

240

Chalazion

511

1.55

3.46

1.7

1.3

6.85

6.78

g/l

0.07

364

Palmar fascial fibromatosis [Dupuytren]

503

1.56

3.46

1.4

1.3

6.59

7.40

g/l

0.98

354

Persons encountering health services in circumstances related to reproduction

427

2371

1.21

3.45

1.3

1.4

6.56

6.63

g/l

0.14

310

1712

Chondrocostal junction syndrome [Tietze]

139

2.11

3.44

1.5

1.3

5.84

6.82

g/l

1.26

102

Unstable angina pectoris

189

1120

1.33

3.43

1.4

6.66

6.99

g/l

0.62

147

771

Bacterial, viral and other infectious agents

387

1.64

3.43

1.4

1.3

6.62

6.67

g/l

0.05

268

Kyphosis

3.58

3.42

1.2

1.3

8.94

8.49

g/l

—

Psoriasis (vulgaris), strict definition

120

2.19

3.39

1.1

1.3

6.62

6.53

g/l

0.04

Malignant neoplasm of thyroid gland, including Hilmo

312

1.71

3.39

1.7

1.4

6.71

6.72

g/l

0.01

225

Use of donepezil

629

0.54

3.39

1.2

1.4

6.07

7.08

g/l

1.27

458

Mixed and other personality disorders

381

1.64

3.38

1.5

1.4

6.11

6.56

g/l

0.65

278

Injury of unspecified body region

298

1.72

3.35

1.5

1.3

6.03

6.70

g/l

0.80

222

Campylobacter enteritis

2.34

3.35

1.3

7.29

6.65

g/l

0.38

Sixth [abducent] nerve palsy

121

2.17

3.33

1.6

1.3

5.68

7.07

g/l

1.25

Malignant neoplasm of breast, ER-positive, including Hilmo

118

1229

0.71

3.32

1.2

1.4

6.92

6.67

g/l

0.32

910

Cholesteatoma of middle ear

162

1.99

3.30

2.2

1.3

6.50

7.10

g/l

0.66

118

Malignant neoplasm of endocrine gland, including Hilmo

353

1.65

3.29

1.6

1.4

6.77

6.74

g/l

0.03

250

Other strabismus

156

1154

1.35

3.28

1.6

1.4

6.64

6.60

g/l

0.05

107

833

Malignant neoplasm of breast, HER-positive

118

1228

0.71

3.28

1.2

1.4

6.92

6.67

g/l

0.32

909

Hypertrophy of tongue papillae

2.83

3.28

1.6

1.3

6.52

6.89

g/l

—

Cardiac arrest

148

1.96

3.28

1.1

1.3

7.02

6.96

g/l

0.03

105

Other disorders of glucose regulation and pancreatic internal secretion

338

1.67

3.28

1.8

1.3

6.93

6.55

g/l

0.30

242

Injuries to unspecified part of trunk, limb or body region

439

1.58

3.27

1.6

1.3

5.95

6.72

g/l

1.36

324

Complications of other internal prosthetic devices, implants and grafts

122

2.15

3.26

1.2

1.3

6.73

6.91

g/l

0.09

Other noninflammatory disorders of vagina

316

1.69

3.25

1.3

7.52

6.82

g/l

0.60

224

Endometriosis of ovary

105

687

1.44

3.24

1.3

6.44

6.83

g/l

0.55

484

Amputation

316

1.68

3.24

1.4

1.2

7.83

6.88

g/l

0.49

229

Primary open-angle glaucoma, strict

142

1039

1.37

3.23

1.4

6.27

6.96

g/l

1.86

735

Sequelae of other external causes

220

1.83

3.23

1.7

1.3

6.31

6.68

g/l

0.19

160

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

407

2630

1.20

3.23

1.4

6.75

6.69

g/l

0.11

283

1954

Carcinoma in situ of skin of upper limb, including shoulder

2.53

3.22

1.4

1.3

5.66

7.66

g/l

1.56

Malignant neoplasm of breast

167

1426

0.75

3.22

1.2

1.4

6.69

6.64

g/l

0.05

111

1060

Suicide or other Intentional self-harm

170

1285

1.33

3.19

1.3

1.4

6.08

6.65

g/l

2.22

121

920

Benign neoplasm: Rectosigmoid junction

130

2.10

3.19

1.1

1.3

8.12

7.13

g/l

0.33

Prolonged pregnancy

735

0.61

3.18

1.2

1.4

6.68

6.43

g/l

0.22

548

Malignant neoplasm of breast, HER2-negative

167

1424

0.75

3.18

1.2

1.4

6.69

6.64

g/l

0.05

111

1058

Embedded teeth, including avohilmo

427

1.58

3.17

1.4

6.20

6.42

g/l

0.29

312

Postmenopausal bleeding

152

583

1.37

3.16

1.3

6.67

6.79

g/l

0.13

108

412

Atopic conjunctivitis

179

1.92

3.15

1.5

1.3

6.40

6.76

g/l

0.34

139

Wet age-related macular degeneration

519

1.51

3.14

1.4

6.67

7.08

g/l

0.59

388

Congenital malformations of ovaries, fallopian tubes and broad ligaments

252

1.76

3.13

1.3

1.4

7.14

6.47

g/l

0.71

187

Normotensive glaucoma

282

1.71

3.12

1.5

1.3

6.44

7.02

g/l

0.62

208

Seborrhoeic dermatitis

413

1.58

3.12

1.3

6.77

6.85

g/l

0.07

309

Abdominal aortic aneurysm (AAA)

272

1.72

3.11

1.5

1.2

7.90

7.17

g/l

0.30

204

Sequelae of injuries of neck and trunk

105

2.21

3.10

1.6

1.3

7.01

7.05

g/l

0.01

Myelodysplastic syndrome

3.72

3.10

1.4

1.3

7.37

6.67

g/l

—

Primary gonarthrosis, bilateral

313

2137

1.23

3.09

1.3

1.4

6.70

6.90

g/l

0.50

243

1548

Effects of foreign body entering through natural orifice

167

1266

1.32

3.09

1.3

1.4

6.59

6.78

g/l

0.30

114

902

Gonarthrosis, primary, with knee surgery

350

2245

1.22

3.09

1.4

6.67

6.86

g/l

0.45

255

1622

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

253

1.75

3.08

1.4

6.00

6.89

g/l

1.13

191

Amiodarone users

360

1.62

3.07

1.2

1.4

7.99

6.92

g/l

0.94

263

Residual foreign body in soft tissue

188

1.87

3.06

1.4

1.3

6.16

7.00

g/l

0.93

131

Melanocytic naevi

216

1697

1.28

3.05

1.4

6.16

6.70

g/l

2.19

169

1223

Benign neoplasm: Cerebral meninges

369

1.61

3.03

1.7

1.4

5.84

6.95

g/l

2.19

265

Disorders of breast

334

2421

1.22

3.03

1.5

1.4

6.30

6.68

g/l

1.31

253

1767

Salpingitis and oophoritis

117

843

1.39

3.01

1.4

6.35

6.69

g/l

0.62

607

Pilonidal cyst

401

1.58

3.01

1.4

1.3

6.26

6.45

g/l

0.22

284

Benign neoplasm of meninges

409

1.57

3.01

1.7

1.4

5.84

6.92

g/l

2.33

290

Glaucoma-related operations

175

1.90

3.00

1.4

1.3

5.70

6.97

g/l

1.77

130

Chondropathies

106

752

1.42

2.99

1.6

1.4

6.11

6.62

g/l

1.09

534

Meralgia paraesthetica

127

2.07

2.98

1.5

1.4

6.39

7.00

g/l

0.61

Unspecified event, undetermined intent

2.26

2.98

1.4

1.3

6.05

6.61

g/l

0.31

Congenital malformations of genital organs

487

1.52

2.97

1.2

1.4

6.71

6.35

g/l

0.52

372

Certain conditions originating in the perinatal period

391

1.55

2.97

1.3

6.19

6.43

g/l

0.33

304

Melanoma in situ

148

1.98

2.95

1.4

6.54

7.06

g/l

0.32

108

Other benign neoplasms of connective and other soft tissue

411

1.57

2.95

1.5

1.4

6.43

6.70

g/l

0.13

295

Other disorders of pigmentation

162

1.93

2.95

1.4

8.00

7.03

g/l

0.38

119

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

120

872

1.38

2.95

1.3

1.4

5.76

6.62

g/l

3.37

617

Malignant neoplasm of breast, including Hilmo

174

1447

0.77

2.93

1.2

1.4

6.65

6.64

g/l

0.01

118

1073

Malignant neoplasm of breast, HER2-negative, including Hilmo

174

1447

0.77

2.93

1.2

1.4

6.65

6.64

g/l

0.01

118

1073

Alcohol abuse, main dg

108

772

1.40

2.93

1.3

1.4

6.26

6.62

g/l

0.57

549

Injuries to the elbow and forearm

506

3716

1.17

2.92

1.4

6.64

6.73

g/l

0.24

370

2696

Certolizumab pegol

2.40

2.91

1.3

7.05

6.19

g/l

0.72

Other diseases of spinal cord

2.23

2.91

1.3

5.42

6.82

g/l

0.91

Disturbances of smell and taste

149

1.96

2.90

1.3

1.5

6.68

6.71

g/l

0.01

106

Peripheral arterial reconstruction

582

1.47

2.90

1.4

6.75

7.12

g/l

0.44

418

Gestational [pregnancy-induced] hypertension

174

1337

1.30

2.90

1.6

1.4

6.46

6.61

g/l

0.30

132

976

Social phobias

389

1.58

2.90

1.5

1.3

6.66

6.63

g/l

0.02

272

Fall on same level involving ice and snow

399

3360

1.19

2.90

1.6

1.4

6.85

6.77

g/l

0.14

289

2441

Monoamine oxidase A inhibitors

477

1.52

2.89

1.2

1.3

6.19

6.96

g/l

1.54

335

Scabies

214

1.79

2.88

1.7

1.3

6.72

6.60

g/l

0.09

157

L01XX Other antineoplastic agents

185

1.85

2.87

1.2

1.4

6.14

7.05

g/l

0.60

136

Sub-endpoint used in defining T1D endpoints

186

1423

1.29

2.87

1.4

1.3

6.68

g/l

0.00

133

1028

150

971

1.33

2.86

1.3

1.4

6.68

7.20

g/l

1.18

103

693

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

157

1.93

2.84

1.4

5.75

6.29

g/l

0.57

123

Cystic kidney disease

116

2.09

2.84

1.3

6.38

7.16

g/l

0.53

Astigmatism

298

1.65

2.82

1.3

1.4

7.07

6.38

g/l

0.79

220

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

238

1.74

2.82

2.2

1.5

6.04

7.06

g/l

1.24

173

Familial hypercholesterolemia, with ischemic heart disease

268

1.69

2.81

1.4

1.3

6.59

7.15

g/l

0.39

199

Other and unspecified primary disorders of muscles

3.67

2.81

2.1

1.3

5.38

6.43

g/l

—

Other and unspecified trigeminal disorders

2.68

2.81

1.1

1.5

5.96

6.99

g/l

—

Acute nephritic syndrome

2.49

2.80

1.6

1.3

5.74

6.78

g/l

—

Superficial injury of head

154

1171

1.32

2.80

1.6

1.3

6.66

6.64

g/l

0.03

126

836

Other puerperal infections

393

1.56

2.80

1.4

6.49

6.36

g/l

0.11

290

Arthropod-borne viral fevers and viral haemorrhagic fevers

401

1.55

2.79

1.4

1.3

6.47

6.63

g/l

0.17

294

Malignant neoplasm of thyroid gland

284

1.67

2.79

1.7

1.4

6.87

6.73

g/l

0.11

207

Benign neoplasm of ovary

103

737

1.40

2.79

1.2

1.5

6.64

6.60

g/l

0.04

527

Other and unspecified local infections of skin and subcutaneous tissue

425

1.54

2.79

1.5

1.3

6.66

6.49

g/l

0.13

317

Speech disturbances, not elsewhere classified

307

1.64

2.79

1.3

6.57

6.80

g/l

0.14

226

Hydronephrosis

433

1.53

2.79

1.4

1.3

7.56

6.62

g/l

1.28

321

Solid cancers, including Hilmo

586

2959

1.15

2.78

1.3

1.4

6.88

6.68

g/l

0.51

402

2162

Emotional disorders starting during childhood or adolecense, excluding more controls

174

1.85

2.78

1.4

1.3

6.23

6.37

g/l

0.13

128

Malignant neoplasm of digestive organs

227

1384

1.26

2.77

1.4

6.73

6.87

g/l

0.21

149

1014

Carbimazole or st.post thyroidectomy, condition for graves disease

139

1045

1.33

2.77

1.7

1.4

6.10

6.73

g/l

1.76

744

Malignant neoplasm, without specification of site, including Hilmo

117

2.06

2.76

1.7

1.4

7.19

7.34

g/l

0.03

Contact with other hot fluids

131

2.00

2.76

1.3

6.17

6.53

g/l

0.24

Varicose veins

369

2336

1.19

2.76

1.5

1.4

6.74

6.73

g/l

0.01

256

1710

Viral haemorrhagic fevers, not elsewhere classified/unspecified

316

1.62

2.75

1.4

1.3

6.58

6.73

g/l

0.14

226

Respiratory tuberculosis, not confirmed, including avohilmo

104

2.13

2.75

2.8

1.3

8.07

6.91

g/l

0.73

Other congenital malformations of skin

167

1.87

2.72

1.3

6.40

6.65

g/l

0.23

129

Acidosis

2.45

2.72

1.1

1.2

9.81

7.35

g/l

0.34

Muscle strain

2.16

2.71

1.2

1.4

6.19

7.13

g/l

0.45

Adenomyosis (Endometriosis of uterus)

541

1.46

2.70

1.2

1.4

6.25

6.79

g/l

0.91

385

Peripheral artery operations in Hilmo

420

1.53

2.70

1.5

1.3

7.90

6.79

g/l

0.74

309

L02BG Aromatase inhibitors

110

1476

0.73

2.70

1.2

1.4

6.65

6.67

g/l

0.02

1074

Congenital malformations of the circulatory system

106

745

1.39

2.69

1.6

1.4

7.23

6.56

g/l

0.87

559

Corns and callosities

249

1.70

2.69

1.2

1.4

7.18

6.82

g/l

0.18

182

Mental and behavioural disorders due to opioids

161

1.88

2.67

1.5

1.3

6.06

6.52

g/l

0.23

112

Specific development disorders of speech and language

277

1.65

2.67

1.4

1.3

6.47

6.40

g/l

0.05

211

Entropion and trichiasis of eyelid

227

1.73

2.66

1.5

1.3

6.22

7.21

g/l

1.09

165

Uterine polyps

165

739

1.31

2.66

1.3

6.28

6.79

g/l

1.06

122

523

Alzheimer’s disease (Late onset)

637

0.63

2.66

1.1

1.4

6.63

7.18

g/l

0.45

456

Other benign neoplasms of skin

233

1882

1.24

2.65

1.6

1.4

6.59

6.80

g/l

0.49

177

1340

Behavioural disorders, excluding more controls

2.35

2.64

1.3

5.56

6.27

g/l

—

Infective bursitis

2.23

2.64

1.2

1.3

7.69

7.31

g/l

0.13

Malignant neoplasm of endocrine gland

312

1.61

2.64

1.7

1.4

6.87

6.76

g/l

0.08

225

Personal history of other diseases and conditions

575

1.44

2.64

1.5

1.4

5.93

6.45

g/l

1.45

440

Other menopausal disorders

163

696

1.31

2.62

1.7

1.3

6.30

6.76

g/l

1.23

120

492

Other other unspecified disorders of the circulatory system

127

1.99

2.61

2.0

1.3

6.29

6.80

g/l

0.24

100

2.12

2.60

2.1

1.3

6.49

6.59

g/l

0.06

Other local infections of skin and subcutaneous tissue

457

1.50

2.59

1.5

1.3

7.13

6.56

g/l

0.41

339

Allergic contact dermatitis due to drugs in contact with skin

2.32

2.59

1.3

5.92

7.02

g/l

—

Isolated proteinuria with specified morphological lesion

3.11

2.58

3.1

1.4

5.95

6.40

g/l

—

Pustular psoriasis

185

1.80

2.57

1.2

1.5

6.44

6.69

g/l

0.19

136

Other specified disorders of kidney and ureter

114

2.04

2.57

1.5

1.3

6.08

7.15

g/l

0.92

Hypertrophic cardiomyopathy

149

1.89

2.57

1.4

1.3

5.71

6.93

g/l

1.39

108

Pregnancy hypertension

276

2033

1.22

2.56

1.5

1.4

6.46

6.60

g/l

0.34

209

1493

Malignant neoplasm of small intestine, including Hilmo

2.15

2.55

1.1

1.5

6.23

6.91

g/l

0.30

Embedded and impacted teeth

195

1255

1.26

2.55

1.4

6.40

6.65

g/l

0.61

155

899

Crossbite

362

1.53

2.55

1.3

1.4

6.06

6.51

g/l

0.68

290

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

285

1585

1.21

2.54

1.7

1.4

6.28

6.82

g/l

2.09

211

1169

All dysplastic lesions of the vagina

101

2.10

2.54

1.5

1.4

8.79

6.50

g/l

1.06

Alcohol use disorder, ICD-based

265

2181

1.22

2.54

1.2

1.4

6.78

6.81

g/l

0.04

171

1556

Congenital malformations of eye, ear, face and neck

300

1.61

2.53

1.3

6.73

6.41

g/l

0.25

223

Maltreatment syndromes

231

1.70

2.53

1.2

1.4

6.56

6.28

g/l

0.36

171

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

147

1131

1.30

2.52

1.2

1.4

6.77

6.66

g/l

0.14

103

813

Dysplasia of cervi uteri

140

747

1.32

2.52

1.4

6.76

6.91

g/l

0.17

100

532

Transient ischemic attack

301

1993

1.20

2.52

1.4

6.29

6.86

g/l

2.24

219

1420

Vertical strabismus

129

1.96

2.51

1.3

6.99

7.13

g/l

0.06

101

Oligomenorrhoea

136

1.93

2.51

1.8

1.4

6.20

6.86

g/l

0.64

102

Papillary adenocarcinoma of thyroid gland

209

1.73

2.50

1.9

1.4

7.04

6.63

g/l

0.29

152

Female infertility, tubal origin

209

1.73

2.50

1.2

1.4

5.71

6.81

g/l

1.63

155

Superficial injury of forearm

502

1.46

2.50

1.5

1.4

6.60

6.55

g/l

0.03

367

2.13

2.50

1.3

6.05

5.87

g/l

0.08

Emotionally unstable personality disorder

627

1.41

2.49

1.4

6.50

6.41

g/l

0.10

451

Respiratory tuberculosis, not confirmed

102

2.07

2.47

2.9

1.3

7.84

6.95

g/l

0.51

Open wound of wrist and hand

308

2490

1.20

2.47

1.3

1.4

6.68

6.78

g/l

0.17

232

1769

Type 1 diabetes, wide definition

144

1107

1.30

2.47

1.4

6.71

6.74

g/l

0.04

107

810

Other degenerative diseases of the nervous system

147

822

1.31

2.47

1.4

6.30

7.08

g/l

1.88

106

585

Cystic kidney disease, including avohilmo

123

1.97

2.46

1.3

6.38

7.08

g/l

0.47

Other symptoms and signs involving general sensations and perceptions

137

1.91

2.46

1.2

1.3

6.02

7.00

g/l

0.90

100

Essential (haemorrhagic) thrombocythaemia

123

1.97

2.46

1.2

1.4

6.88

7.14

g/l

0.10

Benign neoplasm of bone and articular cartilage

398

1.52

2.46

2.0

1.4

5.78

6.50

g/l

1.44

285

Congenital ovarian cysts

203

1.74

2.45

1.2

1.4

7.07

6.26

g/l

0.84

151

Stroke, excluding SAH

350

2132

1.19

2.45

1.2

1.5

7.18

6.84

g/l

0.70

258

1509

Impotence

218

1.71

2.45

1.4

1.3

6.77

6.90

g/l

0.10

148

Secondary polycythaemia

2.26

2.45

1.4

1.3

5.46

6.64

g/l

—

Other noninflammatory disorders of uterus, except cervix

120

596

1.35

2.45

1.5

1.3

6.72

6.71

g/l

0.01

423

Other arterial embolism and thrombosis

2.26

2.45

1.4

1.3

5.39

6.60

g/l

1.29

Contraceptive management

294

1708

1.21

2.44

1.4

6.68

6.66

g/l

0.03

216

1238

Other malignant neoplasms of skin (=non-melanoma skin cancer)

271

1516

1.21

2.44

1.6

1.4

6.26

6.82

g/l

2.24

201

1112

Impacted teeth

145

958

1.30

2.44

1.3

6.54

6.62

g/l

0.12

119

686

Benign neoplasm of other and unspecified intrathoracic organs

2.95

2.43

1.9

1.4

7.44

6.78

g/l

—

Aortic valve malfunction, age under 60 years

448

1.48

2.42

1.6

1.3

7.70

6.61

g/l

0.64

330

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

124

768

1.33

2.42

1.2

1.4

6.47

6.91

g/l

0.67

551

Benign neoplasm: Long bones of lower limb

131

1.93

2.41

1.8

1.4

5.43

6.86

g/l

1.46

Dementia in Alzheimer disease

477

0.59

2.41

1.1

1.3

6.64

7.04

g/l

0.19

344

Pustulosis palmaris et plantaris

160

1.83

2.40

1.1

1.5

6.63

6.78

g/l

0.11

121

Use of antiglaucoma preparations and miotics

227

1.68

2.39

1.3

6.45

6.87

g/l

0.35

170

104

715

1.36

2.39

1.3

1.4

6.69

7.28

g/l

1.01

512

Benign neoplasm: Pelvic bones, sacrum and coccyx

4.25

2.38

1.4

1.2

5.38

5.75

g/l

—

Other renal tubulo-interstitial diseases

2.23

2.38

1.1

1.3

7.69

6.03

g/l

0.75

Other and unspecified mood [affective] disorders

313

1.57

2.38

1.2

1.4

6.51

6.59

g/l

0.06

222

Postprocedural musculoskeletal disorders, not elsewhere classified

274

1.62

2.37

1.4

1.5

5.62

6.88

g/l

2.26

202

Hallux rigidus

525

1.43

2.35

1.4

1.6

7.11

6.87

g/l

0.24

383

Medical abortion

418

1939

1.17

2.35

1.3

1.4

6.43

6.69

g/l

0.86

312

1414

Other disorders of breast

668

1.38

2.35

1.4

6.18

6.59

g/l

0.90

476

Psychotic depression

221

1.68

2.34

1.2

1.5

7.36

6.89

g/l

0.19

153

Drug-induced systemic lupus erythematosus

3.30

2.33

1.4

7.84

6.39

g/l

—

Background retinopathy and retinal vascular changes

2.33

2.32

1.5

1.2

6.35

6.50

g/l

—

Inflammatory diseases of prostate (prostatitis)

510

1.44

2.32

1.2

1.4

6.58

7.13

g/l

0.97

357

Benign neoplasm: Skin of eyelid, including canthus

661

1.38

2.32

1.7

1.4

6.90

6.69

g/l

0.30

474

Heart failure and hypertrophic cardiomyopathy

2.40

2.30

1.4

1.3

5.86

7.22

g/l

—

Ménière disease

364

1.52

2.29

1.5

1.4

6.64

6.88

g/l

0.22

260

Intussusception

2.24

2.28

1.3

5.27

7.43

g/l

2.30

Brain meningioma, including Hilmo

185

1.74

2.28

1.6

1.5

5.27

6.75

g/l

2.63

134

Benign neoplasm: Tongue

2.08

2.28

1.6

1.3

5.01

7.01

g/l

2.05

Melanocytic naevi, other sites/unspecified

373

1.51

2.27

1.6

1.4

5.99

6.54

g/l

0.89

265

Hypoglycaemia, other or unspecified

254

1.62

2.27

2.0

1.3

6.32

6.53

g/l

0.20

182

Presence of other devices

129

975

1.30

2.27

1.3

1.4

7.17

6.87

g/l

0.46

104

728

Major anomalies of jaw size

113

1.97

2.26

1.3

7.41

6.43

g/l

0.65

Vitreous haemorrhage

398

1.49

2.25

1.4

6.79

6.72

g/l

0.06

294

Myeloproliferative diseases

294

1.57

2.24

1.2

1.4

6.45

7.06

g/l

0.53

215

Emotional disorders and disorders of social functioning with onset specific to childhood

242

1.63

2.23

1.4

6.27

6.32

g/l

0.05

185

Impacted cerumen

448

1.46

2.23

1.4

1.3

7.04

6.90

g/l

0.10

330

Malignant neoplasm of liver and intrahepatic bile ducts

2.11

2.23

1.3

1.2

6.96

7.59

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

115

872

1.32

2.23

1.4

6.42

6.77

g/l

0.69

635

Urethral stricture

179

1.74

2.22

1.2

7.83

7.06

g/l

0.41

135

Oral leukoplakia, including avohilmo

2.06

2.22

1.3

6.24

7.53

g/l

0.74

Other diseases of peritoneum

157

1.80

2.22

1.4

7.30

6.93

g/l

0.11

121

Mental and behavioural disorders due to alcohol, excluding acute intoxication

280

2330

1.19

2.22

1.2

1.4

6.69

6.79

g/l

0.16

181

1672

Benign neoplasm: Adrenal gland

319

1.54

2.21

1.2

1.4

6.76

6.77

g/l

0.01

231

Benign neoplasm: Skin, unspecified

150

1.81

2.21

1.2

1.4

5.82

6.74

g/l

0.64

109

Degenerative macular diseases

400

1.48

2.20

1.5

1.3

7.24

7.01

g/l

0.21

294

Endometriosis diagnosis and infertility diagnosis occurring together

559

1.40

2.18

1.4

6.11

6.45

g/l

0.44

397

Open wound of forearm

426

1.46

2.17

1.3

7.34

6.74

g/l

0.61

306

Other congenital malformations of circulatory system

2.04

2.17

2.8

1.3

7.05

6.74

g/l

0.18

Amputation of toe

234

1.63

2.17

1.3

1.2

7.49

7.09

g/l

0.24

170

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

151

1.80

2.17

1.4

1.3

7.07

6.81

g/l

0.14

114

Other predominantly sexually transmitted diseases, not elsewhere classified

121

929

1.31

2.16

1.3

1.4

6.84

6.61

g/l

0.33

662

Ischaemic Stroke, excluding all haemorrhages

320

1999

1.18

2.15

1.3

1.4

7.19

6.89

g/l

0.53

232

1423

Benign thyroid growths and nodules

185

1389

1.24

2.15

1.8

1.4

6.43

6.64

g/l

0.33

136

1002

Somnolence, stupor and coma

144

1.82

2.15

1.4

5.68

6.88

g/l

1.12

110

Additional codes for the location of defect, injury or illness

227

1.64

2.15

1.6

1.3

7.08

6.69

g/l

0.19

165

Endometriosis ASRM stages 3,4

142

1115

1.28

2.14

1.4

6.22

6.70

g/l

0.98

112

794

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.40

2.13

1.1

1.4

8.17

6.72

g/l

—

Polyp of the female genital tract

170

765

1.26

2.13

1.3

6.22

6.81

g/l

1.42

127

541

Varicella [chickenpox]

220

1.65

2.13

1.2

1.3

6.62

6.47

g/l

0.09

159

Diabetic nephropathy, excluding more controls

545

1.36

2.12

1.4

1.5

7.16

6.58

g/l

0.79

366

IgA nephropathy (IgA glomerulonephritis)

2.07

2.12

1.7

1.3

6.24

6.75

g/l

0.34

Nontoxic multinodular goitre

104

784

1.33

2.12

1.5

1.4

6.57

6.79

g/l

0.20

563

Other and unspecified injuries of ankle and foot

167

1.75

2.12

2.0

1.3

7.47

6.35

g/l

1.00

119

Hyperprolactinaemia

145

1.81

2.11

1.4

6.33

6.59

g/l

0.19

103

Lesion of femoral nerve

3.26

2.11

1.1

1.4

6.55

6.22

g/l

—

Hypertrophy of breast

117

898

1.31

2.11

1.5

1.4

6.11

6.68

g/l

1.20

647

Glucosamine medication

254

1693

1.20

2.10

1.3

1.4

6.95

6.90

g/l

0.07

183

1218

Blepharochalasis

162

1297

1.25

2.08

1.5

1.4

6.66

6.84

g/l

0.25

116

929

Malignant neoplasm of skin, including Hilmo

316

1799

1.18

2.08

1.6

1.4

6.46

6.78

g/l

0.78

233

1324

Coxarthrosis, primary

349

2490

1.16

2.06

1.3

1.4

6.57

6.88

g/l

1.04

282

1779

Superficial injury of thorax

693

1.35

2.06

1.6

1.3

6.49

6.78

g/l

0.39

506

Benign neoplasm: Skin of trunk

161

1.75

2.06

2.2

1.3

6.89

6.84

g/l

0.03

125

Hypertensive Renal Disease

1.99

2.05

1.7

1.3

6.37

7.26

g/l

0.46

Autism spe, excluding more controls

1.99

2.05

1.5

1.4

4.86

6.22

g/l

2.05

UC patients in KELA-register (code 208), prior to 1994

154

1.77

2.04

1.6

1.4

6.70

6.88

g/l

0.12

115

Motor disorders, excluding more controls

2.14

2.03

1.7

1.2

5.73

6.58

g/l

0.52

Pediculosis, acariasis and other infestations

278

1.56

2.03

1.6

1.3

7.05

6.64

g/l

0.29

201

Other vitreous opacities

147

1.78

2.03

1.4

7.07

6.77

g/l

0.18

109

Other specified and unspecified strabismus

2.54

2.02

1.3

6.19

6.10

g/l

—

Status post-ami

119

695

1.30

2.02

1.3

1.4

7.20

7.01

g/l

0.23

101

483

Vestibular neuronitis

359

1.48

2.02

1.3

1.4

8.02

6.78

g/l

0.83

266

Other abnormal findings in urine

2.53

2.02

1.5

1.4

4.69

6.86

g/l

—

Unspecified urinary incontinence

327

1.50

2.00

1.4

7.07

6.98

g/l

0.06

227

Short stature starting before birth

2.68

1.98

1.4

1.2

6.57

6.26

g/l

—

Malignant neoplasm of brain

119

1.86

1.97

1.3

1.2

6.38

6.96

g/l

0.27

Stroke, including SAH

371

2307

1.15

1.95

1.3

1.4

7.19

6.81

g/l

0.85

276

1630

Recurrent dislocation and subluxation of joint

289

1.53

1.95

1.2

1.4

6.32

6.67

g/l

0.34

195

Injury of muscle and tendon at shoulder and upper arm level

215

1788

1.20

1.95

1.4

6.33

6.89

g/l

1.77

152

1281

Primary hyperparathyroidism

437

1.42

1.94

1.7

1.4

6.69

6.91

g/l

0.24

305

Use of glatiramer acetate

2.14

1.93

1.3

1.4

5.94

6.12

g/l

—

Insulin, fast-acting (human)

632

1.35

1.93

1.3

6.52

6.70

g/l

0.23

446

Non-small cell lung cancer, adenocarcinoma

180

1.67

1.92

1.1

1.4

6.74

7.23

g/l

0.43

133

Calcific tendinitis of shoulder

211

1.62

1.91

1.2

1.4

6.08

6.97

g/l

0.95

146

Injury of muscle and tendon at hip and thigh level

497

1.39

1.91

1.3

1.4

7.08

6.70

g/l

0.35

361

Fracture of skull and facial bones

135

1071

1.26

1.91

1.5

1.3

6.89

6.69

g/l

0.22

754

Malignant neoplasm of bronchus and lung, including Hilmo

104

663

1.31

1.91

1.2

1.5

6.59

6.96

g/l

0.48

483

Arterial embolism and thrombosis of lower extremity artery

1.93

1.90

1.2

5.68

6.56

g/l

0.52

Other infective otitis externa

235

1.58

1.90

1.2

1.4

6.80

6.96

g/l

0.12

172

Pedestrian injured in transport accident

275

1.53

1.89

1.3

1.4

6.59

6.80

g/l

0.14

199

Malignant neoplasm of oral cavity, including Hilmo

143

1.76

1.89

1.2

1.3

5.98

7.02

g/l

0.67

106

Hydatidiform mole

0.00

1.89

0.0

1.5

—

6.08

—

Chronic periodontitis, including avohilmo

673

3868

1.11

1.88

1.4

6.78

6.73

g/l

0.10

508

2753

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

292

1.51

1.87

1.5

1.3

5.55

6.57

g/l

1.66

213

L02BA Anti-estrogens

756

0.70

1.86

1.1

1.5

6.63

6.66

g/l

0.04

542

Biomechanical lesions, not elsewhere classified

174

1.68

1.86

1.2

1.4

6.04

6.81

g/l

0.78

127

Foreign body in respiratory tract

205

1.62

1.86

1.5

1.4

7.25

6.67

g/l

0.40

155

Brain meningioma

182

1.66

1.85

1.7

1.5

5.10

6.75

g/l

3.39

132

In situ neoplasms

236

1990

1.19

1.85

1.3

1.4

7.02

6.84

g/l

0.26

164

1438

Atlantoaxial subluxation

3.59

1.85

1.2

1.5

6.42

g/l

—

False labour

205

1053

1.21

1.84

1.3

1.4

6.54

6.47

g/l

0.11

143

787

Foreign body on external eye

707

1.32

1.84

1.2

1.3

6.73

6.62

g/l

0.12

503

Preterm labour and delivery

162

1319

1.23

1.83

1.4

6.59

6.62

g/l

0.03

112

971

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

100

768

1.31

1.83

1.4

6.54

6.73

g/l

0.28

567

Bitten or struck by other mammals

570

1.36

1.82

1.4

6.03

6.52

g/l

0.90

410

Haemangioma, any site

376

1.44

1.82

1.7

1.4

6.87

6.54

g/l

0.43

271

Benign lipomatous neoplasm

174

1429

1.22

1.82

1.3

1.4

6.34

6.84

g/l

1.21

115

1032

Cysts of oral region, not elsewhere classified

238

1.56

1.81

1.7

1.4

6.37

6.75

g/l

0.45

174

Other eating disorders

230

1.57

1.81

1.3

1.4

6.40

6.18

g/l

0.23

163

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

168

1.68

1.81

1.5

1.3

6.83

6.61

g/l

0.13

130

Unspecified dementia

271

0.53

1.81

1.0

1.3

7.89

6.77

g/l

0.39

207

Early complications of trauma

168

1.68

1.81

1.4

1.3

6.57

7.01

g/l

0.37

120

!Aliquae complicationes praecoces traumatis

168

1.68

1.81

1.4

1.3

6.57

7.01

g/l

0.37

120

Dronedarone medication

1.93

1.81

1.3

1.1

5.93

6.54

g/l

0.29

Primary coxarthrosis, bilateral

152

1232

1.24

1.80

1.4

6.22

6.90

g/l

2.20

123

868

Melanocytic naevi of lower limb, including hip

176

1.66

1.80

1.5

1.3

5.99

6.91

g/l

1.46

128

Myeloproliferative diseases (CML excluded)

263

1.53

1.78

1.2

1.4

6.68

7.03

g/l

0.24

192

Universal erythroderma, KELA reimbursement

2.37

1.78

1.1

1.4

5.42

7.01

g/l

—

Postmenopausal atrophic vaginitis

140

608

1.26

1.77

1.6

1.3

6.87

6.79

g/l

0.07

114

430

Malignant neoplasm of small intestine

2.11

1.76

1.1

1.5

5.94

7.20

g/l

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

216

1.58

1.76

1.6

1.4

7.26

6.87

g/l

0.24

162

Injury of muscle and tendon at wrist and hand level

635

1.33

1.74

1.4

6.14

6.84

g/l

0.95

457

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

330

1.46

1.74

1.4

6.62

6.68

g/l

0.04

238

Other/unspecified disorders of vestibular function

147

1.71

1.74

1.1

1.4

5.86

7.04

g/l

1.12

112

Other superficial mycoses, including avohilmo

515

1.36

1.74

1.2

1.4

6.10

6.62

g/l

1.09

375

Perineal laceration during delivery

771

0.74

1.74

1.7

1.4

6.85

6.41

g/l

0.36

562

Other otitis externa (chronic)

282

1.50

1.71

1.4

6.33

6.68

g/l

0.32

209

Acute alcohol intoxication, ICD10

127

1016

1.25

1.71

1.4

6.35

6.68

g/l

0.51

733

Open wound of abdomen, lower back and pelvis

118

1.79

1.70

1.2

6.97

6.63

g/l

0.13

Other appendicitis

365

1.43

1.70

1.2

1.4

7.24

6.54

g/l

0.62

259

Other specified/unspecified hearing loss

324

1.46

1.69

1.6

1.3

6.19

6.98

g/l

1.56

236

Cardiomyopathy, Hypertrophic obstructive

2.20

1.68

1.5

1.3

6.30

6.93

g/l

—

Contusion of ankle

172

1.64

1.67

1.6

1.3

7.83

6.36

g/l

0.72

126

Periodontitis

670

3874

1.10

1.67

1.4

6.78

6.73

g/l

0.11

507

2757

Other acquired deformities of ankle and foot

3.20

1.67

1.2

1.6

7.67

7.35

g/l

—

Cerebral aneurysm, nonruptured

375

1.42

1.67

1.4

5.96

6.75

g/l

0.95

267

Hepatocellular carcinoma, including Hilmo

1.94

1.65

1.4

1.2

6.64

7.78

g/l

—

Contact with heat and hot substances

237

1.53

1.62

1.3

5.88

6.88

g/l

1.21

176

Fitting and adjustment of other devices

196

1450

1.19

1.62

1.4

7.08

6.82

g/l

0.51

164

1038

Malignant neoplasm of skin

291

1704

1.16

1.62

1.6

1.4

6.39

6.82

g/l

1.17

216

1254

Diffuse brain injury

1.85

1.62

1.1

1.3

8.34

7.36

g/l

0.16

Graves disease, strict definition

480

1.36

1.60

1.4

6.18

6.67

g/l

0.72

350

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.96

1.60

1.5

1.4

4.56

7.21

g/l

—

Congenital malformations of the nervous system

106

1.81

1.59

1.2

1.3

6.26

6.31

g/l

0.03

Left bundle-branch block

238

1.52

1.59

1.3

7.10

6.58

g/l

0.34

173

Superficial injury of shoulder and upper arm

558

1.33

1.59

1.6

1.4

6.75

6.67

g/l

0.07

406

Other disorders of Eustachian tube

106

1.80

1.59

1.3

5.26

6.96

g/l

1.70

Haemangioma and lymphangioma, any site

421

1.38

1.59

1.6

1.3

6.81

6.54

g/l

0.37

307

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

337

1.43

1.58

1.2

1.4

6.32

6.80

g/l

0.54

226

Peripheral retinal degeneration

1.83

1.57

1.4

1.3

4.67

6.89

g/l

—

Overexertion and strenuous or repetitive movements

456

1.36

1.57

1.3

1.4

6.56

6.64

g/l

0.07

328

Intentional self-harm by sharp object

114

1.77

1.57

1.3

6.13

6.63

g/l

0.34

Conduct disorder

1.86

1.56

1.3

5.56

6.10

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

397

1.39

1.56

1.2

1.5

6.51

6.40

g/l

0.10

291

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

199

1.56

1.55

1.5

1.4

6.68

6.97

g/l

0.19

148

Basal cell carcinoma, including Hilmo

263

1535

1.16

1.55

1.7

1.4

6.39

6.80

g/l

1.33

196

1129

Alzheimer’s disease (Atypical or mixed)

282

0.56

1.55

1.1

1.3

7.72

7.05

g/l

0.22

216

L01XE Protein kinase inhibitors

176

1.60

1.55

1.4

1.3

7.87

6.81

g/l

0.50

129

Other conjunctival vascular disorders and cysts

1.94

1.55

1.7

1.3

6.42

7.24

g/l

—

Melanocytic naevi of trunk

596

1.31

1.54

1.2

1.4

6.20

6.67

g/l

0.85

437

Hydrocele

432

1.37

1.54

1.3

1.4

6.30

7.22

g/l

1.09

306

Car occupant injured in other and unspecified transport accidents

119

959

1.24

1.54

1.6

1.4

6.80

6.65

g/l

0.18

686

Glaucoma, exfoliation

281

1.46

1.54

1.4

1.3

6.18

6.99

g/l

1.15

212

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

399

1.38

1.52

1.2

1.4

6.51

6.57

g/l

0.05

281

Retinal detachments and breaks

195

1651

1.18

1.52

1.6

1.4

6.69

6.94

g/l

0.45

145

1200

Carcinoma in situ of skin

282

1.46

1.52

1.4

6.71

6.96

g/l

0.14

205

Other congenital malformations of skin, including avohilmo

374

1.40

1.52

1.3

6.70

6.46

g/l

0.30

271

Congenital lens malformations

2.92

1.52

1.2

1.5

5.09

6.34

g/l

—

L02BB Anti-androgens

296

0.57

1.51

2.8

1.2

8.12

6.97

g/l

—

218

Lichen sclerosus et atrophicus

485

1.34

1.51

1.6

1.4

6.74

6.82

g/l

0.07

341

Varicella [chickenpox], including avohilmo

266

1.47

1.51

1.2

1.4

6.67

6.33

g/l

0.25

200

Lesion of sciatic nerve

108

1.77

1.50

1.3

1.2

7.13

7.50

g/l

0.22

Varicose veins of other sites

250

1.49

1.50

1.2

1.3

7.56

6.65

g/l

0.48

180

Solid cancers

543

2876

1.11

1.49

1.3

1.4

6.79

6.70

g/l

0.18

370

2099

Disorders of synovium and tendon in diseases classified elsewhere

2.08

1.49

1.4

1.3

7.68

7.33

g/l

—

Family history of other conditions

2.02

1.49

1.2

1.3

6.37

6.27

g/l

—

Contusion of other and unspecified parts of foot

234

1.50

1.49

1.2

1.3

7.39

6.36

g/l

0.69

162

malignant neoplasm of male genital organs

731

0.79

1.48

1.3

1.5

6.95

6.97

g/l

0.02

532

Mental disorders, not otherwise specified

385

1.38

1.47

1.3

1.4

6.42

6.51

g/l

0.07

279

Sequelae of infectious and parasitic diseases, including avohilmo

301

1.43

1.46

1.5

1.4

6.98

6.70

g/l

0.19

214

Use of interferon beta-1a

102

1.78

1.45

1.3

1.4

6.00

6.34

g/l

0.25

Acute alcohol intoxication

150

1247

1.21

1.45

1.4

6.44

6.76

g/l

0.56

101

899

Other and unspecified disorders of adult personality and behaviour

2.77

1.44

1.2

1.5

5.46

6.21

g/l

—

Anomalies of dental arch relationship, including avohilmo

135

1004

1.22

1.44

1.4

6.27

6.61

g/l

0.76

101

729

Conductive hearing loss, unspecified

336

1.40

1.43

1.3

7.02

6.57

g/l

0.40

243

Benign neoplasm of urinary organs

164

1.59

1.43

1.2

1.3

6.08

6.86

g/l

0.60

120

Fracture of neck

204

1.53

1.43

1.1

1.3

7.15

6.99

g/l

0.05

149

Single spontaneous delivery

179

1119

0.84

1.42

1.4

6.44

6.50

g/l

0.11

112

859

Fracture of lower leg, including ankle

349

3046

1.13

1.40

1.5

1.4

6.83

6.75

g/l

0.15

262

2186

Sequelae of infectious and parasitic diseases

296

1.42

1.39

1.5

1.4

7.01

6.68

g/l

0.21

212

Injury of eye and orbit

721

1.27

1.39

1.2

1.3

6.38

6.62

g/l

0.38

508

Other salmonella infections, including avohilmo

150

1.61

1.38

1.6

1.3

7.17

6.59

g/l

0.29

110

Diabetic retinopathy

209

1110

1.17

1.38

1.4

6.55

6.64

g/l

0.14

137

777

Exposure to other and unspecified forces of nature

2.65

1.37

1.8

1.2

6.47

7.24

g/l

—

Early lumbar disc prolapse operation

555

1.30

1.37

1.2

1.4

6.97

6.49

g/l

0.47

386

Intermittent heterotropia

280

1.43

1.37

1.4

6.23

6.44

g/l

0.21

210

Malignant neoplasm of respiratory system and intrathoracic organs

100

664

1.25

1.37

1.2

1.5

6.70

6.88

g/l

0.20

484

Hypermetropia

348

1.38

1.36

1.5

1.4

7.37

6.46

g/l

1.44

266

Other salmonella infections

112

1.71

1.35

1.4

1.3

7.43

6.80

g/l

0.27

Outcome of delivery

536

0.77

1.35

1.2

1.4

6.50

6.43

g/l

0.07

399

Foreign body in ear

1.88

1.35

1.4

1.3

6.23

6.70

g/l

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

240

1.47

1.35

1.6

1.4

6.60

6.68

g/l

0.05

174

Malignant neoplasm of prostate

689

0.80

1.34

1.3

1.5

6.82

6.96

g/l

0.14

505

Diabetic nephropathy

725

1.26

1.33

1.4

1.5

7.14

6.66

g/l

0.62

498

Benign neoplasm: Brain, supratentorial

2.06

1.33

1.5

1.4

6.95

6.38

g/l

0.12

Alzheimer’s disease (Late onset), excluding more controls

327

0.69

1.33

1.1

1.6

6.99

7.29

g/l

0.15

224

All dysplastic lesions of the vulva

184

1.53

1.32

1.3

1.5

8.92

6.55

g/l

1.25

139

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

168

1.56

1.31

1.3

1.4

8.20

6.80

g/l

0.31

126

Complications predominantly related to the puerperium

165

1400

1.18

1.31

1.5

1.4

6.57

6.64

g/l

0.09

126

1025

Wide developmental disorders, excluding more controls

141

1.60

1.30

1.4

1.3

5.14

6.24

g/l

1.49

105

Enterobiasis

2.83

1.29

1.8

1.1

6.43

5.82

g/l

—

Sequelae of injuries of upper limb

464

1.32

1.29

1.2

1.4

6.34

6.62

g/l

0.24

336

Bicipital tendinitis

177

1.53

1.29

1.3

6.68

7.01

g/l

0.22

126

Malignant neoplasm of brain, including Hilmo

169

1.55

1.29

1.3

1.4

6.06

6.89

g/l

0.56

130

Pediculosis, acariasis and other infestations, including avohilmo

117

964

1.22

1.28

1.5

1.4

6.47

6.60

g/l

0.19

698

Undefined dementia

248

0.59

1.28

1.0

1.3

7.89

6.90

g/l

0.33

186

Basal cell carcinoma

246

1465

1.15

1.27

1.7

1.4

6.31

6.83

g/l

1.87

183

1071

329

0.64

1.27

1.1

1.3

8.77

6.90

g/l

0.62

243

Alzheimer disease, excluding more controls

412

0.74

1.26

1.2

1.5

6.65

7.19

g/l

0.39

282

Parkinson's disease

552

0.72

1.25

1.7

1.3

6.98

6.96

g/l

0.01

401

Ovarian dysfunction

354

1.36

1.25

1.4

1.5

5.71

6.44

g/l

1.40

259

Disorder of external ear, unspecified

123

1.64

1.24

1.6

1.4

6.51

7.11

g/l

—

Behavioural disorders

100

1.71

1.24

1.3

1.2

5.56

6.38

g/l

—

Other congenital malformations of the digestive system, including avohilmo

260

1.42

1.23

1.6

1.3

7.36

6.39

g/l

0.63

204

Sequelae of other and unspecified infectious and parasitic diseases

237

1.44

1.22

1.6

1.4

6.63

6.71

g/l

0.05

171

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

399

1.33

1.22

1.2

1.4

6.74

6.78

g/l

0.02

280

Impacted maxillary molar

288

1.39

1.21

1.5

1.4

6.82

6.30

g/l

0.48

201

Scabies, including avohilmo

808

1.23

1.20

1.6

1.4

6.49

6.57

g/l

0.13

586

Retinal vascular occlusion

400

1.33

1.20

1.2

1.3

6.23

7.03

g/l

0.93

288

Bursitis of shoulder

1.84

1.19

1.5

1.4

5.76

7.34

g/l

—

Injury of muscle and tendon at lower leg level

728

1.24

1.19

1.8

1.3

7.08

6.86

g/l

0.17

521

Congenital malformations of great arteries

138

1.58

1.19

1.7

1.4

5.90

6.26

g/l

0.15

117

Early syphilis

2.12

1.19

2.8

1.3

6.35

7.18

g/l

—

Malignant neoplasm of head and neck

289

1.39

1.19

1.2

1.4

5.65

6.94

g/l

1.66

211

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

332

1.36

1.18

1.2

1.4

6.53

6.34

g/l

0.17

238

Benign neoplasm: Skin of other and unspecified parts of face

401

1.33

1.18

1.5

1.4

6.20

6.82

g/l

0.74

297

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

358

1.34

1.18

1.1

1.4

6.99

6.91

g/l

0.05

263

Benign mammary dysplasia

604

1.26

1.18

1.5

1.4

6.55

6.71

g/l

0.11

422

Diabetic maculopathy

553

1.27

1.18

1.4

1.5

6.65

6.46

g/l

0.19

383

Organic, including symptomatic, mental disorders

216

1736

0.87

1.17

1.2

1.4

6.96

6.94

g/l

0.02

147

1233

Non-small cell lung cancer, adenocarcinoma, helper endpoint

206

1.46

1.17

1.1

1.4

6.74

7.03

g/l

0.23

156

Other congenital malformations of the digestive system

213

1.45

1.17

1.6

1.3

7.54

6.40

g/l

0.67

166

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

0.00

1.16

0.0

1.3

—

6.43

—

Foreign body entering into or through eye or natural orifice

359

1.34

1.16

1.3

6.63

6.66

g/l

0.02

264

Benign neoplasm of thyroid gland

118

1.62

1.15

2.4

1.3

7.45

6.90

g/l

0.17

Infectious mononucleosis

412

1.31

1.15

2.1

1.4

6.77

6.42

g/l

0.37

295

Infectious mononucleosis, including avohilmo

412

1.31

1.15

2.1

1.4

6.77

6.42

g/l

0.37

295

Motorcycle rider injured in other and unspecified transport accidents

266

1.40

1.14

1.4

1.2

6.16

6.67

g/l

0.65

191

Congenital malformations of heart and great arteries

649

1.24

1.14

1.3

1.4

7.11

6.44

g/l

0.65

488

Eating disorders

526

1.28

1.14

1.3

1.4

6.18

6.52

g/l

0.41

387

Pregnancy with abortive outcome

414

1955

1.10

1.13

1.4

6.41

6.68

g/l

0.86

299

1426

Focal brain injury

191

1.47

1.13

1.5

1.3

6.33

6.95

g/l

0.57

140

Malignant neoplasm of urinary organs, including Hilmo

413

1.31

1.13

1.1

1.4

7.26

6.96

g/l

0.23

305

Obstructed labour due to maternal pelvic abnormality

716

1.23

1.12

1.3

1.4

6.32

6.61

g/l

0.42

517

Premature rupture of membranes

838

0.82

1.12

1.3

1.4

6.64

6.49

g/l

0.11

627

Unspecified maternal hypertension

1.98

1.12

1.1

1.4

6.87

6.02

g/l

—

Laparoscopic right hemicolectomy

192

1.46

1.11

1.3

7.84

7.18

g/l

0.35

142

Sequelae of injuries of head

217

1.43

1.11

1.5

1.3

7.52

6.75

g/l

0.23

153

Orchitis and epididymitis

362

1.33

1.11

1.3

1.4

7.44

7.13

g/l

0.19

252

Malignant neoplasm of head and neck, including Hilmo

362

1.33

1.11

1.2

1.5

5.69

6.95

g/l

2.12

268

Parkinson's disease, strict definition

493

0.73

1.11

1.8

1.3

7.03

g/l

0.00

354

Amblyopia ex anopsia

176

1.48

1.10

1.2

1.3

6.99

6.53

g/l

0.40

136

Retinal vascular disorders

406

1.31

1.10

1.2

1.3

6.23

7.06

g/l

0.99

294

Use of disulfiram, acamprosate or naltrexone

415

1.31

1.10

1.4

1.3

5.95

6.68

g/l

1.39

290

Congenital cataract

2.42

1.10

1.0

1.5

4.90

6.34

g/l

—

Sexual dysfunction

1.83

1.09

1.7

1.4

6.13

6.83

g/l

0.44

Retinal haemorrhage

1.74

1.09

1.4

1.3

5.66

7.23

g/l

—

Coxarthrosis, primary, with hip surgery

249

2050

1.13

1.09

1.3

1.4

6.66

6.94

g/l

0.63

198

1457

Bipolar affective disorders

113

947

1.20

1.08

1.4

1.3

6.43

6.68

g/l

0.40

660

Intrahepatic Cholestasis of Pregnancy (ICP)

338

1.34

1.08

1.2

1.4

6.53

6.32

g/l

0.18

252

Assault

684

1.23

1.07

1.2

1.4

6.43

6.51

g/l

0.08

477

Benign neoplasm: Choroid

244

1.40

1.07

1.2

1.5

6.11

6.80

g/l

0.64

181

Malignant melanoma of skin

490

0.73

1.07

1.4

7.31

6.76

g/l

0.18

358

Parkinson's disease, including avohilmo

581

0.76

1.07

1.6

1.3

6.82

6.99

g/l

0.11

422

Malignant neoplasm of prostate, including Hilmo

705

0.83

1.06

1.3

1.5

6.97

6.95

g/l

0.02

517

Macular pucker

622

1.24

1.06

1.7

1.4

6.77

7.02

g/l

0.29

444

Other and unspecified mononeuropathies of lower limb

1.68

1.04

1.2

1.3

6.49

7.05

g/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

1.85

1.03

1.5

1.3

7.20

6.01

g/l

—

Other and unspecified mononeuropathies, also in other diseases

1.64

1.03

1.4

1.3

5.10

7.10

g/l

2.54

Exposure to other and unspecified animate mechanical forces

138

1.53

1.03

1.4

1.3

7.02

6.52

g/l

0.26

107

Eating disorder

455

1.28

1.02

1.3

1.4

6.04

6.43

g/l

0.63

338

Myocardial infarction, with ST-elevation

626

1.23

1.01

1.2

1.4

6.67

7.06

g/l

0.42

455

Other and unspecified injuries of abdomen, lower back and pelvis

1.89

1.00

1.0

1.2

5.65

6.06

g/l

—

LSIL lesion of the cervix uteri, vagina or vulva

736

1.21

1.00

1.4

7.79

6.41

g/l

2.08

525

Other lesions of median nerve

1.72

0.99

1.1

1.2

6.06

7.25

g/l

—

Fracture of forearm

354

2896

1.10

0.99

1.3

1.4

6.54

6.67

g/l

0.36

258

2096

Non-small cell lung cancer, including Hilmo

513

1.25

0.98

1.1

1.5

6.75

6.98

g/l

0.25

377

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

0.00

0.98

0.0

1.3

—

5.77

—

Nontoxic goitre/thyroid nodule

158

1375

1.15

0.98

1.8

1.4

6.45

6.71

g/l

0.39

118

980

Specific developmental disorder of motor function

1.62

0.98

1.7

1.3

5.73

6.37

g/l

0.37

malignant neoplasm of male genital organs, including Hilmo

105

749

0.84

0.97

1.3

1.5

7.12

6.98

g/l

0.14

542

Malignant neoplasm of mesothelium and soft tissue

124

1.54

0.97

1.5

1.4

7.39

6.85

g/l

0.20

Benign neoplasm: Kidney

116

1.56

0.96

1.2

1.4

6.29

7.04

g/l

0.40

Erectile dysfunction

284

1.34

0.96

1.8

1.2

8.49

6.84

g/l

0.89

207

Malignant neoplasm of stomach, including Hilmo

157

1.47

0.96

1.4

1.3

5.57

6.96

g/l

1.27

118

Fracture of femur

122

939

1.17

0.95

1.4

6.37

6.96

g/l

1.21

664

Primary ovarian failure

1.70

0.95

1.3

5.91

6.49

g/l

—

Short Achilles tendon (acquired)

1.70

0.95

1.5

1.4

7.71

7.39

g/l

—

Focal epilepsy

120

1025

1.17

0.95

1.3

1.4

6.79

6.63

g/l

0.14

742

Anorexia (incl.atypical)

259

1.35

0.94

1.1

1.4

6.31

6.49

g/l

0.11

182

Primary angle-closure glaucoma

125

1.53

0.94

1.7

1.4

5.01

7.08

g/l

2.84

Meningococcal infection

2.25

0.94

1.2

1.1

7.21

6.39

g/l

—

Meningococcal infection, including avohilmo

2.25

0.94

1.2

1.1

7.21

6.39

g/l

—

Periodontal disease, other/unspecified

101

1.59

0.94

1.4

6.72

6.53

g/l

—

Other ill-defined and unspecified causes of mortality

277

1.34

0.93

1.2

8.27

6.97

g/l

0.85

204

Abnormal findings in secretions and smears from cervix uteri vagina vulva

311

2077

1.10

0.93

1.4

6.79

6.62

g/l

0.37

229

1545

Open wound of head

335

2870

1.10

0.93

1.5

1.4

6.54

6.76

g/l

0.53

227

2037

Delivery

188

1122

0.88

0.92

1.5

1.4

6.44

6.51

g/l

0.11

122

861

Long labour

114

1129

0.85

0.92

1.3

1.4

6.96

6.50

g/l

0.52

834

Motor disorders

101

1.59

0.92

1.7

1.3

5.73

6.25

g/l

0.29

Delivery, wide proxy

146

892

0.87

0.92

1.4

6.32

6.52

g/l

0.35

102

670

Inguinal hernia

339

2055

1.10

0.91

1.3

1.4

7.20

6.70

g/l

1.24

240

1434

Pedestrian injured in collision with pedal cycle

102

1.58

0.90

1.4

1.3

6.52

6.51

g/l

0.00

Pedal cyclist injured in noncollision transport accidents

598

0.78

0.90

1.5

1.4

6.08

6.56

g/l

0.57

432

Crushed, pushed or stepped on by crowd or human stampede

376

1.28

0.89

1.2

1.3

6.74

6.58

g/l

0.16

271

Malignant neoplasm of stomach

135

1.49

0.89

1.4

5.32

7.01

g/l

1.84

104

Carcinoma in situ of breast, intraductal

359

0.72

0.89

1.3

1.4

7.26

6.77

g/l

0.23

255

Diabetic neuropathy

508

1.24

0.88

1.5

1.4

6.83

6.68

g/l

0.13

347

Sequelae of cerebrovascular disease

177

1336

1.13

0.88

1.3

1.4

7.47

6.84

g/l

0.80

132

937

Other fall from one level to another

136

1182

1.15

0.88

1.3

1.4

6.27

6.76

g/l

1.30

107

860

Malignant neoplasm of bronchus and lung

571

1.20

0.87

1.2

1.5

6.69

6.91

g/l

0.22

422

Non-small cell lung cancer

347

1.28

0.86

1.2

1.4

6.56

7.19

g/l

0.67

254

Open bite

299

1.31

0.86

1.3

1.4

6.79

6.19

g/l

0.63

227

Focal epilepsy, strict definition

109

934

1.17

0.86

1.3

6.41

6.68

g/l

0.30

676

Contact with machinery

477

1.24

0.85

1.2

1.3

5.94

6.76

g/l

1.45

342

Alzheimer’s disease (Atypical or mixed), excluding more controls

180

0.66

0.85

1.1

1.5

7.72

7.15

g/l

0.18

127

Retinoschisis and retinal cysts

1.68

0.85

2.7

1.3

6.79

7.17

g/l

—

Toxic effects of substances chiefly nonmedicinal as to source

550

1.22

0.85

1.2

1.3

6.11

6.56

g/l

0.73

398

Emotional disorders starting during childhood or adolescence

245

1.34

0.84

1.4

6.23

6.33

g/l

0.09

193

Thiazolidinediones

433

1.25

0.84

1.3

1.4

6.99

6.90

g/l

0.05

313

Spontaneous abortion

283

1722

1.10

0.84

1.3

1.4

6.49

6.69

g/l

0.46

213

1267

Schizophrenia or delusion

149

1692

0.88

0.84

1.1

1.4

6.69

6.60

g/l

0.09

1197

Diabetic retinopathy, strict definition

724

1.18

0.83

1.4

1.5

6.81

6.66

g/l

0.17

496

Scissor bite

164

0.60

0.83

1.5

6.10

6.37

g/l

—

134

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

1.71

0.83

1.5

1.3

7.20

6.33

g/l

—

Early syphilis, including avohilmo

1.75

0.83

2.8

1.3

6.35

7.00

g/l

—

Schizophrenia, schizotypal and delusional disorders

150

1700

0.88

0.82

1.1

1.4

6.68

6.60

g/l

0.09

1203

Hyperplasia of prostate

181

904

1.13

0.82

1.5

1.4

6.52

7.05

g/l

1.39

136

642

Hereditary corneal dystrophies

113

1.51

0.82

1.2

1.5

6.42

7.21

g/l

0.27

Sequelae of injuries of lower limb

435

1.24

0.82

1.5

1.4

7.18

6.65

g/l

0.24

317

Fracture of shoulder and upper arm

207

1857

1.11

0.82

1.5

1.4

6.48

6.79

g/l

0.69

156

1331

Redundant prepuce, phimosis and paraphimosis

117

997

1.16

0.81

1.2

1.4

6.63

6.86

g/l

0.40

696

Aneurysms, operations, SAH

699

1.19

0.81

1.4

6.52

6.75

g/l

0.24

494

Malignant neoplasm of bladder, including Hilmo

359

1.27

0.81

1.5

1.4

6.82

7.05

g/l

0.18

272

Vascular syndromes of brain in cerebrovascular disorders

130

1.47

0.81

1.3

1.2

7.18

7.28

g/l

0.04

Fall on and from stairs and steps

149

1314

1.14

0.81

1.5

1.3

6.85

6.68

g/l

0.20

106

945

Male infertility

198

1.37

0.80

1.3

7.80

6.74

g/l

0.61

131

Other spirochaetal diseases

203

1825

1.11

0.80

1.4

6.41

6.79

g/l

0.96

167

1309

Other spirochaetal diseases, including avohilmo

205

1844

1.11

0.80

1.4

6.40

6.78

g/l

0.97

168

1324

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.79

0.0

1.3

—

6.70

—

Foreign body or object entering through skin

268

1.31

0.79

1.4

1.3

6.12

6.55

g/l

0.44

194

Other specified/unspecified nutritional deficiencies

0.00

0.79

0.0

1.5

—

6.49

—

Epidural haemorrhage

0.00

0.78

0.0

1.3

—

7.83

—

Exposure to other and unspecified man-made environmental factors

1.63

0.78

1.1

1.3

6.66

6.84

g/l

0.06

Nontoxic single thyroid nodule

286

1.30

0.78

2.0

1.4

5.74

6.92

g/l

2.14

205

Granulomatous disorders of skin and subcutaneous tissue

1.56

0.78

1.7

1.2

5.64

6.97

g/l

—

Assault by bodily force

394

1.25

0.77

1.2

1.3

6.59

6.42

g/l

0.14

278

Juvenile osteochondrosis

132

1.45

0.76

1.7

1.4

6.00

6.33

g/l

0.26

101

Autism

132

1.45

0.76

1.5

1.4

4.86

6.22

g/l

2.14

Polycystic ovarian syndrome, broad definition

549

1.20

0.75

1.4

6.22

6.49

g/l

0.42

409

Typhoid and paratyphoid fevers, including avohilmo

2.11

0.75

1.4

1.3

6.21

6.65

g/l

—

Pedal cyclist injured in collision with pedestrian or animal

2.10

0.75

1.4

1.3

9.45

6.71

g/l

—

Traumatic subdural haemorrhage

420

1.23

0.74

1.5

1.4

7.16

7.23

g/l

0.05

300

Alcohol dependence

145

1285

1.13

0.74

1.1

1.4

6.46

6.83

g/l

0.73

932

Other disorders of cornea

405

1.24

0.74

1.2

1.4

7.09

6.66

g/l

0.31

294

Autism spe

133

1.44

0.74

1.5

1.4

4.86

6.19

g/l

2.08

103

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

1.85

0.73

1.0

1.3

8.16

8.29

g/l

—

Isolated patent ductus arteriosus

1.69

0.73

1.6

1.3

5.33

6.13

g/l

—

Other congenital malformations of heart

1.81

0.73

1.6

1.2

7.45

6.67

g/l

—

Colitis due to radiation

2.01

0.73

1.4

1.3

4.72

8.12

g/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

177

1552

1.11

0.72

1.4

7.03

6.53

g/l

0.92

133

1134

Aggressive periodontitis

1.59

0.72

1.2

1.3

6.67

6.58

g/l

—

Migraine with aura, drug-induced

1.76

0.71

2.7

1.4

6.03

6.49

g/l

—

Medical treatment for female infertility

130

1138

1.13

0.71

1.4

6.64

6.42

g/l

0.35

103

826

Unspecified parasitic disease, including avohilmo

1.94

0.71

1.0

1.2

9.03

6.42

g/l

—

Pregnancy, childbirth and the puerperium

125

742

0.88

0.71

1.3

1.5

6.38

6.64

g/l

0.47

552

Thyrotoxicosis with toxic single thyroid nodule

1.94

0.71

1.8

1.5

5.82

6.05

g/l

—

Puerperal sepsis

581

1.19

0.71

1.7

1.4

6.37

6.58

g/l

0.15

416

Viral agents as the cause of diseases classified to other chapters, including avohilmo

101

1.49

0.70

1.3

6.99

7.13

g/l

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

381

1.24

0.70

1.3

1.4

6.41

6.23

g/l

0.17

276

Helminthiases

1.56

0.70

1.4

1.3

6.63

6.29

g/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

102

888

1.15

0.69

1.3

1.4

6.67

6.68

g/l

0.00

640

Other disorders of the genitourinary system

518

1.20

0.69

1.5

1.4

7.36

6.85

g/l

0.39

366

Lesion of plantar nerve

230

1.31

0.69

1.9

1.4

6.78

6.89

g/l

0.06

167

Prepatellar bursitis

152

1.39

0.69

1.1

1.3

7.06

7.22

g/l

0.08

109

Undescended testis, unilateral

1.68

0.69

1.0

1.4

7.36

6.14

g/l

—

Femoral hernia

127

1.42

0.68

1.3

6.22

7.02

g/l

—

Mandibular retrognathia

319

1.25

0.67

1.5

1.4

5.96

6.31

g/l

0.34

235

Polycystic ovarian syndrome

249

1.29

0.67

1.3

1.4

5.67

6.37

g/l

1.24

176

Abscess of Bartholin gland

111

1.45

0.66

1.1

1.3

6.30

6.75

g/l

0.21

Generalized epilepsy, mode (most common among epilepsy diagnosis)

128

1.41

0.66

1.4

1.3

6.93

6.32

g/l

0.45

Ill-defined and unknown causes of mortality

304

1.25

0.65

1.2

8.12

6.86

g/l

0.86

225

Malignant melanoma of skin, including Hilmo

591

0.83

0.64

1.3

1.4

7.05

6.80

g/l

0.11

428

Foreign body in alimentary tract

207

1.31

0.63

1.4

1.3

6.35

6.81

g/l

0.26

152

Retinal breaks without detachment

737

1.16

0.63

1.7

1.4

6.57

6.81

g/l

0.35

539

Burn and corrosion of head and neck

1.53

0.63

1.2

1.3

6.93

6.74

g/l

0.07

Maternal care for other known or suspected fetal problems

150

844

1.12

0.63

1.3

1.4

6.39

6.44

g/l

0.07

105

638

Infections of genitourinary tract in pregnancy

442

1.20

0.62

1.4

1.5

6.40

6.80

g/l

0.53

319

Open wound of shoulder and upper arm

1.56

0.62

1.2

1.3

8.78

6.77

g/l

—

Viral hepatitis

324

1.24

0.62

1.1

1.3

6.89

6.71

g/l

0.14

227

Impacted maxillary canine

1.58

0.61

1.4

1.2

7.20

6.34

g/l

—

Malignant neoplasm of kidney, except renal pelvis

316

1.24

0.60

1.1

1.4

7.08

6.82

g/l

0.16

231

Viral hepatitis, including avohilmo

344

1.22

0.60

1.1

1.3

6.85

6.72

g/l

0.09

239

Pathological resorption of teeth

157

1.34

0.59

1.1

1.2

6.81

6.90

g/l

0.04

118

Burn and corrosion of trunk

114

1.41

0.59

1.2

1.3

6.51

6.66

g/l

—

Other disorders of breast and lactation associated with childbirth

1.57

0.59

1.3

6.54

6.01

g/l

—

Mental and behavioural disorders due to cannabinoids

123

1.39

0.58

1.2

1.3

6.43

6.22

g/l

—

Tibial collateral bursitis [Pellegrini-Stieda]

1.72

0.58

1.0

1.4

6.20

7.76

g/l

—

Other chromosome abnormalities, not elsewhere classified

1.69

0.57

1.5

1.3

6.40

5.30

g/l

—

Malignant neoplasm of breast, HER-negative

858

0.87

0.57

1.3

1.5

6.58

6.64

g/l

0.04

627

Struck by thrown, projected or falling objec

229

1.27

0.57

1.2

1.3

6.52

6.46

g/l

0.04

161

Periapical abscess

288

2687

1.07

0.56

1.4

6.63

6.73

g/l

0.14

208

1954

Single delivery by forceps and vacuum extractor

528

0.87

0.56

1.2

1.5

6.64

6.42

g/l

0.30

415

Intracerebral haemorrhage

420

1.19

0.56

1.2

1.3

7.37

6.71

g/l

0.81

300

Complications of the puerperium, not elsewhere classified

194

1.29

0.56

1.3

1.4

6.37

6.29

g/l

0.06

143

Clear cell adenocarcinoma of kidney

150

1.34

0.56

1.0

1.4

7.42

6.98

g/l

0.21

113

1.59

0.54

1.8

1.3

5.57

6.97

g/l

—

Maternal care for known or suspected fetal abnormality and damage

745

0.87

0.54

1.3

1.4

6.62

6.52

g/l

0.11

556

Other and unspecified corneal deformities and disorders

116

1.38

0.54

1.2

1.4

8.01

7.08

g/l

—

Torticollis

1.51

0.54

1.1

1.3

6.08

6.46

g/l

—

Ectopic pregnancy

880

1.13

0.54

1.4

6.53

6.84

g/l

0.29

638

Left ventricular outflow tract obstruction, narrow definition

222

1.26

0.54

1.4

1.3

7.49

6.38

g/l

0.50

158

Transient global amnesia

361

0.80

0.53

2.2

1.3

5.88

7.15

g/l

1.53

261

Other abnormal products of conception

200

1208

1.09

0.53

1.5

1.4

6.14

6.64

g/l

2.13

141

896

Sulfonylureas

120

1057

0.90

0.52

1.1

1.4

7.01

7.08

g/l

0.06

741

Combinations of oral blood glucose lowering drugs

142

1292

1.10

0.52

1.4

7.32

6.95

g/l

0.54

927

Type 1 diabetes, strict (exclude DM2)

497

1.17

0.51

1.2

1.4

6.45

6.57

g/l

0.11

367

Type 1 diabetes, definitions combined

497

1.17

0.51

1.2

1.4

6.45

6.56

g/l

0.10

368

Contact with nonpowered hand tool

170

1.30

0.51

1.4

1.3

5.82

6.58

g/l

0.72

117

Inflammatory disorders of breast

287

1.22

0.51

1.7

1.4

6.21

6.37

g/l

0.13

210

Generalized epilepsy

179

1.29

0.51

1.3

8.73

6.38

g/l

1.10

135

Congenital malformations of cardiac septa

331

1.20

0.51

1.3

1.4

7.51

6.39

g/l

0.71

261

Lyme disease, including avohilmo

196

1813

1.08

0.50

1.4

6.42

6.79

g/l

0.91

163

1303

Lyme disease

196

1813

1.08

0.50

1.4

6.42

6.79

g/l

0.91

163

1303

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

379

0.82

0.50

1.5

1.4

6.00

6.94

g/l

0.85

274

LSIL lesion of the cervix uteri

594

1.15

0.50

1.3

1.4

7.85

6.35

g/l

1.74

427

Right hemicolectomy

180

1.28

0.49

1.2

7.65

7.12

g/l

0.28

132

Coronary artery bypass grafting

642

1.12

0.49

1.7

1.4

7.07

7.05

g/l

0.02

444

Persistent delusional disorders

290

0.79

0.48

1.0

1.4

7.70

6.70

g/l

0.33

209

Spirochaetal infections, other/unspecified, including avohilmo

197

1827

1.08

0.48

1.4

6.41

6.78

g/l

0.93

164

1309

Malignant neoplasm of bladder

172

1.28

0.47

1.4

1.2

5.79

7.36

g/l

1.20

131

Bulimia nervosa (incl. atypical)

146

1.31

0.47

1.3

1.4

6.12

6.23

g/l

0.07

Other viral hepatitis

282

1.21

0.46

1.1

1.3

7.10

6.78

g/l

0.21

202

Maternal care for known or suspected malpresentation of fetus

738

0.90

0.45

1.4

6.36

6.43

g/l

0.08

556

Malignant neoplasm of breast, ER-negative, including Hilmo

917

0.90

0.45

1.2

1.4

6.54

6.62

g/l

0.07

672

Slow fetal growth and fetal malnutrition

1.40

0.45

2.4

1.3

5.73

6.06

g/l

—

Obstructed labour due to malposition and malpresentation of fetus

113

1148

0.91

0.43

1.4

7.15

6.48

g/l

1.05

847

Tarsal tunnel syndrome

1.62

0.43

1.0

1.3

8.20

6.72

g/l

—

Presbyopia

405

1.16

0.43

1.4

6.36

6.59

g/l

0.19

289

Chronic periodontitis, complicated

331

3062

1.05

0.41

1.4

6.55

6.78

g/l

0.59

246

2189

Seminoma of testis, including Hilmo

1.52

0.41

1.0

1.2

8.97

6.96

g/l

—

Other and unspecified vascular occlusions

295

1.19

0.41

1.3

6.14

6.95

g/l

0.82

224

Malignant neoplasm of hypopharynx

0.00

0.41

0.0

1.1

—

7.24

—

Retained placenta and membranes, without haemorrhage

586

1.13

0.40

1.3

1.4

6.06

6.47

g/l

0.59

417

Other viral hepatitis, including avohilmo

305

1.18

0.40

1.1

1.3

7.09

6.69

g/l

0.30

216

Other specified disorders of external ear

132

1.29

0.40

1.6

1.3

5.59

7.30

g/l

1.41

Other and unspecified injuries of head

296

1.18

0.40

1.2

1.3

6.13

6.57

g/l

0.44

215

Other blood glucose lowering drugs, excl. Insulins

634

1.12

0.40

1.3

1.4

6.39

6.92

g/l

0.73

448

Calculus of lower urinary tract

168

1.25

0.40

1.8

1.2

4.79

6.93

g/l

2.27

124

Malignant neoplasm of rectum, including Hilmo

465

0.86

0.40

1.4

6.02

6.88

g/l

0.91

336

Inflammatory disease of cervix uteri

241

1.21

0.40

1.1

1.3

7.26

6.79

g/l

0.14

176

Pre-eclampsia or poor fetal growth

176

1635

1.07

0.39

1.4

6.76

6.55

g/l

0.37

127

1201

Other disorders of iris and ciliary body

1.34

0.39

1.2

1.3

7.03

7.45

g/l

—

Abnormal spermatozoa

494

1.14

0.38

1.3

1.4

6.42

7.05

g/l

0.67

362

All dysplastic lesions of the cervix uteri

152

1390

1.08

0.38

1.4

7.03

6.57

g/l

0.70

109

1023

Benign leiomyoma with endometriosis

674

1.11

0.38

1.3

1.5

6.30

6.63

g/l

0.48

476

Other mental disorders due to brain damage and dysfunction and to physical disease

419

1.15

0.38

1.4

6.76

6.66

g/l

0.05

306

Frostbite

1.36

0.37

1.4

5.92

6.70

g/l

—

Contact with sharp glass

161

1.25

0.37

1.2

1.3

6.22

6.55

g/l

0.17

117

HSIL lesion of the cervix uteri

1008

0.91

0.37

1.4

6.78

6.55

g/l

0.20

736

Cervical polyps

402

1.15

0.37

1.4

5.61

6.71

g/l

2.36

292

Convergent concomitant strabismus

281

1.18

0.36

1.5

1.4

6.91

6.57

g/l

0.20

209

Acute and transient psychotic disorders

576

0.88

0.35

1.2

1.4

6.54

6.77

g/l

0.20

406

Malignant neoplasm of ovary

179

0.78

0.35

1.3

1.5

5.07

6.74

g/l

—

131

Manic episode

1.32

0.35

1.3

6.14

6.79

g/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

363

0.85

0.35

1.5

1.4

6.00

6.97

g/l

0.88

265

Follow-up examination after treatment for malignant neoplasms

282

1.17

0.35

1.2

5.55

6.90

g/l

2.11

169

Retinal detachment with retinal break

527

1.12

0.35

1.5

1.4

6.88

6.79

g/l

0.07

384

Malignant neoplasm of urinary organs

348

1.15

0.34

1.1

1.4

7.10

6.92

g/l

0.11

254

Congenital malformations of aortic and mitral valves

181

1.22

0.34

1.4

1.3

7.18

6.50

g/l

0.22

130

Toxic effect of contact with venomous animals

181

1.22

0.34

1.2

1.3

6.34

6.84

g/l

0.38

134

Car occupant injured in noncollision transport accident

136

1.25

0.33

1.3

6.67

6.80

g/l

0.06

Malignant neoplasm of corpus uteri, including Hilmo

321

1.15

0.33

1.2

1.5

7.12

6.75

g/l

0.22

226

Malignant neoplasm of testis

1.28

0.32

1.2

1.3

7.80

6.65

g/l

—

Other osteochondropathies

313

1.15

0.32

1.5

1.3

6.81

6.58

g/l

0.14

221

Type 1 diabetes, strict definition, subgroup 1

378

1.14

0.32

1.2

1.3

6.13

6.52

g/l

0.34

289

Malignant neoplasm of testis, including Hilmo

1.32

0.31

1.1

1.3

7.92

6.86

g/l

—

Postpartum haemorrhage due to retained placenta

642

0.90

0.30

1.2

1.4

6.68

6.54

g/l

0.18

461

Donors of organs and tissues

1.30

0.30

1.0

1.3

11.80

6.30

g/l

—

Open wound of thorax

1.30

0.30

2.0

1.2

8.93

6.80

g/l

—

Carcinoma in situ of cervix uteri

505

0.89

0.30

1.4

1.5

7.34

6.33

g/l

0.63

367

Leiomyoma of uterus

368

1985

1.04

0.29

1.5

1.4

6.24

6.74

g/l

2.09

261

1469

Inguinal or femoral hernia, bilateral

411

1.12

0.29

1.2

1.4

7.30

6.70

g/l

0.55

301

Embolic stroke

130

1.23

0.28

1.3

1.2

6.08

7.25

g/l

0.80

Other disorders of amniotic fluid and membranes

717

0.91

0.28

1.8

1.4

7.10

6.42

g/l

0.73

533

Other and unspecified nonorganic psychotic disorders

1033

0.93

0.28

1.2

1.4

6.59

6.60

g/l

0.01

717

Supervision of normal pregnancy

112

685

0.93

0.28

1.2

1.4

6.53

6.44

g/l

0.15

513

Kela-code for severe mental illness

187

1968

0.95

0.28

1.2

1.4

6.43

6.73

g/l

0.52

131

1395

Malignant neoplasm of rectum

365

0.88

0.28

1.5

1.4

5.90

6.91

g/l

0.88

265

Gestational diabetes (for exclusion)

206

1487

0.95

0.27

1.2

1.4

6.38

6.61

g/l

0.52

153

1110

Diabetes mellitus in pregnancy

193

1165

1.05

0.27

1.2

1.4

6.30

6.62

g/l

0.81

143

875

Nontraumatic intracranial haemmorrhage

787

1.08

0.27

1.3

1.4

7.40

6.74

g/l

1.04

561

Postpartum hemorraghe, parous women as controls

143

1128

1.06

0.27

1.3

6.91

6.55

g/l

0.79

108

816

Septal defects

321

1.13

0.27

1.2

1.4

7.66

6.33

g/l

0.85

262

Carcinoma in situ of colon

1.27

0.26

1.3

6.24

7.14

g/l

—

Postpartum care and examination

458

0.92

0.26

1.3

1.4

6.50

6.37

g/l

0.14

339

Pervasive developmental disorders excl. Autism + Asperger

1.30

0.26

1.0

1.2

5.40

6.16

g/l

—

Parkinson's disease, excluding more controls

411

0.89

0.26

1.7

1.5

6.97

7.27

g/l

0.18

289

Pedal cyclist injured in transport accident

110

1172

0.94

0.26

1.5

1.3

6.48

6.69

g/l

0.30

844

Malignant neoplasm of ovary, including Hilmo

235

0.85

0.25

1.2

1.5

5.42

6.68

g/l

1.63

168

Burns and corrosions of external body surface, specified by site

549

1.09

0.25

1.5

1.3

6.09

6.52

g/l

0.55

399

Other obstructed labour

349

1.12

0.25

1.2

1.4

6.04

6.61

g/l

0.81

251

Malignant melanoma

627

1.09

0.25

1.3

1.4

7.05

6.78

g/l

0.14

459

Wide developmental disorders

197

1.16

0.25

1.4

5.14

6.04

g/l

1.19

157

Malignant melanoma, including Hilmo

714

1.08

0.25

1.3

1.4

7.02

6.82

g/l

0.12

517

Dislocation, sprain and strain of joints and ligaments of elbow

302

1.13

0.24

1.8

1.4

6.77

6.43

g/l

0.32

225

Other sexually transmitted chlamydial diseases

302

1.13

0.24

1.3

1.4

6.50

6.62

g/l

0.08

205

Other assisted single delivery

0.72

0.24

1.2

1.5

5.49

6.16

g/l

—

Schizophrenia or delusion, excluding more controls

149

1397

1.05

0.24

1.1

1.4

6.69

6.86

g/l

0.22

987

HSIL lesion of the cervix uteri, vagina or vulva

103

1096

0.94

0.24

1.4

6.80

6.59

g/l

0.19

797

Use of galantamine

201

0.85

0.23

1.3

6.98

7.06

g/l

0.05

148

Inguinal hernia, bilateral

408

1.10

0.23

1.2

1.4

7.23

6.69

g/l

0.46

300

Parkinson's disease, strict definition, excluding more controls

374

0.90

0.23

1.8

1.5

7.03

7.31

g/l

0.17

259

Otosclerosis

294

1.12

0.23

1.1

1.5

8.32

6.85

g/l

1.57

215

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

1.29

0.23

1.8

1.2

6.74

6.47

g/l

—

Unspecified lump in breast

727

1.07

0.23

1.6

1.4

6.01

6.60

g/l

1.17

514

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

640

1.08

0.23

1.2

1.4

6.33

6.79

g/l

0.57

465

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1009

0.94

0.22

1.3

1.4

7.48

6.83

g/l

0.47

732

Dementia in other diseases classified elsewhere

153

1.18

0.22

1.2

7.28

7.19

g/l

—

114

Maternal care related to the fetus and amniotic cavity and possible delivery problems

265

1497

1.04

0.22

1.4

6.55

6.56

g/l

0.02

204

1120

Ependymoma

0.00

0.21

0.0

1.2

—

6.78

—

1.19

0.21

1.4

1.1

5.36

6.20

g/l

—

Mental and behavioural disorders of puerperium, not classified elsewhere

1.19

0.21

1.8

1.2

6.74

5.99

g/l

—

Chondrosarcoma

0.00

0.21

0.0

1.2

—

5.87

—

Family history of certain disabilities and chronic diseases leading to disablement

220

0.86

0.21

1.2

1.4

6.68

6.31

g/l

0.43

162

Syndactyly, including avohilmo

0.00

0.21

0.0

1.2

—

5.85

—

Antenatal screening

120

708

0.95

0.21

1.2

1.4

6.59

6.46

g/l

0.23

527

Sequelae of transport accidents

0.00

0.20

0.0

1.4

—

5.59

—

Colorectal adenocarcinoma

769

0.94

0.20

1.7

1.4

6.56

6.91

g/l

0.38

553

Maternal care for cervical incompetence

144

0.83

0.20

1.3

1.4

6.53

6.54

g/l

—

111

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.18

0.19

1.0

1.4

5.88

6.50

g/l

—

Contact with other sharp object(s)

333

0.90

0.19

1.2

1.3

5.84

6.39

g/l

0.61

239

Other disorders of penis

443

1.08

0.18

1.7

1.4

6.43

6.91

g/l

0.56

320

Chronic viral hepatitis

227

0.88

0.18

1.1

1.3

7.55

6.59

g/l

0.43

158

Spermatocele

281

1.10

0.17

1.5

1.4

6.09

7.05

g/l

1.08

195

Injury of nerves at wrist and hand level

138

1.16

0.17

1.3

6.37

6.70

g/l

—

Serous carcinoma of ovary, including Hilmo

110

1.18

0.17

1.2

1.6

5.42

6.97

g/l

—

Non-small cell lung cancer, squamous

110

1.18

0.17

1.4

1.2

6.82

7.42

g/l

—

Colorectal cancer

938

0.95

0.17

1.6

1.5

6.89

6.84

g/l

0.05

674

Antepartum haemorrhage, not elsewhere classified

454

0.92

0.16

1.4

6.92

6.37

g/l

0.27

341

Pregnancy examination and test

529

1.05

0.16

1.7

1.4

6.15

6.42

g/l

0.54

398

Crowding of teeth, including avohilmo

418

1.07

0.16

1.2

1.4

6.28

g/l

0.00

317

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.16

0.15

1.1

1.2

6.59

7.36

g/l

—

487

1.07

0.15

1.2

1.4

6.30

6.42

g/l

0.17

348

Complications of labour and delivery

363

1971

1.02

0.15

1.4

6.53

6.59

g/l

0.13

265

1440

Traumatic amputation of wrist and hand

150

1.13

0.14

1.5

1.3

6.05

6.67

g/l

0.34

103

Colorectal cancer, including Hilmo

106

1028

0.96

0.14

1.5

6.85

6.89

g/l

0.03

749

Macular hole

189

1.11

0.13

1.3

1.5

5.98

7.21

g/l

1.19

143

Other and/or unspecified nontoxic goitre

315

0.92

0.13

3.1

1.3

6.00

6.78

g/l

1.04

224

Failed induction of labour

296

1.08

0.13

1.5

1.4

6.04

6.31

g/l

0.25

220

Colon adenocarcinoma, helper endpoint

458

0.94

0.13

1.9

1.3

6.84

6.78

g/l

0.03

332

Unspecified mental disorder

229

2234

1.02

0.12

1.2

1.4

6.43

6.76

g/l

0.74

163

1595

Carcinoma in situ of other and unspecified digestive organs

152

1.12

0.12

1.2

1.3

7.45

7.20

g/l

0.09

108

Use of levodopa decarboxylase inhibitor

477

0.94

0.12

2.0

1.3

6.88

7.00

g/l

0.07

343

Postpartum haemorrhage due to anatomy

517

0.95

0.11

1.3

7.32

6.45

g/l

1.01

371

severe traumatic brain injury, does not include concussion

936

1.04

0.11

1.4

7.25

6.92

g/l

0.30

670

Malignant neoplasm of corpus uteri

279

1.08

0.11

1.1

1.5

7.34

6.74

g/l

0.34

201

Vascular dementia (subcortical)

1.16

0.11

1.4

1.2

6.01

7.87

g/l

—

Burns and corrosions

721

1.04

0.10

1.4

1.3

6.29

6.53

g/l

0.29

514

malignant neoplasm of female genital organs

623

0.96

0.10

1.2

1.5

6.40

6.76

g/l

0.33

448

Prominent ears

1.14

0.10

1.4

1.2

7.11

6.54

g/l

—

Mental and behavioural disorders associated with the puerperium

1.06

0.09

1.8

1.4

6.74

5.83

g/l

—

Malignant neoplasm of rectosigmoid junction

1.06

0.09

1.2

1.3

7.09

7.41

g/l

—

Other congenital malformations of male genital organs, including avohilmo

1.04

0.09

1.0

1.5

6.44

5.69

g/l

—

Bicuspidal aortic valve syndrome

145

1.10

0.09

1.4

1.3

7.67

6.45

g/l

—

105

Benign neoplasm of breast

523

0.96

0.09

1.4

6.06

6.70

g/l

0.77

373

Pre-eclampsia

107

1040

1.03

0.09

1.6

1.4

6.49

6.59

g/l

0.12

751

Deep bite that required surgery

1.07

0.08

1.5

1.3

5.52

6.25

g/l

—

Liveborn infants according to place of birth

1.03

0.08

1.0

1.2

5.89

5.69

g/l

—

Thyrotoxicosis with toxic multinodular goitre

216

0.93

0.08

2.0

1.5

5.42

7.05

g/l

1.30

157

Type1 diabetes, definitions combined, early onset

350

1.05

0.08

1.2

1.3

6.41

6.42

g/l

0.01

259

Maternal care for known or suspected abnormality of pelvic organs

141

930

1.02

0.08

1.3

1.4

6.43

6.54

g/l

0.15

695

Multiple delivery

419

0.95

0.08

1.5

1.4

6.12

6.55

g/l

0.59

337

Other complications of labour and delivery, not elsewhere classified

565

1.04

0.07

1.2

1.4

6.68

6.38

g/l

0.40

420

Polyhydramnios

215

1.07

0.07

1.4

6.72

6.10

g/l

0.57

156

LeFortI or BSSO operation

176

1.08

0.07

1.3

1.4

5.45

6.43

g/l

1.19

127

Placenta praevia

225

1.07

0.07

1.4

6.45

6.24

g/l

0.09

164

Hypertrichosis

0.86

0.06

1.3

1.4

4.96

6.13

g/l

—

Other disorders of prostate

0.86

0.06

2.0

1.2

5.92

7.40

g/l

—

Abnormal findings on antenatal screening of mother

427

0.96

0.06

1.5

5.34

6.57

g/l

2.47

325

Pedal cyclist injured in other and unspecified transport accidents

542

1.03

0.06

1.4

6.37

6.63

g/l

0.33

392

Noise effects on inner ear

158

1.08

0.06

1.2

1.3

6.82

6.85

g/l

0.01

109

Use of rivastigmine

465

0.96

0.06

1.4

1.3

6.96

7.00

g/l

0.02

335

Abnormalities of forces of labour

537

0.97

0.06

1.2

1.4

6.19

6.48

g/l

0.33

389

Labour and delivery complicated by fetal stress [distress]

137

875

1.02

0.05

1.3

1.4

6.68

6.33

g/l

0.73

103

649

Multiple gestation

464

1.03

0.05

1.5

1.4

6.53

6.39

g/l

0.20

340

Malignant neoplasm of colon

563

1.03

0.05

1.7

1.4

7.34

6.88

g/l

0.44

405

Supervision of high-risk pregnancy

114

672

1.02

0.05

1.5

1.4

6.37

6.46

g/l

0.14

501

Twin gestation

445

1.03

0.05

1.5

1.4

6.48

6.32

g/l

0.22

324

Fall on and from ladder

297

1.04

0.05

1.4

1.2

7.55

6.82

g/l

0.40

221

Single delivery by caesarean section

113

633

1.02

0.05

1.4

1.5

6.51

6.52

g/l

0.02

501

Acute appendicitis, with complications

908

0.98

0.05

1.4

6.23

6.76

g/l

0.85

664

Pre-eclampsia or eclampsia

114

1121

1.02

0.04

1.5

1.4

6.52

6.63

g/l

0.16

811

Deep bite

557

1.02

0.04

1.3

1.4

6.12

6.52

g/l

0.60

422

Postpartum hemorraghe, all women as controls

143

1376

1.01

0.04

1.3

1.4

6.91

6.57

g/l

0.73

108

1012

Hydrocephalus

239

1.05

0.04

2.1

1.3

6.03

6.88

g/l

0.55

187

Alcohol withdrawal state with delirium

281

0.96

0.04

1.1

1.3

5.90

6.95

g/l

1.25

206

Poor fetal growth

676

1.02

0.04

1.3

1.4

7.37

6.39

g/l

1.33

505

Pedal cyclist injured in collision with motor vehicle

122

1.07

0.02

2.1

1.3

6.32

6.71

g/l

—

Gonococcal infection, including avohilmo

132

1.06

0.02

1.4

1.6

6.39

6.88

g/l

—

Family history of malignant neoplasm

540

1.02

0.02

1.2

1.4

7.09

6.60

g/l

0.25

397

malignant neoplasm of female genital organs, including Hilmo

715

0.99

0.02

1.2

1.4

6.61

6.69

g/l

0.07

513

Type 1 diabetes, strict definition

430

1.02

0.02

1.2

1.3

6.24

6.49

g/l

0.20

320

Myocardial infarction, unclassifiable

659

0.99

0.01

1.3

1.4

7.86

6.94

g/l

1.19

475

Vascular dementia

238

0.97

0.01

1.4

1.2

6.90

6.95

g/l

0.02

177

Memory loss

307

0.98

0.01

1.5

1.4

6.56

6.92

g/l

0.12

229

Subarachnoid haemorrhage

377

0.98

0.01

1.4

7.49

6.78

g/l

0.51

267

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

246

0.98

0.00

1.5

1.4

6.65

6.64

g/l

0.00

179

Non-small cell lung cancer, squamous, helper endpoint

131

0.99

0.00

1.4

1.2

6.82

7.25

g/l

—

102

Other obstetric trauma

269

1.00

0.00

1.1

1.4

6.63

6.09

g/l

0.58

197

Other sexually transmitted chlamydial diseases, including avohilmo

495

0.99

0.00

1.3

1.4

6.33

6.55

g/l

0.21

344

Postpartum haemorrhage

143

1176

1.00

0.00

1.3

1.4

6.91

6.50

g/l

0.93

108

870

Divergent concomitant strabismus

338

1.01

0.00

1.7

1.4

6.61

6.64

g/l

0.02

242

Malignant neoplasm of colon, including Hilmo

706

1.00

0.00

1.6

1.4

7.24

6.91

g/l

0.35

508

Benign neoplasm of other and unspecified female genital organs

153

0.98

0.00

1.7

1.6

6.73

6.63

g/l

—

118

Colon adenocarcinoma

427

1.01

0.00

1.9

1.4

6.84

6.93

g/l

0.06

307

Rubella [German measles], including avohilmo

145

0.97

0.00

2.8

1.4

5.74

6.55

g/l

—

103

Rubella [German measles]

145

0.97

0.00

2.8

1.4

5.74

6.55

g/l

—

103

Acne varioliformis

0.00

0.0

1.0

—

5.94

—

Microtia (small ears)

0.00

0.0

1.1

—

6.22

—

Birth injury to skeleton

0.00

0.0

1.4

—

6.97

—

Atrophy of thyroid (acquired)

0.00

-0.00

0.0

1.0

—

6.62

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

0.99

-0.00

1.1

1.2

8.42

6.76

g/l

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.0

—

5.93

—

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

-0.00

0.0

1.4

—

5.17

—

Carcinoma in situ of oral cavity

0.00

-0.00

0.0

1.6

—

6.24

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

-0.00

0.0

1.8

—

7.22

—

Hirsprung

0.00

-0.00

0.0

1.0

—

4.87

—

Renal cell carcinoma of kidney

0.91

-0.00

1.3

1.2

7.22

7.24

g/l

—

Staphylococcal scalded skin syndrome

0.00

-0.00

0.0

1.2

—

7.17

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.99

-0.00

1.1

1.2

8.42

6.76

g/l

—

Hirsutism in women

0.96

-0.00

1.3

1.4

4.96

6.22

g/l

—

Malignant neoplasm of other and unspecified urinary organs

0.00

-0.00

0.0

1.4

—

8.46

—

Congenital malposition of the kidney

0.00

-0.00

0.0

1.0

—

5.90

—

Cellulitis of external ear

1.02

-0.00

1.0

1.3

5.91

6.80

g/l

—

Malignant neoplasm of palate

0.00

-0.00

0.0

1.2

—

7.33

—

Accidental poisoning by and exposure to pesticides

0.00

-0.00

0.0

1.2

—

6.59

—

Other perinatal haematological disorders

0.00

-0.00

0.0

1.1

—

5.81

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG subclass 1 [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS